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General Introduction And Outline Of The Thesis
General Introduction And Outline Of The Thesis
Introduction 
Associations of intrauterine growth restriction and pregnancy outcomes.
Pregnancies complicated by intrauterine growth restriction (IUGR) and children 
born small-for-gestational-age (SGA) are known to have higher perinatal morbid-
ity and mortality, even at term.1 Perinatal morbidity includes meconium aspiration, 
asphyxia, hypothermia and hypoglycaemia.2  In addition, neuro-cognitive devel-
opment and intelligence quotient have been correlated to weight at birth, as well 
as cerebral palsy.3-6 On the long term in later life, low birth weight has been associ-
ated with cardiac ischemic disease in adults, and other chronic conditions such as 
diabetes and hypertension. Moreover, low birth weight is designated as one of the 
“big four” determinants in perinatal mortality in the Netherlands; 85% of perinatal 
deaths are associated with one of these “big four”: congenital abnormality, pre-
mature birth (<37 weeks gestation), low birth weight (<P10) and low Apgar score 
(<7).7;8
Impaired fetal growth has a complex ethiology, where genetics, placental insuffi-
ciency, maternal and fetal conditions and environmental factors interact. Low birth 
weight is correlated with socio-demographic risk factors (i.e. non-marital status 
and lower education levels), smoking, congenital malformations, intrauterine in-
fections and maternal diseases. Several of these factors can be modified to a cer-
tain degree, preferably before conception. It is known that cessation of smoking, 
even during pregnancy can positively influence birth weight.9-10-11-12 Preconcep-
tion programmes focus on BMI and smoking as they have major impact on IUGR 
and stillbirth.13 
Definitions and discrimination of IUGR and SGA
Differentiating between SGA and IUGR during pregnancy is very difficult. The focus 
first of all is on detecting small babies and once detected focus on fetal condition 
and growth potential. 
The terms intrauterine growth restriction (IUGR) and small-for-gestational-age 
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Chapter 1
(SGA) have been used interchangeably, creating confusion on the topic. Intrauter-
ine growth retardation implies that intrauterine growth has been inhibited and that 
the fetus has not attained its optimal growth potential (fetal growth restriction). 
IUGR is a clinical term, but the diagnosis is usually based in retrospect on small size 
for gestational age at birth. The American Society of Obstetricians and Gynaecolo-
gists defines fetal growth restriction as an estimated weight below the 10th per-
centile (P) for gestational age.14 SGA children have an actual birth weight below 
the 10th percentile and seem to represent both physiologically and constitution-
ally small children. Some say that in this group only 30% is growth restricted.15-17 
Roth et al. tried to differentiate between IUGR and SGA by calculating standard de-
viation scores (SDS) of AC and estimated fetal weight (EFW). Growth was expressed 
as change in SDS in time (Δ AC and Δ EFW). A Δ AC of -1.5 was the best predictor 
of growth restriction. IUGR was defined as Δ AC between first and last ultrasound 
greater than -1.5 (SDS) and SGA when Δ AC was less than -1.5 SDS. Despite in-
creased fetal surveillance, nearly one-third of the term IUGR as well as SGA fetuses 
had suffered some, albeit minor, neurological impairment (e.g. passive tone, cor-
tical thumbs, and hypotonia) at birth compared to a control group with normal 
growth. They concluded that the pattern of growth in the third trimester does not 
affect outcome at 1 year, therefore their differentiation between IUGR and SGA was 
not found helpful on the long term.18
Another possibility to classify fetal growth has been to relate abdominal circum-
ference with head circumference.19 If these measurements are symmetrical fetal 
growth is considered to be normal. Dashe et al. compared asymmetrically and sym-
metrically SGA infants to appropriate for gestational age (AGA) matched babies 
and found that symmetric SGA infants were not at increased risk of morbidity com-
pared with AGA infants. A neonatal outcome composite, including one or more of 
respiratory distress, intraventricular haemorrhage, sepsis, or neonatal death, was 
more frequent among asymmetric SGA than AGA infants. Symmetric SGA infants 
were not at increased risk of morbidity compared with AGA infants. 
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Thus screening for asymmetric SGA seems helpful to detect children at risk for ad-
verse outcome.20
The 10th percentile of birth weight for gestational age is associated with an in-
creased but variable risk of neonatal death.21 Regardless of placental function, EFW 
by ultrasound below the 3rd percentile discriminates SGA fetuses with higher risk 
of adverse perinatal outcome from SGA children with outcomes similar to normally 
grown fetuses, defined as a birth weight greater than the 10th percentile.22-23 
At 26 weeks of gestation, infants at the 10th percentile experience a 3-fold risk of 
dying within the first 28 days of life (relative to a group with a 45th to 55th percen-
tile group); whereas at 40 weeks, the risk is 1.13.23 Smaller babies in general have 
worse outcomes as is illustrated by Seeds;  already below the 15th percentile the 
risk of fetal death is two-fold.24
In a prospective 26 years follow-up study of 14189 children, of whom 1064 were 
born small-for-gestational-age (<5th percentile), adults born SGA had significant 
differences in academic achievement and professional attainment compared with 
adults who were appropriate for gestational age (AGA). There were no long-term 
social or emotional consequences of being SGA: these adults were as likely to be 
employed, married, and satisfied with life.25
To dwell on the numerous different calculations for EFW based on ultrasound mea-
surements lies beyond the scope of this thesis, but again emphasises the complexi-
ties that have to be handled in IUGR. 26-28
In summary, many suggestions have been done to distinguish genuine IUGR from 
SGA. Considering that IUGR and SGA are not synonym there is an obvious strong 
correlation between the two entities. To realise a clear differentiation between 
these entities seems to be one of the main goals of prenatal care. Nevertheless, 
all children that are suspected to be too small before birth potentially have an in-
creased risk for adverse outcome. At present, they need more attention regardless 
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of the definition used. We can only prospectively improve perinatal outcomes with 
increased surveillance and possible treatments.
Screening
Accuracy and importance of screening for SGA  and IUGR
Throughout the intrauterine period we are challenged to determine the fetal con-
dition. Of major importance in this challenge is the estimation of the fetal weight. 
Unfortunately we have discovered repeatedly that we are performing very meagre 
in predicting the exact neonatal weight at birth. 
Most studies report sensitivities as low as 25% to 32% to detect SGA.29-31 In an 
urban teaching hospital in Wisconsin they failed to detect 90% of children with a 
birth weight below 10th percentile.32 
While some have illustrated that detection of a small fetus mainly increases ob-
stetrical interventions without improving neonatal outcome30;31;33, others affirm 
the importance of antenatal detection of SGA fetus to improve their outcome. 34;35 
Frøen et al. found that many stillborn babies were small-for-gestational-age. They 
concluded that it was unlikely to be a constitutional smallness, but represented 
a preponderance of intrauterine growth restriction.36 They calculated individu-
alised growth standards in stillbirths that were classified unexplained. With these 
individually adjusted fetal weight standards, 51% of unexplained stillbirths were 
too small. They plead that many ante partum stillbirths, currently designated as 
unexplained, may be avoidable if slow fetal growth could be recognised as a warn-
ing sign. In a recent Dutch study term stillbirths were prospectively collected and 
audited by an expert panel. During a 2 year study period within a specific region, 
37735 normally formed infants were delivered ≥ 37 weeks of gestation. There were 
60 stillbirths (1.59 per 1,000, 95%CI 1.19-1.99). Most of these stillbirths occurred 
during apparently uncomplicated pregnancies. Twenty-one infants (35%) were 
small-for-gestational age but growth restriction was only suspected in 10 (47.6%) 
of these cases.37
Chapter 1
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Improvement of screening and surveillance of IUGR.
Once detected clinicians are challenged to distinguish intrauterine growth restric-
tion from “just” constitutionally small children.
A history of IUGR is associated with recurrence of IUGR and a higher incidence of 
stillbirth in a subsequent pregnancy. Therefore medical history can help to screen 
for IUGR.38;39
Whereas evidence for the use of serial funding height measurement (SFH) alone, as 
a screening tool was indecisive40, plotting SFH measurement on customised charts 
is also found to be a useful screening tool in detection of IUGR.41 This tool gives 
a significantly higher antenatal detection rate of small for gestational age babies 
compared to routine antenatal care (48% v 29%, odds ratio 2.2, 95% confidence 
interval 1.1 to 4.5). It gave a slight decrease in repeat (two or more) third trimes-
ter scans (OR 0.8, CI 0.6-1.0, P = 0.08) and fewer admissions to the antenatal ward 
(OR 0.6, CI 0.4-0.7, P < 0.001).  However, there were no differences in perinatal out-
come.
Customised standards for fetal growth and birth weight improve the detection of 
IUGR by better distinction between physiological and pathological smallness and 
have led to internationally applicable norms. 42-44 Individualising fetal growth po-
tential is the basis of these customised standards. 
These standards are calculated by adjusting for fetal sex and maternal character-
istics as weight, parity and ethnic origin. The fetal growth potential is predicted 
after exclusion of smoking, hypertension, diabetes and previous preterm delivery. 
Finally, the optimal weight is projected backwards for all gestational points, using 
an ultrasound growth based proportionality curve. Computer software calculate 
the individually adjusted curves.45 
Development of these customised growth curves has been propagated widely. 
General Introduction And Outline Of The Thesis
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Some studies challenge this method and found that the process of customising 
population weight-for-gestational-age standards to account for maternal char-
acteristics does little to improve prediction of perinatal mortality.46-47 In a Dutch 
study comparing conventional growth curves and the customised Gardosi curves 
the P50 and P10 showed great overlap between 34 and 38 weeks gestation and 
therefore customised growth curves would be of no additional help in the predic-
tion of perinatal morbidity at term.48 In the Netherlands these customised curves 
are not applied in standard obstetrical management.
Another feature in IUGR screening and surveillance is measurement of amniotic 
fluid volume. Although the amniotic fluid index (AFI) is one of the first variables 
to decrease49, more than 90% of patients with IUGR or SGA have an AFI above 
5.0 cm.50 Oligohydramnios with IUGR seems to be a poor predictor of peripartum 
complications.51 Studies aiming to improve the estimation of AFI by comparing 
AFI, largest amniotic fluid pocket dimension or a more subjective approach did not 
show much improvement in the use of this variable for the prediction of perinatal 
morbidity.52-53 Decreased fetal movements are associated with IUGR and stillbirth, 
however there is insufficient and contradicting evidence for the use of this param-
eter on pregnancy outcomes.54-56
Significant reductions of perinatal mortality and adverse outcomes can be realised 
by using Doppler of the umbilical artery (UA), however only in high-risk pregnan-
cies (e.g. where IUGR was suspected, maternal hypertension, previous pregnancy 
loss).57 Doppler flow measurement has become the cornerstone in screening for 
IUGR and assessment of placental function in IUGR.58 Abnormal Doppler patterns 
in IUGR are characterised by absent or reversed end-diastolic velocities in the um-
bilical artery (UA) and have been found important predictors for perinatal morbid-
ity and mortality in severe early onset IUGR (<32-34 weeks gestation) and can be 
present weeks before acute deterioration. It is concluded that delivery should be 
considered if ductus venosus Doppler or short-term variation becomes persistently 
abnormal.49 Other longitudinal studies also on deteriorating of early-onset IUGR 
described that the pulsatility index (PI) in the middle cerebral artery (MCA) pro-
Chapter 1
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gressively becomes abnormal. In the time sequence of changes in fetal monitoring 
variables in early-onset IUGR amniotic fluid index and umbilical artery pulsatility 
index were the first variables to become abnormal, followed by the MCA, aorta, 
short-term variation, ductus venosus and inferior vena cava. 59-61 The concept of 
fetal brain-sparing illustrated by changes in cerebral artery Doppler has been stud-
ied by Scherjon et al. They linked increased umbilical-cerebral Doppler ratio (UCR) 
to abnormal cognitive function in early onset IUGR. At 5 years of age, children with 
brain-sparing had a 9 point lower IQ compared to children with normal UCR.62
In term IUGR umbilical artery (UA) Doppler recordings seem to be differently relat-
ed to pathofysiology, and absent or reversed end-diastolic velocities are less prom-
inent. In a cohort of 282 early term SGA children 2-year cognitive development 
was related to a number of significant perinatal factors, including the UA Doppler. 
However, in 15% of these SGA babies a suboptimal neurodevelopment was found 
albeit normal UA Doppler indices.63
Observational studies show that in term growth restriction decreased MCA-PI 
could be a proxy for adverse neonatal outcome, independently of UA-PI.64 Eixarch 
compared children with IUGR beyond 37 weeks gestation to AGA children by the 
Ages and Stages Questionnaire (ASQ) at two years of age. Brain-sparing (decreased 
MCA-PI) was associated with a higher rate of acidosis at birth. Children with brain-
sparing scored lower in communication, problem-solving and personal-social ar-
eas, whereas children with normal MCA-PI did not differ from AGA children.65 Pres-
ence of redistribution by detection of abnormal cerebral blood flows in the middle 
cerebral artery has recently been found to identify small fetus at term with normal 
umbilical artery Doppler waveforms with an increased risk of fetal distress and 
delivery by caesarean section.66 Without these flow abnormalities the occurrence 
of fetal distress seems to be minimal; only 4% fetal distress requiring a caesarean 
section.67 There are no randomised trials for timing of delivery in term growth re-
stricted babies with the use of MCA Doppler. 
General Introduction And Outline Of The Thesis
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Management
Determining the optimal management strategy for delivery in IUGR
The next important and crucial question is, assuming we have detected a pregnan-
cy complicated by IUGR as accurately as possible, what would be the appropriate 
management strategy to improve neonatal and obstetrical outcomes. 
From very early in gestation, the fetus appears to be sensitive to the nutrient status. 
One of the most immediate responses to a decrease in substrate delivery is a reduc-
tion in fetal growth, which appears to be the most important factor in balancing 
reduced oxygen delivery and consumption. Placental insufficiency can result in re-
duction of nutrient supply (e.g. oxygen, glucose, amino acids and fatty acids). Cor-
docentesis studies in humans have shown that small-for-gestational-age fetuses 
are relatively hypercapnic, hypoxic, hyperlacticaemic, acidotic and hypoglycaemic 
compared with appropriate-for-gestational-age fetuses.68
The fetus responds with hemodynamic and metabolic compensations, favouring 
organs such as the heart, adrenals and brain (brain-sparing). Although short-term 
survival may be guaranteed by these adaptations, there may be a long-term cost 
(e.g. cognitive dysfunction, chronic lung disease and necrotizing enterocolitis).69 
In animal models, growth restriction can also lead to functional deficits and affect 
behaviour and brain composition, with more prolonged periods of hypoxia being 
associated with a worse outcome.70-71 As a result of chronic oxygen and nutrient 
deprivation in sheep reduced myelination of subcortical white matter, a reduction 
in the number of Purkinje neurons in the cerebellum and severe cortical astrocyto-
sis have been described, as well as damage to the hippocampus.72 
In these situations if the fetus is clearly deteriorating and suggested to be severely 
hypoxic or acidaemic showed by CTG changes the clinicians will end the pregnan-
cy and start delivery. In all other situations the management options are expectant 
management or induction of labour.
Continuing pregnancy in an undernourished environment will likely result in im-
pairment of fetal growth and this will impose detrimental effects on fetal devel-
Chapter 1
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opment or even result in intrauterine death. These arguments would plead for 
induction of labour to pre-empt possible stillbirth and neonatal morbidity and 
mortality. 
On the other hand the fetus could fare better by further growing and maturing 
even in a possible undernourished environment. In addition induced prematurity 
by induction of labour, even beyond 36 weeks gestation might cause perinatal 
morbidity due to (iatrogenic) prematurity, an additional argument for expectant 
management.73-77 Therefore postponing delivery with an expectant management 
policy could be the appropriate strategy to improve neonatal outcome. 
Another possible rationale to postpone delivery is to await spontaneous onset of 
labour and prevent an increase in the rate of instrumental deliveries and caesarean 
sections associated with induction of labour .78-79 Though many recent interven-
tion studies for other indications actually show a reduction of artificial deliveries in 
induced delivery groups.80-82 
Most evidence on timing of delivery and management policies in IUGR is from ret-
rospective studies looking at cohorts of children born with a birth weight below 
the 10th percentile or from pregnancies at lower gestational ages.83-86 Prospec-
tive studies how to ensure safe fetal monitoring in pregnancy where delivery is de-
ferred, have actually not  been performed in the term period; these studies are ur-
gently needed to be able to evaluate effects of currently used and newer scheme’s 
for fetal surveillance regimens in e.g. impaired fetal growth.87
McCowan et al. compared two regimens of fetal surveillance for small-for-gesta-
tional-age fetuses with normal results of umbilical artery Doppler velocimetry. 
In this study fetuses with normal results of umbilical artery Doppler velocimetric 
studies had low rates of neonatal morbidity regardless of whether antenatal sur-
veillance was undertaken at planned fortnightly or planned twice-weekly intervals. 
Intervention (induction of labour) was less common in the fortnightly surveillance 
group. This study was performed in the preterm period and the study did not have 
General Introduction And Outline Of The Thesis
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the power to detect clinically important differences in neonatal outcomes or in 
caesarean delivery rates.88 
Results of the Trial of Umbilical and Fetal Flow in Europe (TRUFFLE) study have not 
been published yet.89 The hypothesis of this study is that among preterm growth-
restricted infants, timing delivery based on the fetal ductus venosus increases 
the rate of normal infant neurological outcome compared with timing of delivery 
based on severe changes in fetal heart short-term variation. The TRUFFLE study did 
not include term gestations.
The Growth Restriction Intervention Trial (GRIT) study approached questions about 
timing of delivery of the growth restricted fetus also in the preterm period (< 34 
weeks gestation).90 They compared the effect of early delivery to pre-empt terminal 
hypoxaemia with delaying for as long as possible to increase maturity. They found 
with expectant management a gestational age increase of on average 4 days. To-
tal deaths (ante partum and neonatal death combined) prior to discharge were 
comparable between the immediate delivery group and the delay group. Delaying 
delivery caused some stillbirths, but immediate delivery resulted in an almost ex-
actly equal number of perinatal deaths. However, the rate of caesarean section was 
three times higher in the immediate delivery group. The GRIT found little difference 
neither in overall mortality nor in 2, 6 and 13-year outcomes of children.91-92 Early 
intervention does not seem to improve short-, nor long term outcomes.
Aim of the thesis - DIGITAT study
Until recently there was no consensus on the appropriate policy in IUGR in the term 
period. A digital questionnaire sent to Dutch gynaecologists and residents showed 
wide divergence in assumptions about IUGR at term, and reflects the equipoise in 
management of IUGR in the Netherlands.93 (Figures 1-3). 
To establish consensus and to collect evidence on the best management policy in 
IUGR at term, the DIGITAT-trial (Disproportionate Intrauterine Growth Intervention 
Trial At Term) was designed. Initially a small randomised pilot study was performed 
Chapter 1
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to compare induction of labour with an expectant monitoring management in 
suspected IUGR at term in 33 women. It showed feasibility to accomplish a larger 
multi-centre trial with sufficient power.94 Embedded in the structure of the Dutch 
Obstetrical Consortium 95 more than 50 hospitals, academic and non-academic, 
agreed to participate in this multi-centre randomised controlled trial to enrol 650 
pregnant women suspected of IUGR. The aim of the DIGITAT study was to com-
pare the effect of induction of labour with an expectant management monitoring 
mother and child for suspected intrauterine growth restriction at term in singleton 
pregnancies in cephalic presentation beyond 36 weeks gestation on neonatal and 
obstetrical outcomes.96 The results of the DIGITAT study including the randomised 
trial form the basis of this thesis and will be described and discussed.
General Introduction And Outline Of The Thesis
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Figure 2
The estimated effect of induction of labour on neonatal morbidity. Data from an inquire under Dutch 
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Figure 3
The assumed effect of induction of labour on the rate of caesarean section. Data from an inquire under 
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Outline of the thesis
Chapter 2 describes the influence of induction of labour on neonatal outcomes 
immediately after birth and mode of delivery in a retrospective cohort of children 
born with a birth weight below the 10th percentile. These data were derived from 
a national dataset (LVR-2).
Chapter 3 outlines the trial protocol and the aims of the DIGITAT study. 
It reflects on existing information on intrauterine growth restriction and 
describes the primary and secondary analyses that were carried out. 
Chapter 4 contains the primary outcomes of the trial, adverse neonatal outcomes 
and route of delivery after induction or expectant management in at term IUGR. 
Maternal outcomes are also compared between the two strategies.
Chapter 5 displays a secondary analysis that approached neonatal outcomes 
in more detail. For this analysis we assessed the (morbidity assessment index in 
newborns) MAIN-score. 
Chapter 6 handles about results of non-participants, but who consented to 
the use of their medical data. To examine external validity of the trial we com-
pared their data that were collected in the same prospective way, to data of 
trial-participants. 
Chapter 7 contains the maternal health-related quality of life (HR-QoL) after 
induction or expectant management in IUGR at term. 
Chapter 8 describes the economic analysis and cost-effectiveness of both 
induction and expectant monitoring that was performed alongside the trial.
Chapter 9 presents long-term follow up of children who were delivered during 
Chapter 1
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the trial. The effects on (neuro)developmental and behavioural outcome at 
2 years of age of induced labour compared with expectant management in 
intrauterine growth restricted infants are described.  
Chapter 10 displays data of a comparison between labour induction and expect-
ant management through integration of trial outcomes and patients preferences.
Chapter 11 gives a different perspective on at term IUGR by describing a study 
looking at outcomes of pregnancies where diagnosis of IUGR was missed, com-
pared to pregnancies where IUGR was diagnosed.  
Chapter 12 discusses the strategies in IUGR at term by evaluation the trial results, 
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Labour and Neonatal Outcome in Small for Gestational Age Babies Delivered Beyond 36+0 Weeks: 
A Retrospective Cohort Study
Chapter 2
Abstract
Objective : Small for gestational age (SGA) is associated with increased neona-
tal morbidity and mortality. At present, evidence on whether these pregnancies 
should be managed expectantly or by induction is lacking. To get insight in current 
policy we analysed data of the National Dutch Perinatal Registry (PRN).
Methods: We used data of all nulliparae between 2000 and 2005 with a singleton 
in cephalic presentation beyond 36+0 weeks, with a birth weight below the 10th 
percentile. We analysed two groups of pregnancies: (I) with isolated SGA and (II) 
with both SGA and hypertensive disorders. Onset of labour was related to route of 
delivery and neonatal outcome. 
Results: Induction was associated with a higher risk of emergency caesarean sec-
tion (CS), without improvement in neonatal outcome. For women with isolated 
SGA the relative risk of emergency CS after induction was 2.3 (95% Confidence In-
terval [CI] 2.1 to 2.5) and for women with both SGA and hypertensive disorders the 
relative risk was 2.7 (95% CI 2.3 to 3.1). 
Conclusions: Induction in pregnancies complicated by SGA at term is associated 
with a higher risk of instrumental deliveries without improvement of neonatal out-
come. Prospective studies are needed to determine the best strategy in suspected 
IUGR at term.
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Introduction
Intrauterine growth restriction (IUGR) and hypertensive disorders in pregnancy are 
important complications of pregnancy and are, also in term pregnancies, associat-
ed with an increased risk of maternal and perinatal morbidity and mortality1–5. At 
present there is evidence on the optimal treatment of pregnancies complicated by 
hypertension at term concerning the prevention of maternal morbidity 6. However, 
evidence on the best management strategy for at term intrauterine growth restric-
tion concerning neonatal outcome and labour process is still lacking. Dutch guide-
lines on the subject suggest either expectant management under strict monitor-
ing of mother and child or induction of labour. On the one hand induction might 
preempt intrauterine fetal death. On the other hand induction of labour is thought 
to be associated with an increased rate of instrumental deliveries or emergency 
caesarean sections in retrospective studies7–9. Also neonatal outcome might be 
less favourable, related to induction of labour at a relatively early gestational age 
10–12. On the contrary, it has been demonstrated prospectively that induction of 
labour does not increase the risk for caesarean section while it reduces the risk of 
severe maternal morbidity 6. Composite neonatal outcome in this study showed 
comparable neonatal outcome after induction and an expectant monitoring policy, 
but these children were not explicitly growth restricted 6. To compare the neonatal 
outcome and intervention rates between induction and expectant monitoring of 
pregnancies complicated by growth restriction at term a multicentre randomised 
trial, the Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT 
trial), was performed 13. Prior to the results of this trial, we investigated current 
management policy on this subject in The Netherlands and analysed retrospective-
ly data of the National Dutch Perinatal Registry (PRN) of pregnancies complicated 
by SGA at term to examine the onset of labour related to the mode of delivery and 
immediate neonatal outcome. 
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Methods
In the National Dutch Perinatal Registry (PRN) a distinction is made between prima-
ry care by midwives of low-risk pregnancies (LVR1) and secondary and tertiary care 
by obstetricians for women with an increased perinatal risk (LVR2). We used data 
of the LVR2 between 2000 and 2005 to select those children delivered with a birth 
weight below the 10th percentile. In addition, we registered if these pregnancies 
were complicated by preeclampsia or gestational hypertension. Only nulliparae 
with a singleton pregnancy in cephalic presentation that ended after 36+0 weeks 
were included. We excluded women with pregnancies complicated by stillbirths as 
well as women who delivered a child with congenital abnormalities. Gestational 
hypertension was defined as diastolic blood pressure above 90 mmHg (Korotkoff 
V), measured at two occasions in normotensive women before pregnancy. Preec-
lampsia was defined as a diastolic blood pressure above 90 mmHg and proteinu-
ria of at least 300 milligrams per 24 hours 14. SGA was defined as a birth weight 
below the 10th percentile, according to the Dutch growth charts of Kloosterman 
15. Between January first 2000 and December 31st 2004 a total of 253.235 nulli-
parae with a singleton pregnancy delivered after 36+0 weeks under secondary 
and tertiary care. Of these 253.235 pregnancies 799 neonates died before delivery. 
Of the remaining 252.436 two groups of women were analysed: (i) 14.416 wom-
en who delivered a child with a birth weight below the 10th percentile without 
hypertension and (ii) 4574 women with pregnancies complicated by both IUGR 
and hypertensive disorders. Of all these women the onset of labour was recorded 
this was either a spontaneous onset, induction of labour with prostaglandins or 
amniotomy, or an elective caesarean section. In both groups of women onset of 
labour was related to the labour process (spontaneously, instrumental vaginal de-
livery and emergency or elective caesarean section) and to immediate neonatal 
outcome (intrapartum death, live birth with Apgar score <7 versus Apgar score ≥7 
after 5 minutes). Adverse neonatal outcome was defined by neonatal outcome of 
5-minute Apgar score <7 or intrapartum death. Both labour process and adverse 
neonatal outcome were primary outcomes of this retrospective study. Differences 
in the groups between the labour process and outcome were expressed as rela-
tive risks with confidence intervals of 95%. Statistical analysis was performed using 
SPSS software (version 16.0, Chicago, IL).
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Results
A total of 14.416 normotensive women delivered a child with a birth weight below 
the 10th percentile (group I). Table 1 shows the data of 14.294 women of whom 
both onset of labour and outcome of delivery, was known. Out of 14.347 pregnan-
cies the immediate neonatal outcome as well as onset of labour was known 
(Table 2). 
Table 1 
Process of labour in pregnancies complicated by SGA.
Route of delivery RR (95% CI)












231 (2) 151 43 37 0 1.3 (0.95–1.7) 0.87 (0.73–1.0)
Oxytocine 
1235 (9) 778 221 236 0 1.5 (1.3–1.7) 0.93 (0.86–1.0)
Prostaglandins 
2191 (15) 1176 394 621 0 2.3 (2.1–2.5) 1.16 (1.1–1.2)
Spontaneous onset 
10182 (71) 6125 2780 1277 0 ref ref
Planned caesarean 
455 (3) 0 0 0 455 n.a. n.a.
Total 14.294/14.416 8230 3438 2171 455
Displayed n (%). RR: relative risk; 95% CI: 95% confidence interval; ref: reference; n.a.: not appropriate
Table 2 
Neonatal condition after birth in pregnancies complicated by SGA.
Displayed n (%). AS: Apgar-score after 5 minutes, RR: relative risk; 95% CI: 95% confidence interval; ref: reference; 
n.a.: not appropriate
Neonatal outcome RR (95% CI)
Intrapartum death AS < 7 AS ≥ 7 AS < 7 or Intrapartum death
Amniotomy 0 7 (3.0) 224 (97.0) 0.96 (0.46–2.0)
Oxytocine 3 (0.2) 31 (2.5) 1202 (97.3) 0.88 (0.62–1.2)
Prostaglandins 5 (0.2) 53 (2.4) 2131 (97.4) 0.84 (0.64–1.1)
Spontaneous onset 30 (0.2) 291 (2.8) 9891 (97.0) Ref
Planned caesarean 1 (0.2) 21 (4.4) 457 (95.4) 1.5 (0.96–2.2)
Total n=  14.347/14.416 39 403 13.905
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Out of 4.574 women with pregnancies complicated by hypertensive disorders 
(preeclampsia or gestational hypertension) a child with a birth weight below the 
10th percentile was born (group II). Table 3 shows the results of the 4540 women of 
whom the onset of labour as well as route of delivery was known. 
Table 4 displays the results of 4557 women of whom both onset of labour and im-
mediate neonatal outcome were known. 
Table 3 
Process of labour in pregnancies complicated by SGA and hypertensive disorders 
(with or without proteinuria).
Table 4 
Neonatal condition after birth in pregnancies complicated by SGA and hypertensive disorders 
(with or without proteinuria).
Displayed n (%). RR: relative risk; 95% CI: 95% confidence interval; ref: reference; n.a.: not appropriate
Displayed n (%). AS: Apgar score after 5 minutes, RR: relative risk; 95% CI: 95% confidence interval; ref: reference; 
n.a.: not appropriate
















112 (3) 63 26 23 0 1.6 (1.1–2.3) 1.1 (0.91–1.4)
Oxytocine 
720 (16) 420 148 152 0 1.6 (1.3 – 1.9) 1.1 (0.97–1.2)
Prostaglandins 
1733 (39) 872 280 621 0 2.7 (2.3–3.1) 1.3 (1.2–1.4)
Spontaneous 
onset 1558 (34) 959 394 205 0 ref ref
Planned caes-
arean 377 (8) 0 0 0 377 n.a. n.a.
Total 4540/4574 2314 848 1001 377
Neonatal outcome RR (95% CI)
Intrapartum death AS < 7 AS ≥ 7 AS < 7 or Intrapartum death
Amniotomy 0 4 (4.0) 108 (96.0) 1.4 (0.50–3.7)
Oxytocine 0 23 (3.0) 697 (97.0) 1.2 (0.74–2.0)
Prostaglandins 2 (0.1) 42 (2.4) 1726 (97.5) 0.95 (0.62–1.4)
Spontaneous onset 1 (0.1) 40 (2.5) 1519 (97.4) Ref
Planned caesarean 1 (0.2) 19 (4.8) 374 (95.0) 1.9 (1.1–3.2)
Total 4557/4574 4 128 4424
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In both SGA groups, we found a higher risk of instrumental delivery after induction 
of labour with prostaglandins (Tables 1 and 3). We also found a higher risk of emer-
gency caesarean section after induction of labour with oxytocine or amniotomy, 
but this was most obvious after priming with prostaglandins; in group I with iso-
lated SGA the relative risk for emergency caesarean section was 2.3 (95% confi-
dence interval (CI) 2.1 to 2.5) and in group II (IUGR complicated by preeclampsia or 
gestational hypertension) the relative risk for emergency caesarean was 2.7 (95% 
CI 2.3 to 3.1). Induction of labour with prostaglandines was not associated with an 
increased risk of adverse neonatal outcome. 
For the women with a combination of SGA and hypertensive disorders we found 
a higher risk of adverse neonatal outcome after elective caesarean section (RR 1.9; 
95% CI 1.1 to 3.2).
Discussion 
We examined a cohort of 18.990 women who delivered a child that was small for 
gestational age in the presence or absence of hypertensive disorders at term. In this 
cohort we found a distinct association between induction of labour and a higher 
risk of emergency caesarean sections. This association was most obvious in priming 
with prostaglandins. We also found a higher risk of instrumental deliveries after in-
duction of labour, whereas induction did not improve the composed adverse neo-
natal outcome (5-minute Apgar score <7 and intrapartum death).The strength of 
the present study is that analysis was performed on a large cohort of women who 
delivered a child with a birth weight below the 10th percentile. We did not find a 
benefit of inducing labour for isolated SGA nor for SGA with pregnancy-related 
hypertensive disorders for the immediate neonatal outcome. In pregnancies with a 
suspected growth restricted child, there are still doubts concerning the best policy 
16. Inducing labour might prevent possible perinatal morbidity and mortality, by 
freeing the growth restricted child from the undernourished environment. On the 
contrary observational studies showed that antenatal detection of growth restric-
tion may be associated with an increased incidence of obstetric interventions, with 
no demonstrable positive effect upon the short-term neonatal outcome 17. Also 
higher rates of preterm delivery are found mainly as a consequence of medical 
interventions to avoid fetal compromise in children with an antenatal diagnosis of 
intrauterine growth retardation 18. 
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Like other retrospective studies, we found that induction of labour in pregnancies, 
complicated by both SGA and hypertensive disorders in pregnancy, is associated 
with an increase in the caesarean section rate. In a study on induction of labour in 
primigravid women a doubling in the numbers of caesarean sections was found 
related to induction. This outcome was independent of the reason of induction 7. 
This finding has to be weighted against the risk for complications for both mother 
and child in a next pregnancy 19. However, most studies contain retrospective data, 
and there is evidence to doubt that these findings also apply in prospective tri-
als 6. Unfortunately, we can not exclude a possible selection bias, where the most 
severe cases (i.e., with the worse antenatal assessments) being induced with a less 
favourable cervix, as information on maternal and fetal condition as well as cervical 
condition are not registered in the PRN database. Moreover, one can only speculate 
about outcomes if these pregnancies would not have been induced but spontane-
ous onset of labour was awaited.
In our cohort we selected children retrospectively after they were born with a birth 
weight below the 10th percentile, so actually we selected children that were born 
small for gestational age. We cannot therefore automatically translate the results of 
this study to pregnancies in which IUGR is suspected antenatally by ultrasound. We 
were also not informed on ethnicity, which could be an important explaining vari-
able for the different outcomes. It is well known that the use of customised growth 
curves results in a better selection of children who are actually growth restricted 
and in a better risk selection of perinatal mortality and morbidity 20. In The Nether-
lands these curves are not generally applied and the PRN does not contain all items 
for the calculation of these customised curves retrospectively. 
In both groups of women direct neonatal outcome after elective caesarean section 
was remarkably less optimal than after a delivery that started vaginally. Fetal com-
promise after elective caesarean before 39 weeks of gestation might have been 
a contributing factor for that finding 21. Furthermore, the occurrence of maternal 
hypotension due to spinal anaesthesia, leading to hypoperfusion of the placenta 
in an already compromised fetal condition, could be an explaining factor 22. More-
over, we cannot exclude that elective caesarean section was performed in the most 
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compromised pregnancies (e.g., with nonreassuring fetal heart rate) and subse-
quently represent a worse adverse outcome.
In a pilot study on pregnancies with IUGR at term it was found that it is feasible to 
randomise for this complication between immediate induction of labour or to a 
careful waiting policy until spontaneous delivery23. The study showed a randomi-
sation to delivery interval of two weeks and an increase in mean birth weight of 
100 grams in the expectant management group. No differences in obstetrical in-
terventions and neonatal morbidity were found. This study was underpowered for 
neonatal outcome, and evidence on the best management strategy awaits pro-
spective evaluation. The DIGITAT trial (Disproportionate Intrauterine Growth Inter-
vention Trial At Term, ISRCT10363217) is investigating early induction versus ex-
pectant management in pregnancies complicated by IUGR at term, and results are 
underway 13. The trial randomised 650 women and studied similar policies as the 
HYPITAT trial did for hypertension during pregnancy 6. These trials are embedded 
in the Dutch Obstetric Consortium. Over 50 hospitals, academic and nonacademic, 
participated in these two trials (http://www.studies-obsgyn.nl). 
In conclusion, data collected via the National Dutch Perinatal Registry show that 
induction of labour is associated with an increased risk of emergency caesarean 
section and instrumental deliveries in pregnancies that delivered a child with a 
birth weight below the 10th percentile with or without preeclampsia or gestational 
hypertension at term. The risk on instrumental delivery is particularly high when 
labour is induced with prostaglandins. Compared to spontaneous delivery, induc-
tion of labour does not seem to improve the neonatal outcomes immediately after 
birth. However, these retrospective data represent outcomes in children selected 
after they are born with a low birth weight and should not be extrapolated to set-
tings where growth restriction is suspected antenatally. 
Results of the DIGITAT trial, concerning not only medical outcomes but also cost, 
quality of life, and treatment preference analyses, as well as data of long-term neo-
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natal followup will help to elucidate aspects of the best management strategy in 
IUGR at term.
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Abstract
Background:  Around 80% of intrauterine growth restricted (IUGR) infants are 
born at term. They have an increase in perinatal mortality and morbidity includ-
ing behavioral problems, minor developmental delay and spastic cerebral palsy. 
Management is controversial, in particular the decision whether to induce labour 
or await spontaneous delivery with strict fetal and maternal surveillance. We pro-
pose a randomised trial to compare effectiveness, costs and maternal quality of life 
for induction of labour versus expectant management in women with a suspected 
IUGR fetus at term.
Methods/Design:  The proposed trial is a multi-centre randomised study in preg-
nant women who are suspected on clinical grounds of having an IUGR child at a 
gestational age between 36+0 and 41+0 weeks.  After informed consent women 
will be randomly allocated to either induction of labour or expectant management 
with maternal and fetal monitoring.  Randomisation will be web-based. The primary 
outcome measure will be a composite neonatal morbidity and mortality. Second-
ary outcomes will be severe maternal morbidity, maternal quality of life and costs. 
Moreover, we aim to assess (neuro)developmental and neurobehavioral outcome 
at two years as assessed by a postal enquiry (Child Behavioral Check List-CBCL and 
Ages and Stages Questionnaire-ASQ). Analysis will be by intention to treat. Qual-
ity of life analysis and a preference study will also be performed in the same study 
population. Health technology assessment with an economic analysis is part of this 
so called DIGITAT trial (Disproportionate Intrauterine Growth Intervention Trial At 
Term). The study aims to include 325 patients per arm.
Discussion:  This trial will provide evidence for which strategy is superior in terms 
of neonatal and maternal morbidity and mortality, costs and maternal quality of 
life aspects. This will be the first randomised trial for IUGR at term. 
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Disproportionate Intrauterine Growth Intervention Trial At Term: 
DIGITAT-the protocol.
Background 
Around 80% of intrauterine growth restricted (IUGR) infants are born at term.1 
When pregnancy is complicated by IUGR, there is, whether term or preterm, a clear 
association with an increase in neonatal mortality and neonatal morbidity (short 
and long term). 2-4 The long term morbidity ranges from behavioral problems and 
minor developmental delay to spastic cerebral palsy. 5-10 However, not all studies, 
especially after excluding congenital anomalies, confirm these findings.11 Besides 
fetal asphyxia, meconium aspiration, fetal heart rate abnormalities and low Apgar 
score, also more admittances to and longer stays at neonatal intensive care units 
are reported. This might partly be related to a higher prevalence of hypoglycaemia, 
neonatal sepsis, hypothermia and haematological problems as thrombocytopenia 
and polycythemia in these neonates.12-14
When a fetus is small for gestational age (SGA), defined on the basis of a birth 
weight below the 10th centile, there is the concern that the fetus might be afflicted 
by IUGR.15 As SGA is defined on the basis of an arbitrary chosen cutoff birth weight 
centile, not all infants falling below the 10th centile are abnormally small because 
of growth restriction.  Many neonates with a birth weight below the 10th centile 
are representing the normal spectrum of fetal growth.11 Variation in birth weight is 
related to many factors as maternal height, weight, parity and fetal gender, but also 
ethnicity.16 For that reason optimal growth for any fetus should be related to the 
fetus’ own individual optimal growth curve.17-19 Intrauterine growth restriction has 
to be defined on further knowledge such as Doppler abnormalities as seen in pla-
cental perfusion, eventually in combination with abnormalities in cerebral perfu-
sion 20;21 and  possibly also by neonatal measurements as the Ponderal Index.22;23 
A reduction of fetal growth is exponentially associated with a higher perinatal 
mortality 24 and morbidity.25-26 Doppler umbilical artery studies have shown that 
absence of end diastolic velocities, indicative of IUGR based on severe placental in-
sufficiency is associated with a higher rate of caesarean deliveries and an increased 
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incidence of perinatal and neonatal mortality. 27-30 However, a normal umbilical 
artery Doppler study at term gestation might be falsely reassuring, while a normal 
cerebral artery study might identify the fetus not likely having a major adverse out-
come.31    
Most of the growth restricted children experience an accelerated growth, espe-
cially of the head circumference, during the first 6 months after birth.32 However, 
this upward centile crossing or ‘catch up growth’ is not complete, even at the age 
of seven years.33 Moreover head circumference seems to correlate with cognitive 
outcome.34 
Long-term neurological and cognitive development of the IUGR infant at term 
have been studied extensively. The Ponderal Index among IUGR infants, but also 
among infants with a normal birth weight, is an independent predictor of neonatal 
morbidity: the lower the Ponderal Index the higher morbidity.25 Learning difficul-
ties, defects in speech and mild neurological deficits and behavioral problems have 
been reported to occur more in term neonates born SGA.35-36 At school ages (7-8 
years) temperamental differences and differences in play behavior are apparent37, 
most probably contributing to increased rate of school failure found in IUGR in-
fants. 
Long-term morbidity might be resulting from subtle nutritional insults to the brain 
in utero. Although the brain growth spurt, being the most vulnerable period of 
the human brain, spans a broad period between mid pregnancy and 6 months of 
postnatal age38;39, it is shown that growth failure occurring around term shows a 
strong association with cognitive disturbances as a poorer mental and psychomo-
tor development at two years of age.40 However, not all studies, even at preschool 
age show this trend of increased problems in growth restricted infants.41-42 Be-
sides (neuro)developmental consequences it is now also clear that children who 
were undernourished during pregnancy (e.g. born with a birth weight more than 
2 SD below the mean birth weight) and especially in combination having had a 
compensatory growth trajectory during childhood have an increased risk in later 
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life for diabetes, hypertension and cardiovascular diseases.43
Given the data from studies concerning the effect of under-nutrition on the brain 
and the effects on long-term cognitive and behavioral outcome, evaluation of the 
possible clinical benefit of early induction of delivery, pre-empting a detrimental 
effect of chronic under nutrition on the fetal brain intervention, is important. By 
such an intervention it might be possible to start earlier with a more optimal feed-
ing, compensating for the poor intra-uterine environment. Induction of labor is 
very often common practice in cases of suspected IUGR.44-45 In the Netherlands at 
33 up to 36 weeks of gestation, 63% of IUGR pregnancies were induced, whereas 
from 37 weeks onwards this percentage is 23%; more than double the percentage 
in non-IUGR pregnancies. In a Dutch obstetric cohort of 14.294 primigravid women 
with IUGR pregnancies, 29% of these pregnancies were induced.46 In these preg-
nancies complicated by IUGR, induction of labour was associated with an increased 
risk of instrumental deliveries and emergency caesarean section, but no difference 
in neonatal outcome immediately after birth was found. 
At present, there is no uniformity on the management of women with IUGR at term. 
Although there is no doubt that the intra-uterine growth retarded fetus should be 
considered as high risk, and should be monitored, there is no consensus on which 
diagnostic methods to evaluate fetal condition and subsequent intervention is 
best. It is unclear whether in this situation either induction of labour or expect-
ant management is beneficial for the mother and her baby, since evidence on the 
subject is lacking. 
For preterm pregnancies complicated by intra-uterine growth retardation, an in-
ternational randomised clinical trial recently showed that expectant management 
had little benefit over early delivery with respect to short term neonatal outcome.47 
However, results of this trial cannot be extrapolated to the situation at term. 
The lack of consensus on the subject in the Netherlands is demonstrated by the 
fact that in 2002 in women with a SGA child, labour was induced in 32% of these 
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women, whereas labour started spontaneously in 56% of these women, the re-
maining 11% had an elective caesarean section. These data are based on actual 
birth weight, and the clinical situation is even more complicated by the fact that 
the antenatal diagnosis of a SGA child is often difficult to make and easily missed 
in clinical practice. 
In view of this clinical dilemma, we propose a randomised clinical trial in which 
induction of labour is compared with expectant monitoring in women with a sus-
pected IUGR child at term. We will compare maternal outcome, neonatal outcome 
and maternal quality of life, as well as costs. Moreover, we will collect, in both ran-
domisation arms, data of the diagnostic tests used in fetal surveillance, i.e. fetal 
heart rate pattern, sonographic measurement of the amniotic fluid index and Dop-




The aim of this study is to investigate whether induction of labour or expectant 
management is the best strategy in terms of neonatal and maternal morbidity and 
mortality, costs and maternal quality of life aspect in pregnancies complicated by 
IUGR from 36 weeks gestational weeks onwards.  
Study Design and Setting
We will perform a randomised controlled multi centre study.This trial is embed-
ded in the Dutch Obstetric Consortium, a collaboration of obstetric hospitals in 
the Netherlands. Approximately 40 hospitals, including all 10 university hospitals, 
teaching hospitals and district hospitals will participate in this trial.
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Participants/Eligibility criteria
All women with a singleton pregnancy, with a child in cephalic presentation, with 
suspicion of IUGR (Fetal Abdominal Circumference < 10th centile, Estimated Fe-
tal Weight < 10th percentile as defined by local protocols), or decreased relative 
growth though still > 10th centile, e.g. from 70th centile to 40th centile) are eligible. 
Gestational age should be between 36+0 weeks and 41+0 weeks. Women with a 
history of caesarean section, serious congenital defects, ruptured membranes, re-
nal diseases, diabetes mellitus, or positive HIV serology will be excluded. 
Procedures, recruitment, randomisation and collection of baseline data
All women with a singleton pregnancy who present at one of the participating 
clinics will be referred to an obstetrician or a specifically appointed research nurse/
midwife for counselling. Eligible women receive participant information. After writ-
ten consent, they are randomised by means of a web-based application. Stratifica-
tion will be applied for previous vaginal birth (nullipara versus multipara) and for 
centre. Randomisation will be in a 1:1 ratio for induction of labour or expectant 
management.
Patients that withhold consent for randomisation are asked permission for data 
collection on pregnancy outcome. Participation to the quality of life study and 
long-term follow up (Child Behavioural Check Lists-CBCL and Ages and Stages 
Questionnaire-ASQ) is asked separately.
Baseline demographic, past obstetric and medical histories will be recorded for all 
women. Cervical length will be measured at the time of randomisation. The qual-
ity of life questionnaires are filled out before randomization, after randomization, 
6 weeks postpartum and 6 months postpartum. The questionnaires contain the 
Hospital Anxiety and Depression Scale (HADS), EuroQoL 5D3L, Short Form (SF-
36), Symptom Check List (SCL-90), and questions on background characteristics, 
intervention preparedness, risk perception and experience with the current preg-
nancy. 
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Intervention
When randomised to the induction arm, induction of labor must start within 48 
hours after randomisation. Induction of labor can be proceded according to local 
protocol (among other things cervical ripening with prostaglandin-gel or tablets 
or with amniotomy, with or without the use of oxytocin). When allocated to the 
expectant management group patients will not be induced unless the fetal or ma-
ternal condition deteriorates and this is for the attending obstetrician a reason for 
induction. The patients will be observed, e.g. with fetal and maternal monitoring 
according to local practice, until labour starts spontaneously. However, monitoring 
must at least include measurement of the umbilical artery Doppler waveform, fetal 
heart rate tracing, blood pressure and urine analysis for albuminuria weekly. Dop-
pler studies of the medial cerebral artery are optional. Reasons for interventions 
and time interval between randomisation and labour will be collected.
Follow up of women and infants
All details of delivery, maternal and fetal assessments and admittance during preg-
nancy are recorded in the case record form that is accessible at the website. In case 
of admittance of the child to the neonatal intensive care unit, details of this admit-
tance are also recorded. 
Long-term follow up of children will be done by recording growth after birth as 
measured at the local infant follow up clinics. 
Outcome measures
The primary outcome measure will be a bad composite neonatal outcome. Adverse 
neonatal outcome will be defined as death before hospital discharge, a 5-minute 
Apgar score < 7, an umbilical artery pH < 7.05 or admission to the neonatal in-
tensive care. Secondary outcome measures are mode of delivery and time until 
delivery, length of admittance at the neonatal intensive care, maternal morbidity, 
hospitalisation of the mother for fetal and maternal surveillance, quality of life, and 
costs.  In the present proposal, no funding is asked for long term follow-up of the 
child, yet. However, if additional funding can be obtained children’s behavioural-, 
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and (neuro)development will assessed by administering with a postal enquiry the 
Child Behaviour Checklist-CBCL and Ages and Stages Questionnaire- ASQ by their 
parents after 2 years.
Statistical issues
Sample size calculations
The study is designed as an equivalence study, whereby both treatments will have 
the same incidence of the primary outcome measure of combined bad neonatal 
outcome. This incidence is assumed to be 6%46. The null hypothesis is that both 
treatments will not be equivalent. To detect equivalence with a power of 80% a 
sample size in both groups of 325 will be needed (PASS SOFTWARE). The margin of 
equivalence, given in terms of the difference, extends from -5.5 % to +5.5 %. The 
actual difference is 0 %. The calculations assume that two, one-sided Z tests are 
used. The significance level of the test is 0.05. 
Data analysis
Data will initially be analysed according to the intention to treat method. The main 
outcome variable, ‘bad neonatal outcome’, will be assessed by calculating rates 
in the two groups, relative risks and 95% confidence intervals as well as numbers 
needed to treat.  
Time to delivery will be evaluated by Kaplan-Meier estimates, with account for dif-
fering durations of gestation at entry, and will be tested with the log rank test. The 
other secondary outcome measures will be approached similarly to the primary 
outcome measure. The analysis will be stratified for parity and centre. 
Non response and inclusion bias
As non-response for follow up is overrepresented in certain outcome-related risk 
categories such as in non-native mothers, mothers with lower educational level 
and in mothers with boys, statistical methods that use imputation of missing data 
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have to be applied.48 To prevent inclusion bias all patients who were asked but 
decline randomisation, will be asked for permission to collect data on pregnancy 
outcome and further follow up according to the same schedule as the randomised 
patients.  
Economic evaluation
The aim of the economic evaluation is to compare optimality, in terms of costs 
and health effects, of both strategies.  As the clinical study is based on equivalence 
design we hypothesize that there will be no relevant difference between maternal 
and neonatal outcome in the two strategies. The economic evaluation will be in the 
form of a cost-effectiveness analysis (CEA), in which the optimal strategy is defined 
as the strategy with the largest health gain at the smallest costs.
Ethical considerations
This study has been approved by the ethics committee of the Leiden University 
Medical Centre (Ref. No. P04.210).
Discussion 
There is uncertainty about the management of IUGR at term, whether to leave 
the child in utero until spontaneous labour starts, or to prevent undernutrition by 
prolonged pregnancy in a poor intra-uterine environment by inducing labour. This 
latter treatment modality will most probably be at the cost of an increase in instru-
mental deliveries.46 As optimal management of a pregnancy at term suspected 
to be complicated by IUGR remains unclear, it is a challenge to develop criteria for 
inducing delivery. An increase in fetal surveillance in these pregnancies (with nor-
mal umbilical artery studies) is thought to be associated with more inductions of 
labour and a shortening of gestational age.49 Neonatal morbidity (and mortality) 
is low in term SGA neonates3, nevertheless these neonates cannot be considered 
just “healthy small babies”. 
Although our primary aim is to study pregnancies complicated by IUGR, the in-
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clusion criteria are obviously based on a suspicion of a SGA child, as we include 
women with a fetus with a Fetal Abdominal Circumference < 10th centile or an 
Estimated Fetal Weight < 10th centile. By patient’s characteristics, such as ethnicity, 
maternal and paternal length as well as tests results as the amount of amniotic fluid 
or the Doppler of the arteria umblicalis, we will be able to evaluate which pregnan-
cies are at risk for a poor neonatal outcome.  
In summary, at the present, there is controversy as to which strategy is the best 
when IUGR at term is suspected. Whether to induce labour or to await spontaneous 
labour under strict fetal and maternal monitoring remains debatable because of a 
lack of evidence. Patients’ management partly depends on the attending doctor 
and on local protocols. To resolve these issues, we will compare both strategies in 
the multi centre randomised trial – DIGITAT.  In a pilot study carried out in one of 
the participating hospitals, we examined the feasibility of the DIGITAT-trial. Prelimi-
nary data from this small pilot show that the interval between randomisation and 
labour was 2 weeks shorter and birth-weight was 100 grams less in the pregnan-
cies that were directly terminated by induction.50 
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Abstract
Objective: To compare the effect of induction of labour with a policy of expectant 
monitoring for intrauterine growth restriction near term.
Design: Multicentre randomised equivalence trial (the Disproportionate Intrauter-
ine Growth Intervention Trial At Term (DIGITAT)).
Setting Eight academic and 44 non-academic hospitals in the Netherlands between 
November 2004 and November 2008.
Participants Pregnant women who had a singleton pregnancy beyond 36+0 weeks 
gestation with suspected intrauterine growth restriction.
Interventions Induction of labour or expectant monitoring.
Main outcome measures : The primary outcome was a composite measure of ad-
verse neonatal outcome, defined as death before hospital discharge, five minute 
Apgar score of less than 7, umbilical artery pH of less than 7.05, or admission to the 
intensive care unit. Operative delivery (vaginal instrumental delivery or caesarean 
section) was a secondary outcome. Analysis was by intention to treat, with confi-
dence intervals calculated for the differences in percentages or means.
Results: 321 pregnant women were randomly allocated to induction and 329 
to expectant monitoring. Induction group infants were delivered 10 days earlier 
(mean difference -9.9 days, 95% CI -11.3 to -8.6) and weighed 130 g less (mean dif-
ference -130 g, 95% CI -188 g to -71 g) than babies born to women in the expectant 
monitoring group. A total of 17 (5.3%) infants in the induction group experienced 
the composite adverse neonatal outcome, compared with 20 (6·1%) in the expect-
ant monitoring group (difference -0.8%, 95% CI -4.3% to 3.2%). Caesarean sections 
were performed on 45 (14.0%) mothers in the induction group and 45 (13.7%) in 
the expectant monitoring group (difference 0.3%, 95% CI -5.0% to 5.6%).
Conclusions: In women with suspected intrauterine growth restriction at term, we 
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Induction versus expectant monitoring for intrauterine growth restriction at term: 
randomised equivalence trial (DIGITAT)
Introduction
Most infants with intrauterine growth restriction are born at term.1 Growth restric-
tion so late in gestation is associated with increased perinatal morbidity in the form 
of fetal distress, hypoglycaemia, seizures, behavioural problems, cerebral palsy, and 
cardiovascular disease, as well as perinatal mortality.2-11 Obstetricians often induce 
labour in cases of intrauterine growth restriction for fear of neonatal morbidity and 
later stillbirth. However, observational comparisons of such infants with matched 
fetuses delivered after spontaneous labour have shown no reduction in short term 
adverse neonatal outcomes. Induction might increase obstetric intervention12-14 
and even cause neonatal morbidity if performed before 39 weeks.15-18 For these 
reasons, expectant management with maternal and fetal monitoring is a common-
ly followed strategy.
The Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT) was 
designed to compare the effect of induction of labour with expectant monitoring 
on a composite adverse neonatal outcome and on operative delivery rates in in-
fants with suspected growth restriction beyond 36 weeks’ gestation. In a pilot trial 
comparing these two interventions in 33 women, neonatal outcomes and opera-
tive delivery rates were comparable, but the precision of the estimate of the effect 
size was limited.19
found no important differences in adverse outcomes between induction of labour 
and expectant monitoring. Patients who are keen on non-intervention can safe-
ly choose expectant management with intensive maternal and fetal monitoring; 
however, it is rational to choose induction to prevent possible neonatal morbidity 
and stillbirth.
Trial registration International Standard Randomised Controlled Trial number 
ISRCTN10363217.
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Methods
The trial was run by the Dutch Obstetric Consortium, a collaboration of perina-
tal centres in the Netherlands, and approved by the University of Leiden institu-
tional review board. The study was staffed by obstetricians, research nurses, and 
midwives associated with the Dutch Obstetric Consortium. They counselled and 
recruited participants, monitored compliance with allocated treatment protocols, 
and collected outcome data. 
Recruitment ran from November 2004 to November 2008. The study began in four 
hospitals, but by the end of the study period recruitment had been rolled out to 
52 maternity hospitals in Holland. Making the crude assumptions that the average 
centre recruited for half the trial duration of three years (that is,18 months), that 
each centre delivered 1500 women a year (adjusting for women seen only in labour 
or who were ineligible because of multiple pregnancy or breech pregnancy), and 
assuming that half of all growth restricted fetuses are detectable, we anticipated 
that about 1326 potentially eligible women would be identified over the recruit-
ment period. 
Participants 
Pregnant women between 36+0 and 41+0 weeks’ gestation who had a single-
ton fetus in cephalic presentation, suspected intrauterine growth restriction, and 
who were under specialised obstetric care were recruited. Suspected intrauterine 
growth restriction was defined as fetal abdominal circumference below the 10th 
percentile, estimated fetal weight below the 10th percentile, flattening of the 
growth curve in the third trimester (as judged by a clinician), or all the presence of 
all three factors.20 Both fetuses with abnormal Doppler flow velocity measurements 
and those with normal Doppler flow velocity measurements were included. 
The DIGITAT recruitment period overlapped with recruitment for the Hyperten-
sion Intervention Trial At Term (HYPITAT),22 which compared similar interventions 
in women with gestational hypertension and mild pre-eclampsia at term. Patients 
with both suspected intrauterine growth restriction and hypertension were pref-
erentially recruited to DIGITAT, and women could not participate in both studies. 
Gestational hypertension and pre-eclampsia were defined according to criteria 
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from the International Society for the Study of Hypertension in Pregnancy.23 Oligo-
hydramnios was defined as an amniotic fluid index of 5 cm or less.
Exclusion criteria were previous caesarean section, diabetes mellitus or gestational 
diabetes requiring insulin therapy, renal failure, HIV seropositivity, prelabour rup-
ture of membranes, severe pre-eclampsia, HELLP syndrome (haemolysis, elevated 
liver enzymes, and low platelet count), or a fetus with aneuploidy or congenital 
abnormalities suspected on ultrasound. Fetuses with decreased or absent move-
ments, and those with abnormal heart rate tracings, were also excluded. 
Cervical length was measured using transvaginal sonography and vaginal digital 
examination was performed to assess the Bishop score before randomisation.21
Randomisation
Participant data were entered into a secure web based database. Women were 
randomly allocated to either induction or expectant monitoring in a 1:1 ratio us-
ing varied sized block randomisation with stratification for centre and parity (nul-
liparous or parous women). Women who declined consent for randomisation but 
authorised use of their medical data were treated at the discretion of the local ob-
stetrician and included in the database. These data were used to study external va-
lidity of the trial. Women who refused both randomisation and collection of identi-
fiable data were registered anonymously. It was not possible to blind participants, 
obstetricians, or outcome assessors. Written informed consent was obtained from 
all participants before randomisation.
Participants allocated to the induction of labour group were induced within 48 
hours of randomisation. If the Bishop score at randomisation was greater than 6, 
labour was induced with amniotomy and, if necessary, augmented with oxytocin. 
Otherwise cervical ripening was performed with intracervical or intravaginal pros-
taglandin (E1 or E2 analogue, repeated once after six hours) or a Foley balloon cath-
eter filled with 30 mL sodium chloride.24
Participants allocated to the expectant monitoring group were monitored until the 
onset of spontaneous labour with daily fetal movement counts and twice weekly 
heart rate tracings, ultrasound examination, maternal blood pressure measure-
ment, assessment of proteinuria, laboratory tests of liver and kidney function, and 
full blood count. Women were monitored as either an outpatient or an inpatient, 
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according to local protocol. In the expectant monitoring group, induction of labour 
or planned caesarean section was performed for obstetrical indications—such as 
suboptimal fetal heart rate tracings, prolonged rupture of membranes, or postma-
turity between T+7 and T+14 days—at the obstetrician’s discretion.
Outcomes
The primary outcome was a composite measure of adverse neonatal outcome. This 
was defined as death before hospital discharge, five minute Apgar score of less 
than 7, umbilical artery pH of less than 7·05, or admission to neonatal intensive 
care. If the umbilical artery pH data were missing and all other components of the 
composite outcome were normal, the neonatal outcome was classified as normal. 
Secondary outcomes were delivery by caesarean section, instrumental vaginal 
delivery, length of stay in the neonatal intensive care or neonatal ward, length of 
stay in the maternal hospital, and maternal morbidity. The latter was defined as 
post-partum haemorrhage of more than 1000 mL, development of gestational 
hypertension or pre-eclampsia (according to International Society for the Study 
of Hypertension in Pregnancy criteria),22 eclampsia, pulmonary oedema, throm-
boembolism, or any other serious adverse event.
Study design, sample size, and statistical analysis
The trial was designed as an equivalence trial in which the null hypothesis was 
that the difference in the risk of the composite outcome between the two treat-
ment groups was greater than 5.5% (absolute percentage). Assuming that the rate 
in the control group was 6% (on the basis of data from the National Dutch Perinatal 
Registry25, this meant that we would exclude the null hypothesis and conclude 
that the two treatments were equivalent if the boundaries of the confidence inter-
val of the observed risk difference were between -5.5% and 5.5%. With a 0.05 risk 
of type I error (α) and 80% (1-β) power, we calculated that we would require 650 
participants (325 per group). The sample size formula for equivalence testing on 
page 39 of Jones et al 26 was used to calculate these numbers, assuming that the 
induction rate and the control rate were both equal to 6% under the alternative of 
equivalence.
Data were analysed according to the intention to treat principle. Continuous vari-
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ables were summarised as means with standard deviations, or medians with inter-
quartile ranges (IQR). Treatment effects were presented as differences in means or 
percentages with 95% confidence intervals (CI). Equivalence of the primary out-
come measure was tested by checking if the 95% CI of the risk difference lay within 
the equivalence margins. Continuous variables were compared using the Student’s 
t test or the non-parametric Mann-Whitney U test. The χ2 square test was used for 
categorical variables. Instances were more than 5% of the observations were miss-
ing are indicated in the footnotes of the tables.
In a secondary analysis, the primary and secondary outcomes for the two groups 
were compared after exclusion of women with hypertension related diseases (pre-
existent hypertension, gestational hypertension, and pre-eclampsia) at randomi-
sation. Given that randomisation was stratified for centre and parity, we also per-
formed a stratified analysis for the primary outcome by using logistic regression 
with parity as fixed covariate and centre as random covariate. Statistical analyses 
were performed using SPSS software (version 16.0; IBM, Chicago, IL) and Stata soft-
ware (version 10.1; Stata Corp, College Station, TX).
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Results
A total of 1116 potentially eligible women were identified. Of these women, 14 
refused any use of identifiable data and 452 declined randomisation. This left 650 
participants, who were randomly assigned to induction (n=321) or expectant mon-
itoring (n=329) (figure 1). The baseline characteristics of participants in the two 
randomised arms and in the non-randomised group are shown in table 1. 
 
Women eligible (n=1116) 
Assigned to induction of labour (n=321) 
 Induction of labour (n=306) 
 Spontaneous onset of labour (n=12) 
 Planned caesarean section (n=2) 
 Unknown (n=1) 
Assigned to expectant monitoring (n=329) 
Induction of labour (n=166) 
 Spontaneous onset of labour (n=151) 
  Planned caesarean section (n=11) 
  Unknown (n=1) 
 
Analysed for primary outcome(n=321) Analysed for primary outcome (n=329) 
 Excluded (n=466) 
Refused use of medical data (n=14) 
Refused randomisation (n=452) 
Induction of labour (n=88) 
Expectant monitoring (n=364) 
Randomised (n=650) 
Figuur 1 
Flow diagram of the process of the trial
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Table 1 
Demographic and baseline characteristics of randomised and non randomised participants
Table shows median (IQR 25th-75th percentile) or number (%).
†: n=275 for induction, n=295 for expectant monitoring, n=364 for non-randomized. 
‡ n=304 for induction, n=312 for expectant monitoring, n=413 for non-randomized. 
§: n=294 for induction, n=311 for expectant monitoring, n=424 for non-randomized. 
╥: n=281 for induction, n=293 for expectant monitoring, n=421 for non-randomized.
║: n=262 for induction, n=277 for expectant monitoring, n=381 for non-randomized. 
: n=299 for induction, n=312 for expectant monitoring, n=31 for non-randomized. 











Nulliparous 182 (56·7) 201 (61·1) 275 (61·0)
Maternal age 27 (23 - 31) 27 (23 - 31) 31 (27 - 34)
BMI at study entry† 22 (20 - 25) 22 (20 - 26) 21 (20 - 24)
Gestational age (days) 263 (258-269) 263 (258-270) 262 (258-269)
Caucasian‡ 254 (83·6) 253 (81·1) 344(83·3)
Education
Lower professional school 168 (52·3) 170 (51·7) 149 (33·0)
Medium professional school 26 (8·1) 37 (11·2) 93 (20·6)
Unknown 127 (39·6) 122 (37·1) 209 (46·3)
Maternal smoking§ 138 (46·9) 127 (40·8) 114 (26·9)
Blood pressure at booking
Systolic 115(105 - 120) 114 (106 - 120) 115 (110 - 120)
Diastolic 70 (60  -  75) 66 (60 - 75) 70 (60 - 75)
Women with gestational hypertension 9 (2·8) 19 (5·8) 25 (5·5)
Women with pre-eclampsia 18 (5·6) 27 (8·2) 27 (6·0)
Inclusion criteria
 Fetal abdominal circumference <10th percentile 262 (81·6) 270 (82·1) 354 (78·5)
 Estimated fetal weight <10th percentile 296 (92·2) 308 (93·6) 418 (92·5)
Deceleration of Fetal abdominal circumference curve 83 (25·9) 84 (25·5) 95 (21·0)
Fetal abdominal circumference (mm) 287 (278 - 297) 289 (279 - 297) 289 (278 - 299)
Oligohydramnios ╥ 87 (31·0) 101 (34·5) 145 (34·4)
Umbilical artery Doppler║
Pulsatility index in the umbilical artery 0·98 (0·85-1·13) 0·93 (0·82-1·10) 0·96 (0·84-1·11)
Absent 7 (2·7) 7 (2·5) 4 (1·0)
Reversed 0 0 1 (0·2)
Cervical length with  transvaginal sonography (mm) 30 (22-37) 30 (24-38) 33 (22-41)
Bishop score ≤ 6†† 280 (94·0) 293 (97·3) 64 (98·5)
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Compared with the induction group, women in the expectant monitoring group 
were more likely to have a Bishop score of less than or equal to 6 and have gesta-
tional hypertension, but otherwise the two randomised arms were comparable. 
Women who declined randomisation were older, had a higher education level, 
were less likely to smoke, had a lower body mass index (BMI), and were less likely 
to have a fetal abdominal circumference below the 10th centile. Most women who 
were randomised met either the fetal abdominal circumference below 10th centile 
inclusion criterion or the estimated fetal weight below the 10th centile criterion. 
Only 13 women in the induction group and 10 women in the expectant monitoring 
group were included because of flattening of the growth curve in isolation.
(Table 1)
Details of the onset of labour are shown in table 2, and pregnancy outcomes are 
shown in table 3. Trial compliance was good, with induction performed in 306 
(95.6%) of the women in the induction group and in only 166 (50.6%) in the ex-
pectant monitoring group, resulting in a median time from randomisation to onset 
of labour of 0.9 days (IQR 0.7 to 1.7) in the induction group and 10.4 days (IQR 5.6 
Table 2 
Onset of labour








percentage or mean 
(95% CI)
Time between randomisation and 
onset of labour (days) 0•9 ( 0•7 - 1·7) 10·4 (5·6 - 16·0) -9·6 ( -10·8; -8·5)**
Gestational age at birth (days) 266 (261-271) 277 (269-283) -9·9 (-11·3; -8·6)**
Onset of labour
Spontaneous 12 (3·7) 151(46·0) -42·3 (-48·1;-36·5)**
Planned caesarean section 2 (0·6) 11 (3·3) -2·7 (-4·9; -0·6)**
Induction 306 (95·6) 166 (50·6) 45·0 (39·2; 50·9)**
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to 16.0) in the expectant monitoring group.
Labour was induced in 166 (50.6%) women in the expectant monitoring group: 
92 for suspected fetal distress; 21 for hypertensive disorders; 24 on maternal re-
quest; nine for prelabour rupture of membranes; five for post-term pregnancy; and 
15 for unspecified maternal reasons. Planned caesarean section was performed in 
Table 3 
Pregnancy outcome 
Table shows median (IQR 25th-75th percentile) or number (%).
* P<0·05 ; Ŧ P=0·2. (Mann-Whitney test).










Mode of Delivery 
Spontaneous 249 (77·6) 257 (78·1) -0·5 (-6·9; 5·8)
Vaginal instrumental 27 (8·4) 27 (8·2) 0·2 (-4·0; 4·4)
Caesarean section 45 (14·0) 45 (13·7) 0·3 (-5·0; 5·6)
Indications for caesarean section
Suspected fetal distress (+/- arrest of labour) 37 (82·2) 40 (88·9) -6·7 (-21·1; 7·8)
Arrest of labour 5 (11·1) 2 (4·4) 6·7 (-4·3; 17·6)
Other 3 (6·7) 3 (6·7) 0·0 (-10·3; 10·3)
Indications for instrumental vaginal delivery
Suspected fetal distress (+/- arrest of labour) 21 (77·8) 25 (92·6) -14·8 (-33·3; 3·7)
Arrest of labour 6 (22·2) 2 (7·4) 14·8 (-3·7; 33·3)
Adverse maternal outcome
Maternal death 1 (0·3) 0 NA
Progression to gestational hypertension 1 (0·3) 6 (1·8) -1·5 ( -3·1; 0·1)
Progression to pre-eclampsia 12 (3·7) 26 (7·9) -4·2 (-7·7; -0·6) *
Eclampsia, lung-edema, trombo-embolic events 0 0 NA
Abruption placentae (partial) 1 (0·3) 0 NA
Postpartum haemorrhage 10 (3·2) 15 (4·7) -1·5 (-4·5; 1·5)
Maternal admission‡
Length of stay in hospital 4·0 (2·0 - 6·0) 4·0 (2·0 - 7·0) Ŧ 
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two (0.6%) women in the induction arm: one because of fetal distress, the second 
because of primary genital herpes infection. A total of 11 (3.3%) women in the ex-
pectant monitoring arm had a planned caesarean section: in 10 cases for fetal dis-
tress and one for unpredicted breech position. In the expectant monitoring arm, 
the median time from randomisation to delivery among women who delivered 
by planned caesarean section was 4.5 days. The numbers of operative and instru-
mental deliveries were comparable between the groups (27 (8.4%) in the induction 
group and 27 (8.2%) in the expectant monitoring group).
One (0.3%) woman allocated to induction of labour died at home 10 days after de-
livery. She had delivered a healthy child vaginally at 38+4 weeks of gestation after 
spontaneous onset of labour. No cause for her death was found at postmortem and 
it was classified as a serious unrelated adverse event. No women in the expectant 
monitoring group died during the study.
Neonatal outcomes are shown in table 4. There were no stillbirths or perinatal 
deaths. A total of 17 (5.3%) neonates in the induction arm and 20 (6.1%) neonates 
in the expectant monitoring arm had the primary composite adverse neonatal out-
come (difference -0.8%, 95% CI -4.3% to 2.8%). No differences between groups in 
any of the components of the composite adverse neonatal outcome were found. 
Median birth weight was lower in the induction group than in the expectant moni-
toring group (2420 g v 2550 g; difference -130 g, 95% CI -188 g to -71 g; P<0.001). 
Despite this difference, more fetuses in the expectant monitoring arm had a birth 
weight below the third percentile (100 (31%) v 40 (13%); difference -18.1%, 95% CI 
-24.3% to -12.0%; P<0.001).
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The numbers of infants admitted to neonatal intensive care and median duration 
of stay in unit was comparable between the two groups (9 (2.8%) from the induc-
tion group and 13 (4.0%) of the expectant monitoring group; duration 9 days, IQR 6 
Table 4 
Neonatal outcome
Table shows median (IQR 25th-75th percentile) or number (%). 
*P<0·05; **P < 0·001; ***P=0.5 (Mann-Whitney test) †: percentiles according to Dutch fetal growth 
charts (weight related to gestational age).36
 ‡: n=279 for induction, n=288 for expectant monitoring.









Birth weight (grams) 2420 (2220 – 2660) 2550 (2255 – 2850)-130 (-188; -71) **
Birth weight percentiles †
< P 3 40 (12·5) 100 (30·6) -18·1 (-24·3; -12·0)**
P 3 - P5 82 (25·5) 79 (24·2) 1·3 (-5·3; 8·0)
P5 - P10 88 (27·4) 62 (18·9) 8·5 (-2·0; 14·9)
P10 - P25 88 (27·4) 66 (20·2) 7·2 (0·7; 13·8)
>P25 23 (7·2) 20 (6·1) -1·1 (-2·8; 4·9)
Composite adverse neonatal outcome 17 (5·3) 20 (6·1) -0·8 ( -4·3; 2·8)
fetal deaths 0 0
neonatal deaths 0 0
Apgar score after 5 minutes <7 7 (2·2) 2 (0·6) 1·6 (-0·2; 3·4)
Arterial pH <7·15 ‡ 34 (12·2) 38 (13·2) -1·0 (-6·5; 4·5)
Arterial pH <7·10 ‡ 12 (4·3) 19 (6·6) -2·3 (-6·0; 1·4)
Arterial pH <7·05 ‡ 4 (1·4) 10 (3·5) -2·1 (-4·6; 0·5)
Arterial Base Excess < -10 ‡ 16 (5·7) 26 (9·0) -3·3 (-7·6; 1·0)
Admission to intensive care 9 (2·8) 13 (4·0) -1·2 (-4·0; 1·6)
Neonatal admission
Intermediate-care 155 (48·4) 118 (36·3) 12·1 (4·6; 19·7)*
Maternal ward 89 (27·8) 116 (35·7) -7·9 (-15·0, -0·7) *
No admission 67 (20·9) 78 (24·0) -3·1 (-9·5; 3·4)
Length of stay
NICU children 9 (6-14) 13 (6-22) ***
All admissions 4 (2 - 8) 4 (2 - 8) 0·2 (-1·4; 1·8)
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to 14 and 13 days, IQR 6 to 22, respectively). However, more neonates in the induc-
tion group were admitted to a ward providing an intermediate level of neonatal 
care (155 (48.4%) v 118 (36.3%); difference 12.1%, 95% CI 4.6% to 19.7%; P<0.05).
Exclusion of pregnancies complicated by hypertensive disease at randomisation 
did not alter the results for the composite adverse neonatal outcome or caesarean 
section (data not shown). Stratified analysis for centre and parity using logistic re-
gression showed no treatment differences among the participating centres (data 
not shown).
Discussion
This study has shown that among women with a singleton pregnancy complicated 
by suspected intrauterine growth restriction at a gestational age of between 36+0 
and 41+0 weeks, a policy of labour induction neither affects the rate of adverse 
neonatal outcomes nor the rates of instrumental vaginal delivery or caesarean sec-
tion. 
The present study has only ruled out a difference in adverse neonatal outcomes 
larger than 4.3%. We have not ruled out an effect on the rarer outcome of perinatal 
death. One theoretical argument in favour of induction is that it might pre-empt 
intrauterine fetal death, so clinicians who wish to follow expectant management 
should monitor the ongoing pregnancy closely.
In our study the number of admissions to neonatal intensive care was comparable 
in both arms, but more neonates in the induction group were admitted to interme-
diate levels of care. This finding might be an artefact of the inevitable lower birth 
weight in this group given that the policy was to admit infants below a certain 
weight, but complications of late prematurity cannot be ruled out. Limiting induc-
tion to infants with a gestational age of greater than 37 weeks would reduce the 
incidence of this outcome, but we cannot know whether this approach would be 
associated with better long term outcomes.27
The higher median birth weight in the expectant monitoring group indicates that 
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infants in this group gained on average 130 g during the roughly 10 additional 
days’ gestation they experienced compared with the induction group. Presumably, 
although most neonates in the present trial were born with a weight below the 
10th percentile, a number were not really growth restricted but rather constitu-
tionally small. Constitutionally small infants have the potential to grow at term, 
whereas growth restricted infants might experience intrauterine undernourish-
ment and decelerated growth. We also observed that the number of children with 
a birth weight below the third percentile differed significantly between the induc-
tion of labour group(12.5%) and the expectant monitoring group (31%).This sug-
gests that a substantial number of children in the expectant monitoring group did 
not continue to grow along their own expected growth curves. Being born severely 
growth restricted appears to be associated with worse long term outcomes.27 Al-
though not defined as a primary outcome in our study, this suggestion could be a 
compelling reason for induction and certainly merits further investigation.
When women with hypertension or pre-eclampsia at the time of randomisation 
were excluded, the incidence of the composite adverse neonatal outcome did not 
differ between the study groups, nor did this result in a lower incidence of cae-
sarean section among women in the expectant monitoring group. Results from 
the HYPITAT trial support a strategy of inducing women who develop a hyperten-
sive disorder after 37 weeks of pregnancy to prevent possible maternal complica-
tions.22 This probably also applies to women who develop hypertensive disorders 
in addition to growth restriction, but the number of such women in this trial was 
too small to investigate this possibility in detail.
Comparison with other studies
Previous observational studies suggest that antenatal detection and induction are 
associated with an increased incidence of obstetric interventions, without a de-
monstrable neonatal benefit.12-14 However, our finding of no effect of induction 
on adverse neonatal outcomes, which is from a randomised trial, should super-
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sede findings from observational studies. The finding that induction did not affect 
the rate of operative deliveries in our study should also not be surprising because 
observational studies that suggested an increase in operative intervention with in-
duction have been contradicted by later randomised trials. Observational studies 
of the effect of induction near term for other fetal indications—such as post-ma-
turity, ruptured membranes, and hypertensive disease—on the rate of operative 
deliveries have been similarly misleading.22 28 29
A similar trial of timed delivery among much more severely compromised pre-term 
fetuses, the Growth Restriction Intervention Trial (GRIT), was reported in 2004.30 
31 At two year follow-up, the risk of disability was reduced in the delayed delivery 
group compared with the immediate delivery group among babies younger than 
31 weeks of gestation at randomisation. Because growth restriction is associated 
with a less favourable (neuro)developmental outcome in the term period as well as 
poor outcomes at delivery,32 we plan to investigate the wellbeing of the children 
randomised during DIGITAT at two years follow-up.
Strengths and limitations of study 
The main strength of this study is the comparison of randomised groups and the 
large size of the study population. There have been no other randomised trials in 
this area.
Identifying fetuses at risk of true intrauterine growth restriction is a diagnostic chal-
lenge. Customised growth centile charts33 are rarely applied in the Netherlands 
and were not used in the present study, but might identify fetuses at risk. Although 
we encountered no perinatal deaths among the randomised women, the associa-
tion between low birth weight and perinatal death is well accepted.1-4 However, 
many thousands of participants would be required to power a study on the effects 
of induction on perinatal death. 
The relatively favourable neonatal outcomes in both study groups could reflect the 
fact that participants and clinicians were more alert to possible complications and 
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women received cautious attention from their doctors. Monitoring is also intensi-
fied in ordinary practice in the Netherlands, but monitoring and therefore neonatal 
outcomes could have been biased because of the study setting. The study results 
should be extrapolated with caution to settings where close monitoring cannot be 
offered.
It was possible to defer delivery in the expectant monitoring group for on average 
9.6 days after randomisation, resulting in an average gestational age of 39+3 weeks. 
Prolongation of gestational age in this group led to more instances of spontaneous 
vaginal delivery than in the induction group, but did not reduce the number of cae-
sarean sections. Compared with other countries (that is, the United States and the 
United Kingdom), rates of caesarean section in the Netherlands have always been 
relatively low,34 and the rate in this group of high risk pregnancies was even lower 
than the average rate of 15% in the Netherlands.25
The fact that women who declined randomisation were older, more highly educat-
ed, and smoked less might suggest that the study recruited a slightly biased group 
of women. This may have an effect on the generalisability of the results. 
Conclusions and policy implications
In conclusion, we found equivalent fetal and maternal outcomes for induction and 
expectant monitoring in women with suspected intrauterine growth restriction at 
term, indicating that both approaches are acceptable. In practice, however, obste-
tricians and patients will let factors other than growth restriction guide decision 
making at delivery.35 It is reasonable for patients who are keen on non-interven-
tion to choose expectant management with intensive maternal and fetal monitor-
ing because, as far as we can tell, this approach is safe for the baby. However, it 
is more rational to choose induction to prevent possible neonatal morbidity and 
stillbirth on the grounds that we showed no increase in operative and instrumental 
delivery rates. However, our study was underpowered to show differences in late 
pregnancy loss. 
Induction versus expectant monitoring for intrauterine growth restriction at term: 
randomised equivalence trial (DIGITAT)
DEF-zw-Proefschrift-KIM-13april-2012.indd   75 13-4-2012   13:13:16
76
By inducing labour in cases of intrauterine growth restriction, infants that will not 
grow any further can be released from their undernourished environment. Future 
studies should focus on how to distinguish before childbirth fetuses with genu-
ine growth restriction and those that are constitutionally small, and on elucidating 
which ante partum factors predict adverse outcomes.
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Abstract
Objective:  The DIGITAT-trial compared induction of labor and expectant manage-
ment in suspected intrauterine growth restriction (IUGR) at term. In this sub-anal-
ysis, we report neonatal morbidity between the policies based on the morbidity 
assessment index for newborns (MAIN).
Study design : We used data from the DIGITAT-trial. For each neonate, we calcu-
lated the MAIN score, a validated outcome scale. 
Results: There were no differences in mean MAIN scores, nor in MAIN morbidity 
categories. We found that neonatal admissions are lower after 38 weeks gestation-
al age compared to 36 and 37 weeks in both groups
Conclusions: The incidence of neonatal morbidity in IUGR at term is comparable 
and relatively mild either after induction or after an expectant policy. However, 
neonatal admissions are lower after 38 weeks of pregnancy, so if induction to pre-
empt possible stillbirth is considered, it is reasonable to delay until 38 weeks, pro-
vided watchful monitoring.
Keywords: Digitat-trial, MAIN score, neonatal morbidity, induction of labor, intra-
uterine growth restriction at term.
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Neonatal morbidity after induction versus expectant monitoring in 
intrauterine growth restriction at term – a subanalysis of the DIGITAT RCT.
Introduction
AIntrauterine growth restriction is defined as an estimated fetal weight or an ab-
dominal circumference below the 10th centile for gestational age 1. Postnatally, 
children with a birth weight below the 10th centile are classified as small for gesta-
tional age (SGA). The latter condition is only identified after birth. However, IUGR2-5 
and SGA6-13 are associated with perinatal morbidity and mortality, even at term. 
There is no consensus on the management of pregnancies complicated by IUGR.14-
16 We recently performed the Disproportionate Intrauterine Growth Intervention 
Trial at Term (DIGITAT)17 to investigate whether induction of labor for pregnancies 
with suspected IUGR beyond 36 weeks gestation reduced neonatal morbidity and 
mortality compared with an expectant approach with fetal and maternal surveil-
lance.  Unlike many retrospective studies on growth restriction, our study did not 
look retrospectively at children being born small for gestational age, but followed 
children prospectively with suspected IUGR at term.
The study showed comparable primary fetal outcomes (a composite of perinatal 
death, 5 minute Apgar score below 7, umbilical arterial pH below 7.05 or admission 
to neonatal intensive care unit (NICU)) as well as comparable rates of operative de-
liveries.  Although the total number of children admitted to intensive care did not 
differ between the groups, more children in the induction group were admitted to 
an intermediate level of care than in the expectant group (48% v. 36%, difference 
12% [95% CI: 5% to 20%]). Complications of late prematurity13-18-19 might explain 
this, since children in the induction group were born on average ten days earlier 
than in the expectant group, (266 days vs. 277 days, difference -9.9 days, 95% CI: 
-11 to -9)17. However, the difference may simply reflect policies for admission to 
intermediate levels of care related to prematurity rather than clinically relevant 
morbidity. It is important to resolve these two competing explanations because, in 
the expectant group, more children were severely growth restricted, defined as a 
birth weight below the third percentile (13% v 31%: difference -18% [95% CI -24% 
to -12%]) and therefore had a possible higher risk of neonatal morbidity.2-4-6-12 
To study the net influence of the two policies on neonatal morbidity in detail, the 
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MAIN (Morbidity Assessment Index for Newborns) score, a validated outcome mea-
sure for neonatal morbidity, was calculated and compared. 20-21
Subjects and Methods
This is a secondary analysis of the DIGITAT-trial. The original trial was approved by 
the University of Leiden institutional review board (P04.210). Written informed 
consent was obtained from all participants before randomization.
The study population consisted of children born to mothers who participated in 
the DIGITAT-trial. Between November 2004 and November 2008, pregnant women 
with a singleton fetus in cephalic presentation, and suspected IUGR between 36+0 
and 41+0 weeks were recruited. Suspected IUGR was defined as a fetal abdominal 
circumference (AC) or an estimated fetal weight (EFW) below the 10th percentile, 
or deceleration of the fetal abdominal circumference in the third trimester.20 Ex-
clusion criteria were previous caesarean section, diabetes mellitus or gestational 
diabetes requiring insulin therapy, renal failure, HIV seropositivity, prelabor rupture 
of membranes, severe pre-eclampsia, HELLP syndrome (hemolysis, elevated liver 
enzymes, and low platelet count), or a fetus with aneuploidy or congenital abnor-
malities suspected on ultrasound. Fetuses with decreased or absent movements, 
and those with abnormal heart rate tracings, were also excluded.
Consenting women were randomly allocated to either induction or expectant 
monitoring. Participants allocated to the expectant monitoring group were moni-
tored until the onset of spontaneous labor with daily fetal movement counts and 
twice weekly heart rate tracings, ultrasound examination, maternal blood pressure 
measurement, assessment of proteinuria, laboratory tests of liver and kidney func-
tion, and full blood count. Women were monitored as either an outpatient or an in-
patient, according to local protocol. In the expectant monitoring group, induction 
of labor or planned caesarean section was performed for obstetrical indications—
such as suboptimal fetal heart rate tracings, prolonged rupture of membranes, or 
post maturity between T+7 and T+ 14 days—at the obstetrician’s discretion.
Morbidity was calculated using the MAIN score.20-21 This score was developed 
Chapter 5 Neonatal morbidity after induction versus expectant monitoring in 
intrauterine growth restriction at term – a subanalysis of the DIGITAT RCT.
DEF-zw-Proefschrift-KIM-13april-2012.indd   82 13-4-2012   13:13:17
83
to provide a numeric index of early neonatal outcomes of prenatal care and ad-
verse prenatal exposures in babies delivered beyond 28 weeks of gestation. It is 
a sensitive and discriminative outcome measure for obstetric clinical trials and 
is particularly suited for studies with outcomes other than extreme preterm de-
livery. The data items, such as Apgar scores at 5 and 10 minutes, cord blood pH, 
hyperbilirubinemia, hypoglycemia, intraventricular hemorrhage and the need for 
intubation, can all be obtained from the hospital discharge summaries. The final 
score is divided into four morbidity categories: below 150 (no/minimal morbidity), 
151 to 500 (mild morbidity), 501 to 800 (moderate morbidity) and more than 800 
(severe morbidity).21 A MAIN score greater than zero is considered as a positive 
MAIN score. For children admitted to NICU or intermediate level care, items for the 
MAIN score were obtained from the discharge summaries. For those discharged 
home immediately after birth or admitted only to the maternal ward no separate 
discharge summaries are written, so for them 5 and 10 minute Apgar scores and 
arterial umbilical artery pH only, were used, assuming that the other items, if not 
reported were normal. 
Data were analyzed according to intention-to-treat. Continuous variables were 
compared using Student’s t-test or Fisher exact test when data were normally 
distributed, or the nonparametric Mann-Whitney U test for skewed data. The chi-
square test was used for categorical variables. Treatment effects were presented 
as difference in percentages with 95% confidence intervals (CI). P-values less than 
0.05 were considered to indicate statistical significance. If more than five percent 
of observations were missing, this was indicated in the footnote of the table. The 
scores for the induction and expectant groups were compared for all babies and 
stratified by gestational age at time of randomization and for the different admis-
sion types.
We studied the effect of gestational age at randomization on different outcome 
parameters, such as mean MAIN score, severe MAIN score and composite adverse 
neonatal outcome. This was done using generalized additive logistic regression 
models where the effect of gestational age is estimated with a smoothed curve.22
We tested for differences between the two groups using likelihood ratio tests.
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Results
In the DIGITAT-trial, 321 women were randomized for induction and 329 for an 
expectant management policy (figure 1). The MAIN score was assessed in 308 in-
duction group babies and in 315 expectant management group babies. Baseline 
characteristics and main trial results are displayed in Table 1. 
There were no differences between the randomized groups in maternal co-mor-
bidities such as pre-eclampsia or gestational hypertension, heart and vascular dis-
orders or autoimmune disease (data not shown).
As a result of deferring delivery for 10 days with expectant management, gesta-
tional age and birth weight differed significantly between the two groups. More 
babies were admitted to intermediate level of care after induction. No other differ-
ences at baseline were found. 
Most women who were randomized met either the fetal abdominal circumference 
below 10th centile or the estimated fetal weight below 10th centile criterion (Table 1.) 
Only 13 women in the induction group and 10 in the expectant monitoring group 
were included because of flattening of the fetal abdominal circumference growth 
curve only.
Figuur 1
Flow diagram of study subjects and their admission categories.
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Table 1 
Baseline characteristics of randomized participants as well as main trial results
** p < 0·001, * p<0·05
Table shows median (interquartile range 25th to 75th percentile or number (%)).
an=275 for induction, n=295 for expectant monitoring.
bn=294 for induction, n=311 for expectant monitoring.
cn=304 for induction, n=312 for expectant monitoring.
Data were analyzed with the Student t-test or chi-squared test.
Characteristic









Nulliparous 182 (56.7) 201 (61.1) - 4.4 ( -12.0, 3.2)
Maternal age 26.9 (23.3 – 31.2) 27.4 (23.3 – 31.4) -0.04 (-8.6, 7.8)
BMIa at study entrya 21.9 (19.7 – 25.5) 22.2 (19.7 – 25.6) -0.1 (-1.0, 0.7)
Maternal smokingb 138 (46.9) 127 (40.8) -6.1 (-1.8, 14)
Gestational age at randomization (days) 264 (258-269) 264 (258-268) -0.7, (-2.1, 0.7)
Caucasianc 254 (83.6) 253 (81.1) - 2.5 (-3.6, 8.5)
Education
Lower professional school 168 (52.3) 170 (51.7) 0.6, (-7.0, 8.4)
Medium professional school 26 (8.1) 37 (11.2) -3.1, (-7.7, 1.4)
Unknown 127 (39.6) 122 (37.1) -2.5 (-5.0, 10.0)
Inclusion criteria
Fetal abdominal circumference 
<10th percentile 262 (81.6) 270 (82.1) -0.5 (-6.4, 5.5)
Estimated fetal weight <10th percentile 296 (92.2) 308 (93.6) -1.4 (-5.4, 2.5)
Flattening of fetal abdominal 
circumference curve 83 (25.9) 84 (25.5) - 0.4 (-6.4, 7.0)
Onset of Labor
Spontaneous 12 (3.7) 151 (46.0) - 42.3 (-48.1, -36.5)
Induction 306 (95.6) 166 (50.6) 45.0 (39.2, 50.9)
Elective Caesarean section 2 (0.6) 11 (3.3) -2.7 – 4.9, -0.6)
Mode of Delivery 
Spontaneous 249 (77.6) 257 (78.1) 0.5 (-6.9, 5.8)
Vaginal instrumental 27 (8.4) 27 (8.2) 0.2 (-4.0, 4.4)
Caesarean section 45 (14.0) 45 (13.7) 0.3 (-5.0, 5.6)
Time between randomization 
and onset of labor (days) 0.9 ( 0•7 - 1.7) 10·4 (5·6 - 16·0) -9.6 (-10.8, -8.5)**
Gestational age at birth (days) 266 (261-271) 277 (269-283) -9.9 (- 11.3, - 8.6)**
Birth weight (grams) 2420 (2220 – 2660) 2550 (2255 – 2850) -130 (-188, -71)**
Birth weight by percentile
< 3rd percentile 40 (12.5) 100 (30.6) -18.1 (- 24.3, – 12.0)**
3rd – 5th percentile 82 (25.5) 79 (24.2) 1.3 (-5.3, 8.0)
5th to 10th percentile 88 (27.5) 62 (18.9) 8.5 (-2.0, 14.9)
10th to 25th percentile 88 (27.4) 66 (20.2) 7.2 (0.7, 13.8)
>25th percentile 23 (7.2) 20 (6.1) -1.1 (-2.8, 4.9)
Composite adverse neonatal outcome 17 (5.3) 20 (6.1) - 0.8 (-4.3, 2.8)
Neonatal admission
Intensive Care 9 (2.8) 13 (4.0) -1.2 (-4, 1.6)
Intermediate-care 155 (48.3) 118 (35.9) 12.4 (4.9, 20.0)*
Maternal ward 89 (27.8) 116 (35.7) -7.9 (-15, -0.7)*
No admission 67 (20.9) 78 (24.0) -3.1 (9.5, 3.4)
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The categories of the MAIN scores (no/minimal, mild, moderate and severe mor-
bidity) did not differ between the induction and expectant group. When we looked 
at components of the MAIN score, more children suffered from hyperbilirubinemia 
>220 mmol/L or the need for phototherapy after induction of labor (Table 2). In 
table 2 composite neonatal morbidity (CNM) is shown. 
Table 2 
Distribution of MAIN score, frequently scored/relevant MAIN items and CNM in the two trial groups110
** p < 0·001, * p<0·05, a>2 consecutive readings
Data were analyzed with the Student t-test chi-squared test or Fisher exact test.
Morbidity or MAIN score item









Morbidity according to MAIN score.
No/minimal (<150) 259 (84.1) 258 (81.9) -2.2 (-3.7, 8.1)
Mild (151-500) 47 (15.3) 51 (16.2) -0.9 (-6.7, 4,8)
Moderate (501- 800) 2 (0.7) 5 (1.6) -0.9 (-2.6, 0.7)
Severe (>800) 0 (0) 1 (0.3) -0.3 (-0.9, 0.3)
MAIN score item
Serum bilirubin 251-340 umol/L 
or phototherapy 32 (10.4) 18 (5.7) 4.7 (0.4, 8.9)*
Apnea and need for oxygena 2 (0.7) 5 (1.6) -0.9 (-2.6, 0.7)
Assisted ventilation beyond 24ha 0 (0.0) 5 (1.6) -1.6 (-3.0, -0.2)
Cord blood pH<7.1 11 (3.6) 19 (6.0) -2.4 (-5.8, 0.9)
Hypoglycemia (glucose concentration < 2.2 
mmol/L) 35 (11.4) 34 (10.8) 0.6 (-4.4, 5.5)
Intraventricular hemorrhage grade I or II 0 (0) 1 (0.3) -0.3 (-0.9, 0.3)
Subdural or intracerebal hematoma 0 (0) 1 (0.3) -0.3 (-0.9, 0.3)
Composite neonatal morbidity
Intraventricular hemmorhage 0 (0) 1 (0.3) -0.3 (-0.9, 0.3)
Periventricular malacia 0 (0) 0 (0) NA
Proven sepsis 0 (0) 1 (0.3) -0.3 (-0.9, 0.3)
Nectrotizing enterocolitis 0 (0) 0 (0) NA
Respiratory distress syndrome 0 (0) 0 (0) NA
Bronchopulmonary dysplasia 0 (0) 0 (0) NA
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When we stratified for different admission types (NICU, Intermediate level care, 
ward), we also found comparable MAIN scores (Table 3). Stratification for different 
weight percentiles showed no differences between the MAIN score (Table 3). Five 
children were admitted to intensive care with a MAIN score of zero.
Table 3 
Mean MAIN score shown for different admission categories and different growth centiles
Table shows mean; median (interquartile range 25th to 75th percentile)
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Figure 2 shows the percentage of neonatal admissions related to gestational age at 
randomization for both groups. Gestational age had a significant effect on the risk 
of being admitted to neonatal care (NICU and Intermediate level care), with a high-
er risk at a lower gestational age. The percentage of children admitted to neonatal 
care was lower after an expectant management. We also compared the percentage 
of babies born after induction of labor with a positive MAIN score to babies born 
after an expectant management. Although we found fewer babies with a positive 
MAIN score beyond 38 weeks randomization as compared to randomization at 36 
or 37 weeks, the percentages in the two groups were comparable (Figure 3). In Fig-
ure 4 we compared the primary outcome of the trial (composite adverse neonatal 
outcome; perinatal death, arterial umbilical artery pH below 7.05, 5 minute Apgar 
below 7 or admission to NICU) in relation to gestational age at randomization. In 
both the induction group as well as in babies born after expectant management, 
at the different gestational ages, comparable percentages of composite adverse 
outcome were found. For all three outcomes (neonatal admissions, positive MAIN 
score and composite adverse outcome) we compared induction versus expectant 
management in women randomized before 38 weeks, from 38 till 40 weeks and af-
ter 40 weeks. The only difference was a higher percentage of neonatal admissions 
after induction before 38 weeks gestational age; 125 (61%) admissions vs. 92 (44%) 
after expectant management, difference 16% ([95% CI: 6.7% to 26%], p=0.001).
Figuur 2
Gestational age at randomization vs. percentage of neonatal admission.
Chapter 5 Neonatal morbidity after induction versus expectant monitoring in 
intrauterine growth restriction at term – a subanalysis of the DIGITAT RCT.
DEF-zw-Proefschrift-KIM-13april-2012.indd   88 13-4-2012   13:13:17
89
Figuur 3
Gestational age at randomization vs. percentage of neonates with an adverse composite outcome.
Figuur 4
Gestational age at randomization vs. percentage of neonates with a positive MAIN score.
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Discussion
This study confirmed findings of the DIGITAT-trial, where no significant differences 
in neonatal morbidity between induction and expectant management were found. 
This supports the hypothesis that the higher rate of admissions after induction of 
labor was a regular care driven effect of a lower gestational age and lower birth 
weight, rather than due to defined complications.
Our study was limited to babies suspected of growth restriction at term, which is 
when most IUGR is detected.23 In the DIGITAT-trial around 70% of children in fact 
had a birth weight below the 10th centile, with a higher percentage of very low 
birth weight (<P2.3) after expectant management. Apparently, the group of pa-
tients with suspected growth restriction is mixed, with some babies who are really 
growth restricted where normal physiological growth is inhibited, and others who 
are small for gestational age, but grow along their own growth trajectory. Expect-
ant management makes the contribution of those who stopped growing more 
prominent.  
The mean MAIN scores reported in the present study 49 were lower than those pub-
lished by Verma et al (235).21 Neonates in our study showed no or minimal morbid-
ity whereas Verma’s score indicated mild morbidity for neonates with an IUGR. One 
explanation is that we limited our study to pregnancies beyond 36 weeks, whereas 
Verma included neonates from 28 weeks onwards.  Another explanation might be 
that we used discharge summaries, whereas Verma used full hospital records to 
calculate the MAIN score.   Finally, the growth restriction in our population was less 
severe than the patients included in Verma`s study, that defined IUGR as a birth 
weight below the 3rd centile. 
The fact that five children admitted to the intensive care unit had a MAIN score of 
zero supports the hypothesis that sometimes admission to intensive care was relat-
ed to only gestational age or birth weight rather than morbidity.  Even though ad-
mission to NICU implies serious morbidity, these children were admitted mainly for 
neonatal observation. For example one child in the expectant management group 
was admitted to NICU with a birth weight of 1670 grams but no serious morbidity. 
During the trial, IUGR pregnancies were closely monitored and therefore we can-
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not exclude that pregnant women and their babies received more than usual at-
tention because of the setting of the study. The results should not be extrapolated 
to settings where such monitoring cannot be provided. This monitoring also might 
explain why our morbidity as defined by MAIN score was relatively mild. 
The observation that more babies in the induction group had hyperbilirubinemia is 
probably explained by being born at an earlier gestational age following an induc-
tion policy.24
The lack of effect of the induction policy on hypoglycemia, which might have been 
expected in relatively premature, growth restricted babies might be explained by 
some neonates born after expectant management getting more severely growth 
restricted and undernourished, also leading to hypoglycemia. In general, in the 
expectant management group there was no exclusive neonatal complication that 
contributed to the MAIN score. However, although not statistically significant, 
more children were having respiratory problems, which means different and pos-
sibly more serious morbidity during expectant monitoring. Two of these children 
were born with a birth weight above the 10th percentile, which reminds us of the 
challenges of defining true growth restriction prenatally.
Children born with a low birth weight are prone to develop diseases in later life 
and associations with metabolic syndrome in adolescence and adult life have been 
studied extensively.4 However, the consequences of late prematurity with low birth 
weight, compared to longer exposure to an undernourished intrauterine environ-
ment, on neuro-cognitive and physical development needs to be studied in detail 
through future follow-up studies. 
We found that neonatal admissions were lower after expectant management for 
those who were randomized before 38 weeks gestational age, while the neonatal 
admission rates were comparable between both groups after 38 weeks. This sug-
gests that if induction is contemplated the optimal time to do it is around 38 weeks 
gestational age.
However, in general in pregnancies with IUGR there is an increased risk of stillbirth, 
with an even higher risk in children with a birth weight below the 3rd percentile 
6;17, and we found a higher percentage of these very low birth weights after ex-
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pectant monitoring.18Therefore in the presence of other pathologic findings, such 
as abnormal Doppler measurements or abnormalities in fetal surveillance, induc-
tion may be implemented at lower gestational ages.
In conclusion, the apparent excess of neonatal care admission in the induction arm 
of the DIGITAT trial is probably a benign side effect of late prematurity and neonatal 
admission policies, rather than a marker of serious neonatal morbidity.  This means 
that those who believe for other reasons that induction may pre-empt late still-
births in this group, can be reassured that such a policy does not appear to increase 
short-term neonatal morbidity. 
If a policy of induction for near term growth restriction is to be followed, deferring 
induction until 38 weeks, while strictly monitoring mother and child, may prevent 
complications of late prematurity. Late effects of these policies need further study. 
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Abstract
Objective: The Disproportionate Intrauterine Growth Intervention Trial at Term 
(DIGITAT) compared induction with expectant management for pregnant women 
with a suspected growth restricted foetus at term. To measure the  external validity 
of the trial we compared  trial participants outcomes with those of non-partici-
pants. 
Design: Secondary analysis of a randomised equivalence trial (The Disproportion-
ate Intrauterine Growth Intervention Trial at Term (DIGITAT).
Setting: Eight academic and 44 non-academic hospitals in the Netherlands be-
tween November 2004 and November 2008.
Participants: Pregnant women who had a singleton pregnancy beyond 36+0 
weeks’ gestation with suspected intrauterine growth restriction and participated in 
the DIGITAT trial, and all patients who declined randomisation, but gave authorisa-
tion for the use of their medical data. Identical data were collected prospectively.
Main outcome measures: A composite measure of adverse neonatal outcome 
(neonatal death before hospital discharge, a 5-minute Apgar score < 7, an umbili-
cal artery pH <7·05 or admission to the neonatal intensive care unit), and operative 
delivery.  Comparisons are between participants and non-participants, regardless 
of the group they are randomised to or treatment received. Propensity scores are 
used to adjust for baseline differences between the groups.
Results: 650 women were randomised and  452 declined. Non-participants were 
older, had a lower body mass index (BMI), smoked less frequently and had a higher 
level of education.
A total of 37 (6%) infants of participants experienced the composite adverse neo-
natal outcome, compared with 32 (8%) among non-participants (adjusted differ-
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Comparison of participants and non-participants in a trial of induction of labour versus expectant 
monitoring for intrauterine growth restriction at term (the DIGITAT trial); a prospective cohort study.
ence -2.0% (95% CI -5.2% to 1.1%)). Among  non-participants  3 (0.7%) deaths (2 
stillbirths, 1 neonatal death) occurred, compared with none  in the randomised 
women (difference -0.7% (95% CI -1.4% to 0.1%), p=0.06). Caesarean sections were 
performed on 90 (14%) participants and on 71 (16%) non-participants (adjusted 
difference -2.8% (95% CI -7.5% to 1.8%)). After adjustment for baseline imbalances 
in maternal age, smoking, BMI, education level and hypertensive disorders the ad-
justed difference and (95% CI) for perinatal death after participation in the trial was 
-0.5% ((-1.4% to 0.4%), p=0.27)).
Conclusions: We found a tendency towards better outcomes in participants, even 
after adjusting for baseline characteristics. Participation in a randomised clinical 
trial may be good for you. 
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Introduction
Around 80% of intrauterine growth restricted (IUGR) infants of nulliparae are born 
at term.1 Such pregnancies are associated with increased neonatal mortality and 
short and long term morbidity.2-8 The DIGITAT trial compared labour induction 
with expectant monitoring in these pregnancies and showed no important differ-
ences in maternal or neonatal outcome.9-10  
Randomised controlled trials (RCTs) must be internally valid, but to be clinically 
useful the result must also be relevant to a definable group of patients in a particu-
lar clinical setting. Lack of consideration of external validity is the most frequent 
criticism of RCTs.11-12 Factors influencing external validity include selection of par-
ticipating centres and recruitment from primary, secondary or tertiary care. Patient 
factors affecting external validity include eligibility, exclusion criteria, pre-randomi-
sation diagnosis and the percentage of patients that were non-randomised. Factors 
related to participation in trials are widely discussed 11-13-15 and women’s choice to 
participate is influenced by preferences and socio-economical background.13-16-
This inclusion bias might decrease the generalisability of the trial findings. 
We used the data of non-participants to assess their characteristics and clinical out-
comes and to compare these outcomes to patients who consented to randomisa-
tion during the trial. By this means we aimed to determine generalisability of the 
study outcomes and to detect harmful effects of trial participation.
 
Methods
Study design and patients
The design of the DIGITAT trial has been described elsewhere.9 In short pregnant 
women between 36+0 and 41+0 weeks’ gestation who had a singleton fetus in 
cephalic presentation with suspected intrauterine growth restriction were ran-
domised between induction of labour or expectant monitoring.  Suspected intra-
uterine growth restriction was defined as fetal abdominal circumference below the 
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10th percentile, estimated fetal weight below the 10th percentile, flattening of the 
growth curve in the third trimester, or the presence of all three factors. 
The trial was run by the Dutch Obstetric Consortium, a collaboration of perinatal 
centres in the Netherlands, and approved by the University of Leiden institutional 
review board. Teaching, academic, as well as non-teaching hospitals participated 
to the trial.
Eligible patients who declined randomisation, but agreed the use of their medical 
data, were treated according to local protocols at the discretion of the attending 
obstetrician. Data were collected the same way as for the participants. 
Patients who refused randomisation either had induction of labour or an expect-
ant monitoring strategy. The appropriate strategy was in that case elected by the 
attending obstetrician based on his experience considering the maternal and fetal 
condition, guided by the preferences of both doctor and patient and local proto-
cols. In the expectant monitoring group of participants labour started either spon-
taneously, or was initiated by induction for obstetrical indications such as suspect-
ed fetal distress, prolonged rupture of membranes, or post maturity between T+7 
and T+14 days at the obstetrician’s discretion or planned caesarean section. 
Statistical analyses
PContinuous variables were summarized as medians with interquartile ranges 
(IQR). Treatment effects were presented as differences in means or in percentages 
with 95% confidence intervals (CI). Continuous variables were compared using the 
Student’s t-test or the nonparametric Mann-Whitney U test. The chi-square test and 
the Fisher exact test were used for categorical variables. If more than 5% of the 
observations were missing, this is indicated in the footnote of the table. Propensity 
score methods were used to adjust for group imbalances.17 The propensity score 
was calculated for all patients based on the demographic and baseline character-
istics using logistic regression. Mean differences and risk differences were adjusted 
for the propensity score in linear regression models and additive risk models. Mul-
tiple imputation was used to handle missing data in the baseline variables. Statisti-
cal analysis was performed using SPSS software (version 16•0, Chicago, IL), and R 
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(version 2.10.0, R Foundation for Statistical Computing, Vienna, Austria.), using the 
package MICE.18
Results
Between 2004 and 2008, 1116 women were eligible, of whom 650 were randomised 
and 466 declined. Of the 466 women who declined, 452 consented for use of their 
medical data, of which 410 women were initially monitored expectantly, and 42 
had induction of labour within 48 hours (Figure 1). 
The baseline characteristics of the participants and the non-participants are listed 
 
1116 eligible women  
650 randomly assigned to treatment 
321 induction of labour 
329 expectant monitoring 
452 refused randomisation 
42 induction within 48 hours  
410 expectant monitoring 
 
 
analysed for primary outcome 
 
 
analysed for primary outcome 
14 refused use of medical data 
  
1102 women enrolled for analysis of medical data 
Figuur 1 
Flow diagram of the process of the study
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in Table 1. Participants compared to non-participants were younger (27 years vs. 31 
years, mean difference -3.2; 95% CI (-3.9 to -2.6), p<0.001), had a higher BMI (22 vs. 
21, mean difference 1.0, 95% CI (0.4 to 1.6), p=0.001), were less educated (84% low-
er professional education vs. 62% among non-participants, mean difference 23%, 
95% CI (16% to 30%), p<0.001) and smoked more (44% vs. 27%, mean difference in 
percentage 17, 95% CI 11 to 23, (p<0.001). 
Pregnancy outcome and mode of delivery are shown in Table 2. Participants were 
Table 1 









Maternal age 27 (23 - 31) 31 (27 - 34) -3.2 (-3.9 to-2.6) ***
Body mass index at study entry 22 (20-26) 21 (20-24) 1.0 (0.4 to 1.6) **
Gestational age 263 (258 – 269) 262 (258 – 269) 0.9 (-1.0 to 2.7)
Nulliparous 383 (58.9) 275 (60.8) -1.9 (-7.8 to 3.9) 
Caucasian ¥ 507 (82.3) 344 (73.3) -1.0 (-5.7 to 3.7)
Education §
Lower professional 338 (84.3) 149 (61.6) 22.7 (15.6 to 29.8)***
Higher professional 63 (16) 93 (38) -22.7 (-29.8 to -15.6)***
Maternal smoking 265 (43.8) 114 (26.9) 16.9 ( 11.1 to 22.7) ***
Blood pressure at booking (mmHg)  
Systolic 115 (105-120) 115 (110-120) -0.8 (-2.4 to 0.8)
Diastolic 69 (60-75) 70 (60-75) -1.2 (-2.4 to -0.1)
Blood pressure at study entry (mmHg)
Systolic 120 (110-130) 120 (110-130) -0.8 (-2.6 to 0.9)
Diastolic 72 (65-80) 75 (70-85) -1.5 (-2.8 to -0.1)*
Women with gestational hypertension 28 (4.3) 25 (5.5) -1.2 (-3.8 to 1.4)
Women with pre-eclampsia 45 (6.9) 27 (6.0) 0.9 ( -2.0 to 3.9)
Foetal abdominal circumference (mm) 288 (278-297) 289 (278-298) 0.9 (-2.1 to 2.3)
Foetal abdominal circumference (mm) 288 (278-297) 289 (278-298) 0.9 (-2.1 to 2.3)
Comparison of participants and non-participants in a trial of induction of labour versus expectant 
monitoring for intrauterine growth restriction at term (the DIGITAT trial); a prospective cohort study.
Data are median (IQR 25th-75th percentile) or number (%)
 *p<0.05, ** p=0.001, *** p<0.001
¥ (n=616 for participants, n=413 for non-participants)
 § (n=401 for participants, n=242 for non-participants) 
 (n=605 for participants, n=424 for non-participants)
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more often induced, delivered earlier and they tended to deliver spontaneously 
more often. Significantly more women outside the trial developed gestational hy-
pertension.
Table 3 displays neonatal outcome. More babies of non-participants were severely 
Table 2 
Pregnancy outcome and onset of labour
Data are median (IQR 25th-75th percentile) or number (%). CI denotes confidence interval. 






tage or mean (95% CI)
Adjusted difference 
in percentage
 or mean (95% CI)
Time between randomisation and 
onset of labour (days) 3 (1-11) 8 (3-17) -3.6 ( -4.9 to -2.3)** -4.3 (-5.4 to -3.2)**
• Induction 1 (1-2) 1 (0-1)
• Expectant management 10 (5-16) 10 (5-18)
Gestational age at delivery (days) 271 (263-279) 275 (268-281) -3.4 (-4.6 to -2.2) ** -3.0 (-4.3 to -1.8)**
• Induction 266 (261-271) 267 (260-273)
• Expectant management 277 (269-283) 276 (269-282)
Onset of labour
Spontaneously 163 (25.2) 197 (43.7) -18.5 (-24.2 to -12.9)** -19.4 (-25.5 to -13.3)**
Planned caesarean section 13 (2.0) 13 (2.9) -0.9 (-2.8 to 1.0) -1.8 (-3.5 to -0.2)*
Induction 472 (72.8) 241 (53.4) 19.4 (13.7 to 25.1)* 20.9 (14.7 to 27.1)**
Mode of Delivery 
Spontaneously 506 (77.8) 328 (72.7) 5.1 (-0.1 to 11) 4.9 (-0.7 to 10.6)
Vaginal instrumental delivery 54 (8.3) 52 (11.5) -3.2 (-6.8 to 4.1) -2.0 (-6.0 to 1.0)
Caesarean section 90 (13.8) 71 (15.7) -1.9 (-6.2 to 2.4) -3.2 ( -7.8 to 1.5)
Indications for caesarean section
Suspected fetal distress 
(+/- arrest of labour) 77 (85.6) 59 (84.3) 2.5 (-8.9 to 13.8) - 0.2 (-3.5 to 1.9)
Arrest of labour 7 (7.8) 5 (7.1) 0.7 (-7.4 to 8.9) 1.0 (-8.3 to 10.2)
Other 6 (6.7) 6 (8.6) -1.8 (-10.1 to 6.5) -2.4 (-12.8 to 7.9)
Adverse maternal outcome
Maternal death 1 0
Progression to gestational 
hypertension 7 (1.1) 13 (2.9) -1.8 (-3.5 to -0.1) -2.1 (-3.8 to -0.3)*
Progression to pre-eclampsia 38 (5.8) 38 (8.4) -2.6 (-5.7 to 0.7) -1.0 (-4.3 to 2.3)
Postpartum haemorrhage 25 (3.9) 23 (5.1) -1.2 (-3.7 to 1.3) - 0.8 (-3.5 to 2.0)
Thrombo embolic events 0 1 
Placental abruption 0 2 
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growth-restricted (<2.3). There were no significant differences for the other out-
comes, but trends were towards more beneficial outcomes for participants. There 
were no perinatal deaths among participants while there were three deaths among 
non-participants. Two deaths occurred after expectant policy at 40+1 and at 41+4 
weeks pregnancy, with time to delivery of 11 and 24 days respectively. Post-mor-
tem examination showed that these stillbirths were associated with IUGR. The third 
child died after induction and emergency caesarean section because of placental 
abruption at 37+2 days gestational age. The suspicion of IUGR had started at 35+6 
weeks pregnancy. This child died after a long hospital admission due to serious 
complications of severe asphyxia. One woman among participants allocated to in-
duction of labour died at home 10 days after delivery. She had delivered a healthy 
child vaginally at 38+4 weeks of gestation after spontaneous onset of labour. No 
cause for her death was found at post-mortem and it was classified as a serious 
unrelated adverse event. No women in the expectant monitoring group of partici-







tage or mean (95% CI)
Adjusted difference 
in percentage
 or mean (95% CI)
Birth weight (grams) 2485 (2235-2750) 2530 (2270-2810) -28 (-76 to 19) -19.2 (-70.9 to 32.5)
Percentiles
< P 2.3a 140 (21.5) 136 (30.1) -8.6 (-13.8 to -2.3)** -8.0 (-13.8 to -0.2)*
P 2.3a - P5 161 (24.8) 108 (23.9) 0.9 (-4.3 to 6.0) - 0.5 (-6.1 to 5.1)
P5 - P10 150 (23.1) 99 (21.9) 1.2 (-3.8 to 6.2) 2.6 (-2.9 to 8.0)
P10 - P25 154 (23.7) 79 (17.5) 6.2 (1.4 to 11.0)* 5.8 (0.6 to 11.1)*
Composite adverse 
neonatal outcome 37 (5.7) 32 (7.1) -1.4 (-4.3 to 1.6) -2.0 (-5.2 to 1.1)
foetal deaths/neonatal deaths 0 3 (0.7) -0.7 (1.4 to 0.1) -0.5 (-1.4 to 0.4)
Apgar score after 5 minutes <7 9 (1.4) 10 (2.2) -0.8 (-2.5 to 0.7) -1.1 (-2.5 to 0.4)
Arterial pH <7.05 † 14 (2.5) 9 (2.4) 0.1 (-1.9 to 2.1) 0.2 (-2.0 to 2.4)
Admission to intensive care 
Neonatal admission
High care/Medium care 273 (42.3) 195 (43.2) -1.1 (-6.9 to 5.0) -2.7 (-9.3 to 3.8)
Maternal ward 205 (31.8) 130 (28.8) 3.0 (- 2.6 to 8.5) 2.1 (-3.9 to 8.2)
No admission 145 (22.5) 110 (24.4) -1.9 (-7.0 to 3.2) 1.6 (-3.9 to 7.1)
Length of stay (days) 4 (2-8) 4 (2-7) Ŧ 0.3 (-1.0 to 1.6)
Data are median (IQR 25th-75th percentile) or number (%). 
CI denotes confidence interval. 
a= severe growth restriction according to Dutch percentiles
* p <0.05, **p <0.001 Ŧ p=0.5 (Mann-Whitney test) 
† n= 567 for participants, n=377 for non-participants 
 percentiles according to Dutch fetal growth charts
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Discussion
In this study comparing the clinical course of women diagnosed with suspected 
growth restriction at term, we could not identify harmful effects from participation 
in a randomised trial comparing induction and expectant management. 
The strength of this study is that data were collected prospectively in an identical 
way, both from participants and non participants. 
Though the median fetal abdominal circumference at baseline was comparable 
for participants and non-participants we found a higher rate of severely growth 
restricted children at birth in non-participants. Besides, we found a trend towards 
less spontaneous deliveries and worse neonatal outcomes (more perinatal mortal-
ity and lower Apgar scores). 
Non-participants were healthier at baseline on important clinical characteristics 
(i.e. BMI, educational level and smoking). Although these characteristics are in gen-
eral associated with better neonatal outcomes,19 opposite associations have been 
observed in low birth weight infants, like lower mortality rates in low birth weight 
infants with smoking mothers.20 This so-called birth weight paradox can be ex-
plained by the fact that smoking causes IUGR in otherwise healthy infants, while 
IUGR in non-smoking women is caused by other medical reasons. Adjusting for the 
baseline differences between participants and non-participants did not change 
the results.
Most non-participants were managed initially with an expectant policy, suggesting 
that this was the preferred management policy of most obstetricians and women 
during the trial period. 
An important difference between the participants and non-participants is that 
non-participants probably had a strong preference for one of the two manage-
ment strategies, while the participants were willing to undergo both strategies.
A possible explanation for declining randomisation could be the fact that women 
did not want to be induced out of fear for medical interventions. Although  fewer 
women that declined participation were induced, this did not lead to a lower rate 
of operative deliveries.21
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Our data are in accord with many other studies which suggest that participation 
in a randomised trial22 or protocol driven management23 improves outcomes re-
gardless of the actual treatment given.14-16-24 It seems that the DIGITAT women 
benefited from the protocol-driven attention of their doctors. Moreover women 
participating in a study are probably also more attentive to their medical status.
Recruitment to clinical trials is influenced by social economic status (SES), and 
women who are less educated are often less willingly to participate.25-30 Converse-
ly, in the DIGITAT trial a lower SES led to more participation.
Overall neonatal admission rates were comparable in the two groups, but more 
children of non-participants were severely growth restricted at birth, probably as 
a result of a longer expectant time to delivery. This is in accord with results of the 
DIGITAT trial. The higher rate of severe growth restricted children might explain the 
tendency towards less favourable outcomes. However, we did not find this asso-
ciation between severely growth restricted children and worse outcomes among 
children of participants who were managed expectantly.31
While none of the children of participating women died, perinatal deaths did occur 
among non-participants. The mutual factor of these 3 children was a relative long 
time of expectant management, and 2 of the 3 were delivered only after 40 weeks. 
These findings might imply that over long prolongation of pregnancy  in IUGR im-
poses perinatal morbidity and mortality, perhaps also due to the lack of protocol 
driven management.
In conclusion we found a tendency towards more favourable outcomes in women 
randomised to the DIGITAT trial than in women who refused to participate, even 
after adjusting for baseline characteristics. Participation in a randomised clinical 
trial on growth restriction did not increase the risk of bad outcome. 
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Chapter 7 Maternal health-related quality of life after induction of labor or expectant monitoring in 
pregnancy complicated by intrauterine growth retardation beyond 36 weeks
Abstract
Objective: Pregnancies complicated by intrauterine growth retardation (IUGR) be-
yond 36 weeks of gestation are at increased risk of neonatal morbidity and mortal-
ity. Optimal treatment in IUGR at term is highly debated. Results from the multi-
center DIGITAT (Disproportionate Intrauterine Growth Intervention Trial At Term) 
trial show that induction of labor and expectant monitoring result in equal neona-
tal and maternal outcomes for comparable cesarean section rates. We report the 
maternal health-related quality of life (HR-QoL) that was measured alongside the 
trial at several points in time.
Methods: Both randomized and non-randomized women were asked to partici-
pate in the HR-QoL study. Women were asked to fill out written validated ques-
tionnaires, covering background characteristics, condition-specific issues and the 
Short Form (SF-36), European Quality of Life (EuroQoL 6D3L), Hospital Anxiety and 
Depression scale (HADS), and Symptom Check List (SCL-90) at baseline, 6 weeks 
postpartum and 6 months postpartum. We compared the difference scores of all 
summary measures between the two management strategies by ANOVA. A re-
peated measures multivariate mixed model was defined to assess the effect of the 
management strategies on the physical (PCS) and mental (MCS) components of 
the SF-36. Analysis was by intention to treat.
Results: We analyzed data of 361 randomized and 198 non-randomized patients. 
There were no clinically relevant differences between the treatments at 6 weeks or 
6 months postpartum on any summary measures; e.g., on the SF-36 (PCS: P =0.09; 
MCS: P =0.48). The PCS and the MCS were below norm values at inclusion. The PCS 
improved over time but stayed below norm values at 6 months, while the MCS did 
not improve.
Conclusions: In pregnancies complicated by IUGR beyond 36 weeks, induction of 
labor does not affect the long-term maternal quality of life.
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Maternal health-related quality of life after induction of labor or expectant monitoring in 
pregnancy complicated by intrauterine growth retardation beyond 36 weeks
Introduction
Pregnancies complicated by intra-uterine growth retardation (IUGR) are at in-
creased risk for adverse neonatal outcome. Suspected IUGR often results in small-
for gestational age (SGA) neonates, perinatal mortality and morbidity, and adverse 
long-term health of the child 1-5. IUGR is associated with hypertensive complica-
tions in pregnancy. Delivery to release the fetus from its nutritionally inadequate 
environment is thought to be the only feasible treatment 6-7. However, there is no 
consensus regarding the optimal management strategy in IUGR at term. Induction 
of labor is believed to result in a higher chance of complications during delivery, 
while expectant monitoring provides a maximal chance of spontaneous labor at 
the expense of possible complications for the child. 
We recently compared induction of labor and expectant monitoring in women 
with an IUGR-fetus beyond 36 weeks of gestation in a nationwide randomized 
clinical equivalence trial called DIGITAT (Disproportionate Intrauterine Growth In-
tervention Trial At Term; ISRCTN10363217). Results indicated that both treatments 
result in equal neonatal and maternal outcomes 8-9. Alongside the DIGITAT trial, we 
conducted a health-related quality of life (HR-QoL) study to examine the impact of 
the non-invasive (expectant monitoring) and the assumed invasive (induction of 
labor) strategy on the mother’s self-reported health as a secondary outcome. Given 
the observed clinical equivalence, maternal outcomes gain importance to support 
clinical decision-making. HR-QoL can be an important factor for women to choose 
one treatment over the other and may lead to better treatment satisfaction.
We compared the impact of the two strategies at six weeks and at six moths post-
partum in terms of self-reported health, anxiety, depression, and physical and 
mental symptoms, using validated questionnaires. The DIGITAT HR-QoL study in-
cludes observational data on patient outcome from patients refusing to participate 
in the trial to address potential bias from trial participation. We hypothesized that 
the invasive strategy would be more burdensome, as it was expected to be associ-
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ated with a higher intervention rate such as instrumental delivery and caesarean 
sections.  
Methods 
Patients and clinical study
In the equivalence DIGITAT trial, primary outcome was defined as a composite 
neonatal adverse outcome, defined as death before hospital discharge, 5-minute 
Apgar score < 7, umbilical artery pH < 7·05, or admission to the neonatal intensive 
care. Eligible patients were women with a singleton pregnancy and a fetus in ce-
phalic presentation between 36+0 to 41+0 weeks gestational age, with suspected 
IUGR. IUGR was defined as fetal abdominal circumference below the 10th percen-
tile, estimated fetal weight below the 10th percentile and/or a decreased relative 
growth. Exclusion criteria were maternal age below 18 years, previous caesarean 
section, ruptured membranes, diabetes mellitus, renal disease, seropositivity for 
HIV, and HELLP syndrome (Hemolysis Elevated Liver enzymes, Low Platelet count) 
upon presentation. Women who refused randomization were included in the study 
as non-randomized patients. Details of the study design have been described else-
where 8;9 
All eight academic and 44 non-academic Dutch hospitals participated in the DIGI-
TAT trial. The trial was approved by the Institutional Review Board of the University 
of Leiden (P170-99) and had local approval from the boards of the other participat-
ing hospitals. Women who were eligible for inclusion in the DIGITAT study received 
study information from a research nurse, midwife, resident, or gynecological staff 
member. Written informed consent was obtained from all patients prior to partici-
pation. Patients were randomly assigned to either induction of labor or expect-
ant management. For logistic reasons the inclusion for the HR-QoL study started 
July 2005, 8 months after the start of the clinical trial; the last HR-QoL patient was 
included October 2008. Individual and aggregate HR-QoL results were not made 
available at any stage during the study. Figure 1 shows a flowchart of the study.
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Clinical interventions and procedure
In women allocated to induction, labor was initiated within 48 hours after ran-
domization. Patients with a Bishop score >6 were induced for labor by amniotomy 
and, if needed, augmented with oxytocin. Patients with a lower Bishop score were 
primed with prostaglandins. In women allocated to the expectant group fetal con-
dition was monitored frequently during hospital or home-care admittance or in an 
outpatient setting, i.e. fetal movements as reported by the mother, electronic fetal 
Included for HR-QoL  
N=674 (100.0%) 
P Expectant n=216 P Induction n=48 RCT Induction n=192 
 
 
RCT Expectant n=200 
Response n=574 
(85.2%) 
P Expectant n=162 P Induction n=36 RCT Induction n=180 RCT Expectant n=181 
Participants eligible to 
DIGITAT trial n=1103 
P n=453 RCT n=650 
P Expectant n=364 P Induction n=89 RCT Induction n=321 
 
 
RCT Expectant n=329 
Excluded: At inclusion 
questionnaires not 
available, n=488 




Flowchart. HR-QoL = Health-related Quality of Life; RTC = randomized controlled trial; 
P = treatment following protocol. 
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heart rate monitoring, and biophysical profile by ultrasound if indicated. Induction 
of labor was recommended in case of fetal distress; i.e. non-reassuring fetal heart 
rate, or decreased or absent fetal movements. Amongst others, reasons for induc-
tion were prolonged rupture of membranes, pre-eclampsia, and post-term preg-
nancy. The study protocol has been described in more detail elsewhere 8-9. 
Background characteristics and clinical data (obstetric history, medical treatment, 
maternal and neonatal outcome, and interventions during hospital stay) were col-
lected by local research midwives or nurses using a web-based case record form. 
Data on maternal and neonatal mortality and morbidity as well as diagnoses at 
discharge were collected until six weeks postpartum. Outcomes of the DIGITAT trial 
indicated that the medical outcomes were equivalent between induction of labor 
and expectant management for composite adverse neonatal outcomes (resp. 6.1% 
versus 6.9%; 95% CI -4·9%; 3·2%), caesarean section rate (resp. 14.0% versus 13·7%; 
95% CI -5·0%; 5·6%) (9).
HR-QoL measures
The participating women received a folder containing instructions, four HR-QoL 
questionnaires to be completed at baseline before inclusion/randomization (B1), 
at baseline after inclusion/randomization (B2), 6 weeks postpartum (6W), and 6 
months postpartum (6M). Each questionnaire took between 10 and 30 minutes to 
complete. Four pre-stamped return envelopes, and reminder stickers –the women 
could stick these stickers in their agenda or on their calendar as a self-reminder 
for filling out a questionnaire on the appropriate date. The folders, including the 
questionnaires, were available in the Dutch and English languages. Patients who 
did not return questionnaire 6W within 7 weeks after delivery or questionnaire 6M 
within 7 months after delivery received a written reminder and a new copy of the 
questionnaire with a pre-stamped return envelope.
Questionnaire B1 contained questions on background characteristics, e.g. date of 
birth, educational level, employment characteristics, household composition, ob-
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stetric history, ethnicity, length, and weight before pregnancy. Questionnaire 6W 
contained the retrospectively report of pain after delivery at day 1, 4, and 7 after 
delivery, using a 4-point pain intensity scale and an ‘I don’t know’ option. All ques-
tionnaires involved validated measures which will be elucidated below. We have 
used the Medical Outcome Study 36-Item Short Form Health Survey (SF-36; ap-
plied to questionnaires B1, 6W, 6M), the European Quality of Life 6 dimensions 3 
levels (EuroQoL 6D3L) with subsequent general health Visual Analogue Scale (VAS; 
questionnaires B2, 6W, 6M), the Hospital Anxiety and Depression Scale (HADS; 
questionnaires B2, 6W, 6M), and the Symptom Check List (SCL-90; questionnaire 
6M); all measures have been validated in Dutch and English 10-16. 
The SF-36 is a generic questionnaire with eight health-status subscales: physical 
functioning, role limitations due to physical health problems, bodily pain, general 
health perception, vitality, social functioning, role limitations due to emotional 
health, and general mental health. The scores on the subscales are aggregated into 
the standardized summary scores Physical (PCS) and Mental Component Score 
(MCS). A standardized score of mean=50 and SD=10 represents the Dutch popula-
tion average 10;11. The EuroQoL 6D3L is an instrument to describe general health 
status with six dimensions (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression, and cognitive functioning). An individual’s (or population’s) 
health description can be expressed in a value between 0 (death) and 1 (perfect 
health) 12;17. The subsequent VAS in our study is a vertical scale (‘thermometer’) 
with values 0 ‘worst possible health state’ (lower anchor) to 100 ‘best possible 
health state’ (upper anchor). Patients indicated their health state by marking the 
VAS, while considering the anchors 18. The HADS is a self-report instrument that ex-
ists of two 7-item scales: one for anxiety and one for depression each with a score 
range of 0 to 21; a lower score indicating less anxiety or depression 14-19. Finally, the 
SCL-90 is a 90-item inventory that is used to measure the psychological symptom 
status. The SCL-90 exists of one overall score and eight symptom subscales: anxiety, 
agoraphobia, depression, somatic complaints, insufficiency of acting and thinking, 
interpersonal sensitivity, hostility, and sleeping problems. Higher scores indicate 
Maternal health-related quality of life after induction of labor or expectant monitoring in 
pregnancy complicated by intrauterine growth retardation beyond 36 weeks
DEF-zw-Proefschrift-KIM-13april-2012.indd   115 13-4-2012   13:13:19
116
worse health 16-20. Because the SCL-90 is a long and demanding measure, we de-
cided to apply the SCL-90 only in the 6M questionnaire.
Analysis
If induction of labor would be more burdensome, we would expect a differential 
impact of intervention strategy on the HR-QoL measures, where induction of labor 
results in a lower HR-QoL. Prior to analysis we checked for the presence of selective 
response regarding neonatal outcome, maternal outcome, and mode of delivery; 
i.e. overrepresentation of either very healthy or very unhealthy patients in our sam-
ple. We defined ‘adverse neonatal outcome’ as the presence of any of the following: 
fetal death, 5-minute Apgar score <7, umbilical artery pH <7.05, admission to neo-
natal intensive care unit, and/or neonatal death (8-9). We defined ‘adverse maternal 
outcome’ as admission to the medium care or intensive care unit 8-9. 
Regarding short-term differences between the randomized induction of labor and 
expectant management groups, we analyzed the retrospectively self-reported 
4-point scale pain intensity after delivery using Mann-Whitney’s U.
Then, we compared the impact of treatment strategy (following intention to treat) 
on HR-QoL for the randomized and non-randomized groups separately on the sum-
mary measures of the SF-36 (separate report on subscales PCS and MCS), EuroQoL 
(Mobility, Self-care, Activity, Pain/Discomfort, Anxiety/Depression), VAS General 
Health, and the HADS (Anxiety, Depression). HR-QoL improvement was defined as 
the difference score between the baseline and a postpartum measurement. The 
difference scores were statistically compared between treatment strategies using 
Student’s t-test for each measurement separately.
The HR-QoL impact on the SCL-90 summary scores (anxiety, agoraphobia, depres-
sion, somatic complaints, insufficiency of acting and thinking, interpersonal sensi-
tivity, hostility, and sleeping problems) at 6 moths post partum was addressed with 
Student’s unadjusted t-test between the randomized intervention strategies.
Chapter 7 Maternal health-related quality of life after induction of labor or expectant monitoring in 
pregnancy complicated by intrauterine growth retardation beyond 36 weeks
DEF-zw-Proefschrift-KIM-13april-2012.indd   116 13-4-2012   13:13:19
117
To explain the changes over time on the ‘physical’ SF-36 PCS and the ‘mental’ SF-36 
MCS scales, we applied a repeated measures linear mixed model with the follow-
ing explanatory components: time of assessment (baseline; 6 weeks postpartum; 6 
months postpartum), intervention strategy following intention to treat (expectant; 
induction), randomization (no; yes), age (≤27; 28-33; ≥34), ethnicity (indigenous/
non-indigenous), pre-pregnancy BMI (underweight; normal weight; overweight), 
parity (nulliparous, multiparous), educational level (lower; higher), and the interac-
tion terms time of assessment*randomization, and time of assessment*intervention 
strategy. 
Analyses were conducted using SPSS 15.0 for Windows (SPSS Inc, Chicago, IL). A 
p-value of <0.05 (two sided) was considered to indicate statistical significance. We 




Of the 1102 participants to the DIGITAT study, 650 (56%) were randomized whereas 
453 (44%) women participated in the non-randomized part of the study. Not all pa-
tients were asked for participation because of logistic reasons because study ma-
terial was not in stock in every hospital; however, this did not lead to systematical 
exclusion of any patient group to the HR-QoL study. Of the randomized patients, 
392 (60%) were asked to participate in the HR-QoL study, versus 264 (58%) of the 
non-randomized patients. Overall, 574 (85%) of the patients that were included 
in the HR-QoL study responded to at least one questionnaire (Figure 1). Response 
rates were 95%, 83%, 72% and 59% for questionnaires B1, B2, 6W, and 6M, respec-
tively. 
Baseline characteristics of the randomized and non-randomized HR-QoL partici-
pants, and of the responding and non-responding patients (i.e. patients who did 
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not respond to any questionnaire) are shown in Table 1.
We tested for selective response regarding maternal outcome, neonatal outcome, 
and mode of delivery. At 6 weeks postpartum there were no significant differences 
between responding and non-responding patients in the proportion of composite 
bad neonatal outcome (14.9% vs. 10.2%; p=.052), the proportion of composite bad 
maternal outcome (3.7% vs. 1.7%; p=.156), caesarean section rates (13.1% vs.15.1%; 
p=.280), and the proportion of assisted vaginal delivery (11.4% vs. 8.1%; p=.109). 
At 6 months postpartum there were also no differences between responding and 
non-responding patients in the proportion of bad composite neonatal outcome 
(14.4% vs. 10.4%; p=.083), the proportion of bad composite maternal outcome 
(3.9% vs. 1.4%; p=.090), caesarean section rates (13.1% vs. 15.3%; p=.251), and the 
proportion of assisted delivery (10.8% vs. 8.4%; p=.192). These results are not tabu-
lated.
Table 1 
Baseline characteristics of the randomized (Rand) and non-randomized (NRand) participants who 
followed induction of labor or expectant monitoring, and the patients who did not return the HQRL 





























Age: mean (SD) 28.0 (5.2) 28.0 (5.2) 31.2 (4.4) 31.8 (4.9) 29.3 (5.4) 29.5 (5.9) <.001 .680
Months to conceive: mean (SD) 9.0 (16.7) 9.9 (18.0) 9.9 (19.1) 7.5 (10.0) 8.8 (15.3) n/a a .355 n/a
BMI pre-pregnancy: mean (SD) 23.3  (5.3) 23.4 (5.2) 22.3 (4.9) 22.3 (4.0) 23.0 (3.9) 22.8 (4.6) .003 .511
Dutch origin: % 89.0 86.4 90.6 84.5 87.2 59.0 .071 <.001
Has a job: % 74.9 75.0 80.6 87.8 79.2 n/a .001 n/a
Lives with partner: % 88.6 88.8 90.6 93.4 90.4 n/a .071 n/a
Nulliparious: % 58.6 58.5 51.6 61.4 59.3 57.0 .417 .369
High educational level  b: % 15.6 18.6 25.8 43.5 25.9 18.0 <.001 .230
Smoking  c: % 45.4 38.0 24.4 25.1 32.0 37.1 <.001 .205
a  These values are not available because they were asked by HR-QoL questionnaire
b  Higher vocational training or university
c  Did not quit smoking before the second trimester 
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Self-reported pain after delivery
There were differences on the retrospectively self-reported pain at day 4 (p=.006) 
and 7 (p=.003) after delivery between the randomized groups in favor of induction 
of labor. Figure 2 shows the pain distributions at day 1, 4, and 7 after delivery per 
randomized group.
Summary measures
One-way ANOVA analyses between the average difference scores of the two ran-
domized groups at 6 weeks and 6 months postpartum are shown in Table 2. 
At 6 weeks postpartum, only the average difference scores of the SF-36 PCS be-
tween the randomized groups were statistically, but not clinically, different (8.99 
vs. 6.49; p=.049). At 6 months postpartum, only the average differences on the Eu-
roQoL Pain and Discomfort domain was statistically, but also not clinically, different 
between the randomized groups (0.007 vs. 0.031; p=.021). 
Mean difference scores between the non-randomized groups did not differ signifi-
cantly either at 6 weeks and at 6 months postpartum. After Bonferroni adjustment 
none of the outcomes were significant.
Figure 2 
In retrospect self-reported pain at day 1, 4, and 7 after delivery between the randomized induction of 
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Figure 3 shows the mean scores of the SF36 PCS and MCS for the randomized groups 
at baseline, 6 weeks postpartum, and 6 months postpartum. The PCS increased 
substantially over time between baseline and 6 weeks (PCS scores 41.6 vs. 49.3; 
p=.038) and between 6 weeks and 6 months postpartum (49.3 vs. 52.2; p=.045); 
the PCS was higher than the Dutch population average at 6 months postpartum. 
The MCS did not vary significantly over time between baseline and 6 weeks (MCS 
scores 47.6 vs. 47.8; p=.559) and between 6 weeks and 6 months postpartum (47.8 
vs. 48.0; p=.615). The average MCS score remained below the Dutch population 
norms (solid line) 11 and both the PCS and MCS remained below the U.S. norms for 
females between 25 and 35 years old (dotted line) 21.
Table 2 
Average HR-QoL difference scores (Δ) per summary measure: comparisons between random-
ized groups (Rand) and between non-randomized (Nonrand) groups (Ind=induction of labor; 

















Summary measure Ind Exp p Ind Exp P Ind Exp P Ind Exp p
SF-36 PCS 8.99 6.49 .049 11.80 9.72 .121 4.73 6.74 .295 12.06 11.62 .832
SF-36 MCS -1.32 -1.14 .894 -0.67 -0.21 .784 -4.11 -1.22 .185 -3.10 0.76 .086
EuroQoL Mobility 0.017 0.023 .367 0.017 0.033 .102 0.036 0.017 .191 0.044 0.022 .196
EuroQoL Self-care 0.014 0.010 .336 0.015 0.013 .536 0.007 0.009 .772 0.007 0.010 .751
EuroQoL Activity 0.048 0.047 .988 0.049 0.053 .727 0.031 0.044 .373 0.048 0.060 .492
EuroQoL Pain/Discomfort 0.018 0.027 .356 0.007 0.031 .021 0.015 0.10 .660 0.009 0.009 .969
EuroQoL Anxiety/Depression 0.008 0.004 .527 0.006 0.005 .898 0.016 0.011 .558 0.020 0.007 .336
VAS general health 1.02 2.09 .649 0.64 4.17 .149 4.75 2.98 .497 8.67 4.15 .143
HADS Anxiety -1.58 -1.74 .761 -1.12 -1.28 .786 -0.50 -0.51 .989 -0.61 -0.33 .740
HADS Depression -1.13 -1.90 .105 -0.87 -1.74 .131 -0.32 -0.88 .368 -0.88 -0.84 .962
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At 6 months postpartum there were no HR-QoL differences between the induction 
of labor and the expectant management (randomized) groups on the SCL-90 sum-
mary score (p=.711), or on its sub-scores Anxiety (p=.756), Agoraphobia (p=.884), 
Depression (p=.909), Somatic complaints (p=.483), Insufficiency of acting and 
thinking (p=.608), Interpersonal sensitivity (p=.888), Hostility (p=.792), and Sleep-
ing problems (p=.914). These results are not tabulated.
Multivariate mixed model
Table 3 shows the results of the multivariate mixed model explaining the change of 
PCS and MCS over time, taking some background characteristics and intervention 
features into account. The β-coefficients represent the change in the dependent 
variable when the covariate changes with one unit of measurement. PCS improved 
substantially after childbirth (6 weeks postpartum: β=5.84, p<.001; 6 months post-
partum: β=10.65, p<.001). The MCS did not vary over time (6 weeks postpartum: 
β=-0.77, p=.557; 6 months postpartum: β=1.73, p=.241). There was no effect of 
Figure 3 
Error bars with 95% confidence interval (CI) of the randomized groups for induction of labor or 
expectant monitoring on the PCS and MCS at inclusion, at 6 weeks postpartum, and at 6 months 
postpartum. The horizontal lines indicate mean Dutch population norm scores (solid line) and U.S. 
population norm scores for females aged 25 to 34. 
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randomization (i.e. participating to the trial as a randomized patient or a non-ran-
domized patient) on PCS (β=-0.62, p=.493), or MCS (β=1.09, p=.376). Intervention 
according intention to treat was not significant on either PCS (Induction of labor: 
β=-1.47, p=.090) or MCS (β=0.92, p=.376). Of the background characteristics, high 
BMI had significant effect on PCS (β=-1.47, p=.015), and age had significant effect 
on MCS (≤27 years vs. 28-33 years: β=2.71, p=.001). None of the interaction effects 
were significant on either PCS or MCS. After post hoc Bonferroni adjustment, BMI 
did not have significant effect. 
Table 3 
Multivariate mixed model with repeated measures: estimates of main and interaction effects and covariates 
with 95% Confidence Interval (CI) on the SF-36 Physical Component Scale (PCS) and the Mental component 
Scale (MCS), N=314.  
PCS MCS
Parameter Estimate (β) p 95% CI Estimate (β) p 95% CI
Intercept 43.38 <.001 40.89 to 45.86 44.53 <.001 41.55 to 47.52
Time
Baseline Ref Ref
6 Weeks postpartum (6Wpp) 5.84 <.001 3.56  to 8.11 -0.77 .557 -3.35 to 1.80
6 Months postpartum (6Mpp) 10.65 <.001 8.38 to 12.93 1.73 .241 -1.17 to 4.62
Randomization status
Not randomized Ref Ref
Randomized -0.62 .493 -2.41 to 1.16 1.09 .320 -1.07 to 3.26
Intervention following ITTa
Expectant monitoring Ref Ref
Induction of labor -1.47 .090 -3.16 to 0.23 0.92 .376 -1.13 to 2.97
Age
≤ 27 years Ref Ref
28 to 33 years 0.98 .141 -0.33 to 2.29 2.71 .001 1.15 to 4.28
≥ 34 years 0.95 .228 -0.60 to 2.50 1.54 .104 -0.32 to 3.39
Parity
Nulliparous Ref Ref
Multiparous 0.14 .814 -1.01 to 1.28 -1.16 .096 -2.53 to 0.21
Indigenous (Dutch) origin
Yes Ref Ref
No -0.41 .642 -2.16 to 1.33 -1.96 .066 -4.04 to 0.13
BMI pre-pregnancy
< 18.5 (underweight) -0.73 .542 -2.96 to 1.50 -0.29 .830 -2.94 to 2.36
18.5 to 25 (normal weight) Ref Ref
> 25 (overweight) -1.47 .015 -2.65 to -0.28 -0.34 .641 -1.76 to 1.08
Educational level
Lower Ref Ref
Higher 0.75 .270 -0.58 to 2.07 -1.12 .167 -0.47 to 2.70
Interactions
6Wpp * Randomized 0.53 .719 -2.37 to 3.44 1.63 .330 -1.66 to 4.93
6Mpp * Randomized -1.32 .372 -4.21 to 1.58 -0.08 .965 -3.77 to 3.61
6Wpp * Induction of labor ITT 1.75 .226 -1.08 to 4.59 -0.20 .904 -3.41 to 3.01
6Mpp * Induction of labor ITT 1.62 .257 -1.19 to 4.44 -0.68 .709 -4.26 to 2.90
a ITT = Intention to treat
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Discussion
We investigated the effect of induction of labor compared to expectant monitor-
ing on health-related quality of life (HR-QoL) of women with a intra-uterine growth 
retardation (IUGR) pregnancy beyond 36 weeks of gestation. We found a differ-
ence in self-reported pain at day 4 and day 7 after delivery in favor of induction of 
labor. However, this difference did not result in HR-QoL differences at six weeks or 
six months postpartum between the treatments. We did not find any clinically rel-
evant HR-QoL differences between the randomized and non-randomized groups. 
The physical and mental health as measured with SF-36 were below the Dutch 
population average at inclusion. The physical health improved over time and was 
above Dutch population norms at six months postpartum but not above adjusted 
norm scores for gender and age from the U.S. population. Mental health stayed 
under the Dutch and U.S. norms.
Maternal HR-QoL has been defined as a secondary outcome to the DIGITAT (Dis-
proportionate Intrauterine Growth Intervention Trial At Term) trial 8-9. The clinical 
outcomes of the DIGITAT trial have already shown that induction of labor and ex-
pectant monitoring result in equal neonatal and maternal outcomes. Caesarean 
section rates were also comparable in pregnancies with IUGR beyond 36 weeks 
of gestation. Other results of the clinical study showed that labor was eventually 
induced in 49% of the patients in the expectant management arm of the trial, and 
in the induction arm 5% of the patients had a spontaneous start of the delivery. We 
have analyzed our HR-QoL data following intention to treat so that our results have 
captured the effect of initial treatment choice. 
Our study has some limitations. First, the patients filled out the questionnaires just 
once during pregnancy at baseline, regardless of the period between inclusion to 
the study and childbirth. Therefore, we do not know the short-term impact of wait-
ing, antenatal stress and/or anxiety on HR-QoL during the expectant management 
period. However, the long-term effect of waiting on HR-QoL was probably small 
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since the average difference of the waiting period was not more than ten days. 
Second, we have asked women to report their pain retrospectively, which may not 
have reflected their real perceived pain but rather their wellbeing during their post-
partum period. Further study is needed to gain insight to prospectively self-report 
of pain after the two treatment strategies. We also don’t know how the self-per-
ceived intensity and duration of pain developed between the 7th day and the 6th 
week after delivery, as we do not have measures between those two time points. 
Third, we have observed a lower response of non-Dutch women, which may reflect 
the proportion of women that have difficulties with understanding and/or reading 
the Dutch or English languages. We have seen that non-indigenous women have 
somewhat lower HR-QoL scores, which indicates that the total group may have 
had a lower HR-QoL score. Fourth, prior exclusion of women with illnesses and ad-
verse conditions to the DIGITAT trial may have its obvious impact on mean HR-QoL 
scores. Our mean HR-QoL scores are therefore not applicable to the total group of 
women with IUGR. Finally, outcomes of the trial suggest that prior treatment pref-
erences exist: most (80%) of the non-randomized women were monitored expec-
tantly. However, the differences in the randomized and non-randomized groups, 
which differed in terms of socio-economic status, did not influence responsiveness, 
or the SF-36 PCS or MCS scores. 
An issue that needs further investigation is the fact that average PCS and MCS 
scores were lower than the population reference norms. The mental health of the 
DIGITAT patients has been low at all three measurement points. We did not find any 
systematic effect of educational level, as a proxy of socio-economic status, on the 
MCS scores. Previous HR-QoL study in women after gestational hypertension or 
preeclampsia at term randomized for induction of labor or expectant management 
showed equal to population average MCS scores at six weeks and six months post-
partum 22. This suggests that the findings of the DIGITAT trial are not due to general 
lower mental health after childbirth. Our findings may, however, have a relation to 
the mother’s concerns, uncertainty or anxiety about the child’s health, which is in 
general suboptimal in the DIGITAT trial as compared to the health of the children 
from the previous HR-QoL study. 
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We have presented the results based on the outcomes of the randomized groups. 
It would also interesting to look at differences in HR-QoL by trial outcomes - e.g. 
those with cesarean section versus those without, those with a adverse maternal or 
neonatal outcome versus those without. As we have insufficient statistical power 
to make such an analysis within DIGITAT data alone, we are planning such an analy-
sis together with HR-QoL data from the HYPITAT study, a similar trial on induction 
of labor versus expectant management in case of hypertensive disease at term 22.
In summary, in women with IUGR at term, maternal HR-QoL is comparable after in-
duction of labor or expectant monitoring at the long-term. Women report to have 
had less pain after induction of labor as compared to expectant management in 
the first week after delivery. In women with a IUGR pregnancy beyond 36 weeks of 
gestation, induction of labor does not affect maternal quality of life on the long-
term.
Maternal health-related quality of life after induction of labor or expectant monitoring in 
pregnancy complicated by intrauterine growth retardation beyond 36 weeks
DEF-zw-Proefschrift-KIM-13april-2012.indd   125 13-4-2012   13:13:19
126
Reference List
(1)  Balcazar H, Keefer L, Chard T. Use of anthropometric indicators and maternal risk factors to 
 evaluate intrauterine growth retardation in infants weighing more than 2500 grams at birth. 
 Early Hum Dev 1994 April 15;36(3):147-55.
(2)  Chang TC, Robson SC, Spencer JA, Gallivan S. Prediction of perinatal morbidity at term in small fetuses:  
 comparison of fetal growth and Doppler ultrasound. Br J Obstet Gynaecol 1994 May;101(5):422-7.
(3)  Ohel G, Ruach M. Perinatal outcome of idiopathic small for gestational age pregnancies at term: 
 the effect of antenatal diagnosis. Int J Gynaecol Obstet 1996 October;55(1):29-32.
(4)  Dijxhoorn MJ, Visser GH, Touwen BC, Huisjes HJ. Apgar score, meconium and acidaemia at birth in 
 small-for-gestational age infants born at term, and their relation to neonatal neurological morbidity. 
 Br J Obstet Gynaecol 1987 September;94(9):873-9.
(5)  Doctor BA, O’Riordan MA, Kirchner HL, Shah D, Hack M. Perinatal correlates and neonatal outcomes 
 of small for gestational age infants born at term gestation. Am J Obstet Gynecol 2001   
 September;185(3):652-9.
(6)  Villar J, de OM, Kestler E, Bolanos F, Cerezo R, Bernedes H. The differential neonatal morbidity of 
 the intrauterine growth retardation syndrome. Am J Obstet Gynecol 1990 July;163(1 Pt 1):151-7.
(7)  van den Hove MM, Willekes C, Roumen FJ, Scherjon SA. Intrauterine growth restriction at term: 
 Induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term 
 (DIGITAT): A pilot study. Eur J Obstet Gynecol Reprod Biol 2005 July 26.
(8)  Boers KE, Bijlenga D, Mol BW, LeCessie S, Birnie E, van Pampus MG, Stigter RH, Bloemenkamp KW, 
 van Meir CA, van der Post JA, Bekedam DJ, Ribbert LS, Drogtrop AP, van der Salm PC, Huisjes AJ, 
 Willekes C, Roumen FJ, Scheepers HC, de BK, Duvekot JJ, Thornton JG, Scherjon SA. 
 Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT. 
 BMC Pregnancy Childbirth 2007;7:12.
(9)  Boers KE, Vijgen SM, Bijlenga D, van der Post JA, Bekedam DJ, Kwee A, van der Salm PC, van Pampus MG,  
 Spaanderman ME, de BK, Duvekot JJ, Bremer HA, Hasaart TH, Delemarre FM, Bloemenkamp KW, 
 van Meir CA, Willekes C, Wijnen EJ, Rijken M, le CS, Roumen FJ, Thornton JG, van Lith JM, Mol BW, 
 Scherjon SA. Induction versus expectant monitoring for intrauterine growth restriction at term: 
 randomised equivalence trial (DIGITAT). BMJ 2010;341:c7087.
(10)  Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. 
 Conceptual framework and item selection. Med Care 1992 June;30(6):473-83.
(11)  Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te VA, 
 Verrips E. Translation, validation, and norming of the Dutch language version of the SF-36 Health 
 Survey in community and chronic disease populations. J Clin Epidemiol 1998 November;51(11):1055-68.
(12)  Hoeymans N, van Lindert H, Westert GP. The health status of the Dutch population as assessed by the  
 EQ-6D. Qual Life Res 2005 April;14(3):655-63.
(13)  Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states: are the United States  
 and United Kingdom different? Med Care 2005 March;43(3):221-8.
(14)  Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983   
 June;67(6):361-70.
(15)  Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. 
 An updated literature review. J Psychosom Res 2002 February;52(2):69-77.
(16)  Arrindell WA, Ettema JHM. SCL-90. Symptom Checklist. Handleiding bij een multidimensionele psycho 
 pathologie-indicator. Lisse, The Netherlands: Swets Test Publishers; 2003.
(17)  Kind P. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, 
 PA: Lippincott-Raven Publishers; 1996.
(18)  Gudex C, Dolan P, Kind P, Williams A. Health state valuations from the general public using the visual  
 analogue scale. Qual Life Res 1996 December;5(6):521-31.
(19)  Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study   
 of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. 
 Psychol Med 1997 March;27(2):363-70.
(20)  Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report.   
 Psychopharmacol Bull 1973 January;9(1):13-28.
(21)  Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Maruish M.E. User’s Manual for the SF-36 Health  
 Survey. Second Edition. 2006. 
(22)  Bijlenga D, Koopmans CM, Birnie E, Mol BW, van der Post JA, Bloemenkamp KW, Scheepers HCJ, Willekes  
 C, Kwee A, Heres MHB, van Beek E, van Meir CA, van Huizen ME, van Pampus MG, Bonsel GJ. 
 Quality of life after induction of labor versus expectant monitoring in gestational hypertension or 
 preeclampsia at term. Hypertens Preg 2011.
Chapter 7
DEF-zw-Proefschrift-KIM-13april-2012.indd   126 13-4-2012   13:13:19
127
Chapter 8
Economic analysis comparing induction of labour and 
expectant management for intrauterine growth restric-







K  de Boer 
HA Bremer 





JMM van Lith 
CA van Meir 
MG van Pampus 
JAM   van der Post JAM 
M Rijken 
FJME Roumen 
PCM van der Salm 
MEA Spaanderman 




DEF-zw-Proefschrift-KIM-13april-2012.indd   127 13-4-2012   13:13:19
128
Abstract
Objective: Pregnancies complicated by intrauterine growth restriction (IUGR) are 
at increased risk for neonatal morbidity and mortality. The Dutch nationwide dis-
proportionate intrauterine growth intervention trial at term (DIGITAT trial) showed 
that induction of labour and expectant monitoring were comparable with respect 
to composite adverse neonatal outcome and operative delivery. In this study we 
compare the costs of both strategies.  
Study design: A cost analysis was performed alongside the DIGITAT trial, which 
was a randomised controlled trial in which 650 women with a singleton pregnancy 
with suspected IUGR beyond 36 weeks of pregnancy were allocated to induction 
or expectant management. Resource utilization was documented by specific items 
in the Case Report Forms. Unit costs for clinical resources were calculated from the 
financial reports of participating hospitals. For primary care costs Dutch standard-
ized prices were used. All costs are presented in Euros converted to the year 2009.  
Results:  ante partum expectant monitoring generated more costs, mainly due to 
longer  ante partum maternal stays in hospital. For the durante partu and postpar-
tum stage, induction generated more direct medical costs, due to longer stay in the 
labour room and longer duration of neonatal high care/medium care admissions. 
From a health care perspective, both strategies generated comparable costs: on 
average € 7,106 per patient for the induction group (N=321) and € 6,995 for the 
expectant management group (N=329) with a cost difference of € 111 (95%CI: 
- € 1,296 to € 1,641). 
Conclusion:  In women with pregnancies complicated by IUGR at term, induction 
of labour generates identical health care costs as compared to expectant manage-
ment.
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Economic analysis comparing induction of labour and expectant management for 
intrauterine growth restriction at term (DIGITAT trial)
Introduction
Intrauterine growth restriction (IUGR) at term is a major problem for obstetricians 
in clinical practice, because it is associated with increased neonatal mortality and 
short and long term neonatal morbidity.1-5 At present there is no consensus among 
obstetricians on what policy to follow in pregnancies with suspected fetal growth 
restriction at term. Induction of labour might increase the risk of instrumental de-
liveries and caesarean sections, and therefore increase maternal and neonatal mor-
bidity as well as costs. Expectant management on the other hand might increase 
the risk of perinatal complications, including stillbirth. 
Since evidence on this point was lacking, we recently performed a randomised 
clinical trial on the subject, named the Disproportionate Intrauterine Growth Inter-
vention Trial at Term (DIGITAT, number ISRCTN10363217).6 In this 650 patient study, 
the composite adverse neonatal outcomes and caesarean sections were compa-
rable in both groups.7
In the expected group babies were delivered on average 10 days later and weight-
ed   130 grams more as compared to the induction group. Overall, in women with 
suspected IUGR at term no important differences were found between induction 
of labour and expectant monitoring concerning immediate adverse neonatal out-
come or operative delivery rate. However, significantly more neonates from the 
induction group were admitted to high or medium levels of care.7 It is unclear 
whether these strategies differ in terms of costs generated by health care utilisa-
tion. At present, evidence on costs and cost-effectiveness of management of wom-
en with suspected IUGR at term is limited.
This study reports the economic evaluation that we performed alongside the DIGI-
TAT trial, in which induction of labour and expectant monitoring were compared in 
pregnancies complicated by suspected intrauterine growth restriction beyond 36 
weeks of gestation.




Full details of the DIGITAT trial were reported previously.6 The trial was approved by 
the Institutional Review Board of the University of Leiden and had local approval 
from Boards of the other participating hospitals. The trial has been registered in the 
clinical trial register as ISRCTN10363217.
In short, the study was a multicentre randomised controlled clinical trial in obstet-
ric departments of 8 academic and 44 non-academic hospitals in The Netherlands. 
Women diagnosed with suspected IUGR beyond 36 weeks of pregnancy with a 
singleton fetus in cephalic presentation were allocated to either induction of la-
bour or expectant monitoring. Suspected IUGR was defined as a fetal abdominal 
circumference (FAC) below the 10th percentile, or an estimated fetal weight (EFW) 
below the 10th percentile, or a flattening of the FAC curve by ultrasound. 
In the induction group, labour was induced within 48 hours after randomization, 
according to local protocol. In the expectant group, patients were monitored by 
local protocol until the onset of spontaneous delivery with daily fetal movement 
counts, and at least twice weekly heart rate tracings and weekly ultrasound exami-
nation. If there were signs of sub-optimality in any of these recordings induction 
of labour was the treatment of choice. Maternal monitoring consisted of frequent 
blood pressure measurements, assessment of proteïnuria and laboratory tests of 
liver and kidney function and full blood count all at the discretion of the attend-
ing obstetricians. Monitoring could take place in an outpatient setting or during 
admission to the hospital.
All patients who declined randomisation, but who gave authorization for the use 
of their medical data were registered as non-participants. Identical data were col-
lected prospectively and entered into the trial database. The primary outcome in 
this trial was a composite measure of adverse neonatal outcome, defined as death 
before hospital discharge, 5-minute Apgar score < 7, umbilical artery pH < 7.05, or 
admission to the neonatal intensive care. 
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Analysis of the clinical endpoints showed comparable neonatal outcomes be-
tween both groups, the prevalence of composite adverse neonatal outcome was 
17 (5.3%) for the induction group versus 20 (6.1%) in the expectant monitoring 
group; difference – 0.8% (95% CI – 4,3% to 3.2%). There was no perinatal mortality 
in the trial. The number of caesarean sections (respectively 45 (14,0%) versus 45 
(13.7%); difference 0.3% (95% CI -5.0% to 5.6%)) were comparable as well.7
Economic evaluation
A cost analysis was performed alongside the trial. We used a health care perspec-
tive, in which only medical costs are included, with a time horizon until hospital 
discharge. Thereby, by documenting details on utilisation of health care resources, 
we provide insight in the clinical origins of costs associated with management of 
these high-risk pregnancies. 
As both strategies were comparable in terms of health outcomes, we performed 
a cost-minimization analysis in which only the costs of both strategies were com-
pared.8 We differentiated three phases of the clinical process in which costs arise: 
ante partum costs (from the moment of randomisation until childbirth), costs re-
lated to the delivery, and postpartum costs (from the moment of childbirth until 
hospital discharge). No discounting was applied because all costs occurred within 
one year. 
Resource utilisation
Resource use during the admission period was documented in the Case Report 
Form (CRF). The following resource items were collected: maternal and neonatal 
admissions, method of delivery, outpatient visits, medication, maternal laboratory 
tests, cardiotocograms (CTGs) and fetal ultrasounds. Maternal admissions were dif-
ferentiated into three levels of care (intensive, medium, or ward). Neonatal admis-
sions were divided into four levels of care (intensive, high, medium, or ward). Neo-
natal admissions on maternal ward were not included in our analyses because we 
assumed these were already included in the maternal ward costs.
As induction of labour takes place inside the labour room, we expected that stays 
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in the labour room will be longer in the induction group due to time needed for 
induction. This difference was accounted for by measuring use of the labour room 
as hours between admission to labour room and birth plus one hour extra for ex-
tended recovery care, and estimated unit costs associated with one hour of labour 
room use. In case a caesarean section was performed, use of the operation room (in 
hours) was estimated as well.
Unit costs
Unit cost estimates were based on several sources: top-down calculations provided 
by the financial departments in one participating academic and one participat-
ing general hospital (for maternal and neonatal admissions to ward, medical care, 
obstetric high care, (N)ICU and neonatal monitoring), bottom-up calculation (one 
hour use of the labour room and operating theatre), Dutch standardized prices (vis-
its to primary and paramedical health care providers and outpatient visits), and 
market prices (medication).9-10 In Table 1 unit costs together with valuation meth-
ods and sources are presented. All unit costs were expressed in 2009 Euros using 
the consumer pricing index.11
Analyses
Group differences in resource use were tested by using the nonparametric Mann-
Whitney U test, because such data are generally not normally distributed. Resource 
use per patient was multiplied by unit costs, and total costs per patient were esti-
mated. Mean total costs per patient as well as median costs were estimated, and 
differences in total costs between study groups are tested using the nonparametric 
Mann-Whitney test. Differences in mean costs and 95% confidence intervals were 
determined by bootstrapping. Statistical and simulation analyses were performed 
using SPSS software (version 16.0) and Microsoft Excel.
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Table 1
Cost-analyses: units of resource use, unit costs, valuation method and volume source
* the mean of the unit cost for an academic hospital and for a general hospital is presented
CRF= Case Report Form   
AQ= additional questionaire   
# the mean of several methods/medications is presented 
  Unit Unit cost Valuation method (source) Volume source
Medical costs
Admission mother*
hospital stay - ward Day 359 top-down calculation CRF
hospital stay - medium care Day 546 top-down calculation CRF
hospital-stay - intensive care Day 1742 top-down calculation CRF
Admission child*
hospital stay - medium care Day 546 top-down calculation CRF
hospital stay - high care Day 1462 top-down calculation CRF
hospital-stay - NICU Day 1514 top-down calculation CRF
specialist care Hour 72 Dutch costing guidelines CRF/AQ
outpatient visit* Visit 85 top-down calculation CRF/AQ
psychologist Hour 35 Dutch costing guidelines AQ
midwife Hour 35 Dutch costing guidelines AQ
general practitioner Visit 22 Dutch costing guidelines AQ
paramedical Visit 25 Dutch costing guidelines AQ
home care Hour 33 Dutch costing guidelines AQ
Induction methods# Gift 16 Pharmacotherapeutic website CRF
Medication# dose per day 7 Pharmacotherapeutic website CRF
Analgesics during labour# procedure 167 top-down calculation CRF
Neonatal monitoring# procedure 93 top-down calculation CRF
Operation room* Hour 145 bottom-up calculation CRF
Labour room* Hour 85 bottom-up calculation CRF
     
Non-medical costs
Travel costs- car Km 0.18 Dutch costing guidelines AQ
Travel costs- public transport km 0.18 Dutch costing guidelines AQ
Informal care Hour 9.10 Dutch costing guidelines AQ
Productivity loss Hour 27 Dutch costing guidelines AQ
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Results
Between November 2004 and November 2008, we approached 1.116 women, of 
whom 650 were randomised to induction (n = 321) or expectant management 
(n = 329), 452 declined randomisation and 14 refused any use of identifiable data. 
Average volumes of resource utilization, total costs in each study group as well 
as average costs per patient are presented in Table 2. During the  ante partum 
phase from moment of randomisation until start of delivery, maternal admissions 
were compared to the induction group longer in the expectant monitoring group, 
respectievely 2.8 versus 8.2 days for medium care (p=< 0.05) and 2.2 versus 4.7 
days on maternal ward (p<0.001). More outpatient CTGs (2.1 versus 4.8, p<0.001), 
more ultrasounds (1,3 versus 2,1, p<0.001), more scheduled outpatient visits (1.9 
versus 4.4, p<0.001), more unscheduled outpatient visits (1.3 versus 1.6, p<0.001) 
and more maternal assessments (5.4 versus 9.9, p<0.001) occurred in the expect-
ant monitoring group. Admission because of labour was somewhat longer in the 
induction group (1.8 days versus 1.4 days, p<0.001). 
The duration of admission in the labour room and/ or operating theatre  was also 
longer for the induced patients in case of spontaneous delivery (15.4 versus 8.3 
hours, p<0.001), in case of vacuum or forcipal extractions (25 versus 11 hours, 
p<0.05) and in caesarean deliveries (18.3 versus 11.9 hours, p<0.05). From child-
birth until hospital discharge no significant differences appeared in the duration 
of maternal and neonatal admissions. However, as can be seen from table 2 more 
neonates in the induction group were admitted to medium care wards compared 
to the expectant monitoring group (44% versus 31%). 
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A summary of the mean and median costs per patient is provided in Table 3. In the 
ante partum period mean costs per patient appeared to be higher in the expectant 
monitoring group (difference - €931). On the other hand, during delivery induction 
of labour generated more costs than expectant management (difference €807), 
mainly because induction required a longer stay labour room and/ or operating 
theatre. 
In the postpartum period, women in the induction group also generated more 
costs than women monitored expectantly (difference: €235). 
Overall, mean costs per patient were €7.106 for induction and €6.995 in the expect-
ant monitoring group (difference €111: 95% CI -1295 to 1640). 
Table 3
Comparison of costs between randomised induction of labour and expectant management
*Induction minus expectant management








Mean Median (IQR) Mean Median (IQR) (95% CI)#
Total  ante partum 443 218 (110-573) 1374 824 (485-1694)
-931
Total delivery 2077 1399 (916-2785) 1270 949 (635-1478) 807
Total postpartum 4586 1941 (596-5136) 4351 1264 (138-4271) 235
Total costs 7106 4680 (2296-8610) 6995 3954 (2164-7569) 111(-1296- 1641)
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Discussion
In this study we estimated the costs of pregnant women with a diagnosis of IUGR 
at term in whom labour was induced and those who were monitored expectantly 
using the data of the DIGITAT trial. The trial did not detect differences in maternal or 
neonatal outcomes or in operative delivery rates, so the economic evaluation was 
set up as a cost-minimization analysis. We found comparable costs after induction of 
labour and expectant management in women with suspected intrauterine growth 
restriction at term. Within a study horizon from moment of randomisation until 
postpartum hospital discharge induction of labour and expectant management 
resulted in comparable medical costs per patient. Unsurprisingly, the distribution 
of costs over the different phases in each strategy shows higher  ante partum costs 
(due to longer maternal admissions) in the expectant group and higher delivery 
costs (due to the induction itself ) in the induction group. Costs due to postpartum 
maternal and neonatal admissions are comparable between both groups.    
This adds to equivalent fetal and maternal outcomes as well as quality of life12, 
indicating that both approaches are both acceptable management strategies. If 
a policy of induction for near term growth restriction is to be followed, deferring 
induction until 38 weeks, while strictly monitoring mother and child, may prevent 
complications of late prematurity and neonatal admissions.13 However, beyond 38 
weeks, there is not much to win by further postponing delivery, neither in medical 
outcomes, and probably nor in costs. 
To our knowledge this is the first economic evaluation that prospectively compared 
these strategies in this patient population. We used trial-based data that were col-
lected prospectively.
In earlier studies we reported comparable neonatal and maternal outcomes after 
labour induction and expectant management in at term IUGR.7 The same applies 
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TAT trial was performed by Bijlenga et al. on behalf of the DIGITAT study group. In 
this study health related quality of life was measured in 361 randomised women, 
6 weeks and 6 months after childbirth using validated questionnaires. From the 
results it could be concluded that in pregnancies complicated by IUGR beyond 36 
weeks, induction of labour does not affect the long-term maternal quality of life. 12    
The equipoise in antenatal and postnatal costs in the DIGITAT trial was not found 
in the cost-analysis of a comparable RCT, that compared induction to expectant 
management in women with gestational hypertension or mild pre-eclampsia at 
term.14-15 In this study induction of labour was less costly than expectant monitor-
ing because of differences in resource use in the  ante partum period.15 
Because more than 50 hospitals from all over the Netherlands, teaching as well as 
non-teaching, participated to the DIGITAT trial the study population was represen-
tative for Dutch population. However, women who declined randomisation were 
older, slimmer, higher educated and smoked less.7,16 In a comparison between 
participants and non-participants, we found a trend towards worse neonatal out-
comes and higher operative delivery rates among non-participants. Probably this 
finding would translate into higher costs in this group, even though they had high-
er SES.16
Our analysis focused on short term and a with a health care perspective. The ad-
vantage of that is the use of direct clinical trial data for both costs and effects. 
We also tried to study longer term and societal costs as well by analyzing question-
naires filled out by a very small subsample of the study population (n=27). After in-
cluding these costs, induction of labour became significantly more expensive than 
expectant monitoring. However, because of the unreliability of the follow-up data 
in this economic analysis we decided to focus on the short-term medical costs. Be-
cause growth restriction is associated with a less favourable (neuro)developmental 
outcome, we also investigated the outcome of children randomised during DIGITAT 
after two years.17 As that follow-up indicated no differences in child behaviour at 2 
years between induction and expectant management, we think it is not necessary 
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to include long term and societal costs for the children in our economic analysis.    
Strengths of our study are the use of trial-based data for the economic analysis, and 
exactly the same patients were studied as for the clinical analysis. Transferring the 
data to the general patient population is valid because of the large number and 
diversity of the participating hospitals. 
With this study we further aimed to define the best strategy in at term IUGR by 
analysing costs generated by induction compared to expectant management, 
since primary neonatal and delivery outcomes, as well as more detailed neonatal 
morbidity and maternal quality of life were comparable between the two strate-
gies. The antenatal costs of expectant management in IUGR were higher due to 
higher consumption of medical care by monitoring mother and child. However, 
induction group babies had a higher medical consumption after birth, mainly due 
to neonatal hospital admissions in exchange. In order to do defer delivery in IUGR, 
both mother and child were strictly monitored, until either labour was induced 
because of fetal or maternal deterioration or spontaneous delivery started. As ex-
pected, this imposed higher resource use antenatal. On the contrary, more chil-
dren were admitted to intermediate levels of care after induction, mainly due to 
lower gestational age and related birth weight at delivery12, accounting for higher 
resource use after birth. Since costs are not higher after expectant management, 
postponing delivery beyond 38 weeks gestation for as long as neonatal condition is 
reassuring is reasonable, providing monitoring of mother and child. By this means, 
the number of neonatal admissions can be restricted. We plan to analyse whether 
this approach will generate less costs. 
Induction of labour and expectant monitoring in at term IUGR have comparable 
outcomes immediately after birth in terms of obstetrical outcomes, maternal qual-
ity of life and costs. Providing strict monitoring of mother and child induction of 
labour is reasonable to pre-empt possible stillbirth in suspected IUGR, if feasible 
after 38 weeks gestation. 
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Abstract
Objective:  To study long term (neuro)developmental and behavioral outcome of 
pregnancies complicated by intrauterine growth restriction at term in relation to 
induction of labor or an expectant management. 
Methods: Parents of 2-year old children included in the DIGITAT-trial answered the 
Ages and Stages Questionnaire (ASQ) and Child Behaviour Check List (CBCL). 
Results: We approached 582 (89.5%) of 650 parents. The response rate was 50%. 
Of these children, 27% had an abnormal score on the ASQ and 13 % on the CBCL. 
Results of the ASQ and the CBCL for the two policies were comparable. Low birth 
weight, positive morbidity assessment index (MAIN score) and admission to inter-
mediate care, increased the risk of an abnormal outcome of the ASQ. This effect 
was not seen for the CBCL. 
Conclusion: In women with IUGR at term, both a policy of induction of labor and 
expectant management do not affect developmental and behavioral outcome 
when compared to expectant management. 
Key words: DIGITAT-trial, intrauterine growth restriction, long-term outcome, Ages 
and Stages Questionnaire, Child Behaviour Checklist. 
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Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with 
expectant management in intrauterine growth restricted infants - long term outcomes of the DIGITAT-trial.
Introduction
Intrauterine growth restriction at term is associated with increased perinatal mor-
bidity and mortality1-7. Long-term morbidity is also increased in pregnancies com-
plicated by IUGR. Studies have reported learning difficulties, defects in speech, 
neurological deficits and behavioral problems to occur more frequently in term 
neonates born small for gestational age (SGA) 8-17. 
The Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) com-
pared the effect of induction of labor in pregnancies complicated by IUGR with an 
expectant monitoring policy18. The results of this study showed no important dif-
ferences in adverse neonatal outcome between the two randomized groups. How-
ever, in de induction group, more neonates were admitted to intermediate care 
after induction than neonates in the expectant monitoring group (48% v. 36%). 
After a policy of expectant management, a larger percentage of neonates were 
born with a birth weight below the 10th centile when compared to neonates in the 
induction group (13% v. 31%, mean difference -18% [95% CI: 12% to 24%]). In both 
groups, neonatal admissions as well as MAIN score (morbidity assessment index for 
newborns) were lower beyond 38 weeks gestational age. 18-19-20. 
The objectives of this study were to1 study the long-term effects on (neuro)de-
velopmental and behavioral outcome of pregnancies complicated by intrauterine 
growth restriction at term and to 2 compare the influence of induction of labor to 
an expectant management policy on these long-term outcomes. 
Methods
Participants
The study population consisted of children born to mothers who participated in 
the DIGTAT-trial. Between November 2004 and November 2008, pregnant women 
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with a singleton fetus in cephalic presentation, and suspected IUGR between 36+0 
and 41+0 weeks were recruited. Suspected IUGR was defined as a fetal abdominal 
circumference (AC) or an estimated fetal weight (EFW) below the 10th percentile, 
or deceleration of the fetal abdominal circumference growth in the third trimes-
ter. Consenting women were randomly allocated to either induction or expectant 
monitoring. Participants allocated to the expectant monitoring group were strictly 
monitored until the onset of spontaneous labor. Details of the DIGITAT trial have 
been described elsewhere18.
Baseline and neonatal characteristics
Data such as maternal characteristics around the time of randomization, gestation-
al age at birth, birth weight, composite adverse neonatal outcome and MAIN score 
were recorded in the original trial. Composite adverse neonatal outcome was de-
fined as neonatal death, five minute Apgar score <7, umbilical artery pH < 7.05 or 
admission to neonatal intensive care.  The MAIN score is a validated numeric index 
outcome of early neonatal outcomes of prenatal care and adverse prenatal expo-
sures in babies delivered beyond 28 weeks gestational age and was calculated for 
all the neonates based on the characteristics recorded around birth. A MAIN score 
greater than zero indicates the presence of neonatal morbidity (ranging from mild 
to severe morbidity)19;20.
Developmental assessment: The Ages and Stages Questionnaire
The Ages and Stages Questionnaire (ASQ)21 is a screening questionnaire designed 
to detect developmental delay in children.  It contains questions to be answered by 
parents about five areas of development of their child: communication, gross mo-
tor, fine motor, problem solving and personal-social. For each area, a mean score is 
calculated. The higher the score, the more abnormal the outcome is. An abnormal 
score is a score of two standard deviations or more below the expected mean of a 
reference population, adjusted for age, and indicates a delay in development and 
a need for further assessment.
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The Child Behaviour Checklist
The Child Behavior Checklist (CBCL)22 consists of 100 items concerning behavioral 
problems, on the basis of which a Total Problem score can be computed.  It also 
informs on 7 narrow band syndrome scales (emotionally reactive, anxious/de-
pressed, somatic complaints, withdrawn, sleep problems, attention problems and 
aggressive behavior), and two broad-band scales (internalizing and externalizing 
behavior). For each scale a standardized T-score is calculated and a score > the 97th 
percentile falls into the clinical range that indicates serious behavior problems. The 
higher the T-score, the more serious the behavioral problems are.
Procedure
Parents of children randomized in the DIGITAT-trial (n=650) were requested to fill 
out the two questionnaires about the development of their child when their child 
was between 23 and 26 months of age. Research nurses contacted the parents by 
phone and subsequently sent out the questionnaires by post. If the parents had 
not responded to the questionnaires, they were contacted again by the research 
nurses. 
Statistical analysis
The number of children with abnormal scores for the ASQ and the CBCL were com-
pared for the two groups with a policy of induction of labor or expectant manage-
ment using the chi-squared test. For both questionnaires, the mean scores per area 
were compared between the two groups using t-tests. Univariate analyses were 
performed using chi-square for categorical values or t-tests for means to identify 
factors of influence on the ASQ and CBCL by comparing children with an abnor-
mal outcome to those without developmental problems. Factors with a p-value 
below 0.10 were entered in a logistical regression model, either as continuous or as 
categorical variables, to assess the joint influence on the outcome of the ASQ and 
CBCL test.  SPSS version 16.0 (IBM, Chicago, IL) was used. 
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Results
Of the 650 parents of children, 582 (89.5%) randomized in the original trial were ap-
proached (Figure 1). Two parents were not approached because their children were 
born with serious congenital abnormalities are caregivers of another child were 
not approached as the mother died post-partum of unknown causes. The response 
rate within the approached group was 54% (n=158) in the induction group and 
46% (n=133) in the expectant monitoring group (p = 0.02). In both groups, a small 
number (n=24) of questionnaires were discarded because they were incomplete or 
filled in when the child was younger than 23 or older than 26 months.
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Baseline characteristics
The baseline characteristics of the two management groups, as well as of the non-
respondents and non-approached participants are shown in table 1. Similar to the 
findings of the primary trial, children in the induction group are lighter at birth with 
a lower gestational age than children in the expectant management group. Base-
line characteristics of the respondents were also compared with the non-respon-
dents/non-approached. The responding mothers were older, less likely to smoke 
and more frequently Caucasian than the non-respondents. When comparing the 
approached group to the non-approached group, we found that women in the 
non-approached group were more likely to smoke.
Ages and Stages Questionnaire
For the Ages and Stages questionnaire, 25% (n=38) of the children in the induction 
group and 29% (n=35) of the children in the expectant management group had an 
abnormal score in one or more areas of development (Table 2). The mean scores 
per problem area were calculated for induction and expectant management. No 
significant differences were found in the mean scores (Table 3) or in the number of 
children with abnormal scores (Table 2) between a policy of induction compared 
to expectant management.
Table 2
Number of children with abnormal scores of the ASQ or CBCL in one or more areas.
Questionnaire Induction of labor n (%)†
Expectant 
Management n (%)§
Difference in percentage 
(95% CI)
Ages and Stages 38 (25) 35 (29) -4 (-14; 7)
CBCL 21 (14) 13 (11) 3 (-5, 11)
†n= 152 for ASQ; n=147 for CBCL
§n=122 for ASQ; n=118 for CBCL
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Child Behaviour Checklist
For the CBCL, 14% in the induction group and 11% in the expectant management 
group had an abnormal score in one or more areas of the CBCL (Table 2). There 
were no differences between the mean T-scores between a policy of induction of 
labor compared to expectant management (Table 3).
Table 4 shows that 43% of children with a birth weight below the 2.3rd centile 
had an abnormal outcome of the ASQ, and that lower percentages with abnormal 
scores were found in higher birth weight centiles (p<0.001). 35% of children with a 
MAIN score greater than zero had an abnormal outcome of the ASQ compared to 
22% of children with a MAIN score equal to zero (p=0.04). None of the four children 
admitted to the intensive care had a poor outcome of the ASQ. However, of the 
children admitted to an intermediate level of care, 34% had an abnormal outcome 
Table 2
Mean scores for the ASQ and CBCL compared between the two groups.
Problem Area ASQ Induction Expectant Management 
ASQ (n=152) ASQ (n=122) p-value
Communication 50.9 (11.7) 51.2 (13.1) 0.8
Gross Motor 53.7 (13.4) 52.3 (10.2) 0.3
Fine Motor 48.7 (9.3) 47.9 (11.2) 0.5
Problem Solving 42.3 (10.4) 44.1 (12.5) 0.2
Personal Social 46.7 (11.0) 47.3 (11.6) 0.7
Syndrome Scale CBCL CBCL (n=122) CBCL (n=118) p-value
Emotionally Reactive 52.9 (5) 52.6 (4.5) 0.6
Anxious/Depressed 51.3 (2.9) 50.9 (2.0) 0.2
Somatic complaints 54.3 (7.1) 54.1 (6.3) 0.8
Withdrawn 53.0 (5.4) 52.3 (4.0) 0.2
Sleep problems 53.0 (5.9) 52.2 (5.5) 0.3
Attention problems 54.1 (5.2) 53.7 (5.0) 0.5
Aggressive behavior 53.9 (5.9) 53.4 (4.9) 0.5
Internalizing 45.5 (10.7) 44.7 (9.2) 0.5
Externalizing 50.2 (9.2) 48.2 (9.9) 0.1
Total problem score 47.6 (9.9) 45.6 (9.8) 0.1
Table shows mean score per area (ASQ) or mean T-score (CBCL) and standard deviation.
Groups were compared using the Student t-test.
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of the ASQ, significantly higher than the 20% abnormal scores found in children not 
admitted or admitted to the maternal ward (p=0.005).  No significant correlation 
was found between gestational age at birth, composite adverse neonatal outcome 
at birth, management policy, maternal smoking during pregnancy or education 
level of mother and an abnormal outcome of the ASQ. We could not identify any 
Table 4






<p 2.3 22 (43%) p<0.001 9 (18 %)
0.3*
p2.3 – p5 20 (29%) p=0.01 5 (8%)
p5 – p10 20 (29%) p=0.01 7 (11%)
>p10 11 (13%) reference 13 (16%)
Gestational Age (weeks)
36 – 36+6 12 (36%)
0.6*
37 – 37+6 12 (19%) 6 (10%)
0.4*
38 – 38+6 20 (29%) 12 (17%)
39 – 39+6 12 (25%) 6 (13%)
40 – 40+6 13 (30%) 2 (5%)








No 72 (27.6%) 22 (14%)





No 44 (22%) 24 (13%)
Admission type after birth
Intensive Care 0 (0%) 0.14 1 (33%)
0.1*Intermediate level of care 41 (34.2%) 0.005 15 (13%)





Expectant Management 35 (29%) 13 (11%)






No 45 (27.4%) 22 (14%)
Education of mother




Higher professional school 5 (14.7%) 2 (6%)
Percentages were compared between normal and abnormal scores using chi-square.
* No significant differences between subgroups.
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factors which were significantly related to the outcome of the CBCL (Table 4).
Logistic regression analysis revealed that birth weight centile (P < 2.3) is the stron-
gest predictor for an abnormal outcome on the ASQ (Odd’s ratio 3.6 compared to a 
birth weight above the 10th percentile) (Table 5).
Discussion
This study shows that there are no significant differences in developmental or be-
havioral outcomes at 2-years of age in children born at term with a clinical sus-
picion of growth restriction between a policy of induction of labor, compared to 
expectant management. The long-term follow-up of the DIGITAT-trial is unique in 
its prospective design, studying neurodevelopmental and behavioral outcomes of 
these children and simultaneously comparing different management strategies. 
Others have previously shown that at term growth restriction can have long-term 
consequences on development, however, this was studied in children born SGA 
and not suspected of IUGR23-25 before birth. 
Important is that children with a lower birth weight centile perform worse on the 
Ages and Stages questionnaire, especially those below the 2.3rd centile. Children 
admitted to an intermediate level of care and children with a higher MAIN score, 






<p 2.3 22 (43%) p<0.001 9 (18 %)
0.3*
p2.3 – p5 20 (29%) p=0.01 5 (8%)
p5 – p10 20 (29%) p=0.01 7 (11%)
>p10 11 (13%) reference 13 (16%)
Gestational Age (weeks)
36 – 36+6 12 (36%)
0.6*
37 – 37+6 12 (19%) 6 (10%)
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40 – 40+6 13 (30%) 2 (5%)
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0.1*Intermediate level of care 41 (34.2%) 0.005 15 (13%)





Expectant Management 35 (29%) 13 (11%)






No 45 (27.4%) 22 (14%)
Education of mother




Higher professional school 5 (14.7%) 2 (6%)
Table 5
The joint effect of factors of influence on the ASQ in a logistic regression analysis.
Odds Ratio 95% Confidence Interval
MAIN score > zero (n=66) 1.4 0.7  - 2.6
Birth weight centile
<p 2.3 (n=48) 3.6 1.5 – 8.8
p2.3 – p5 (n=68) 2.1 0.9 – 4.9
p5 – p10 (n=67) 2.6 1.1 – 6.0
>p10 (n=80) reference
Education of mother
Lower professional school (n=129) 2.1 0.7 – 6.0
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neonatal outcome nor in the long term follow-up, between a policy of induction 
compared to expectant management, more children become severely growth re-
stricted (<p 2.3) after a policy of expectant management. On the other hand, after a 
policy of induction, more children were admitted to an intermediate level of care.
No factors were found to be associated with the increase of behavioral problems 
at 2-years of age. Behavioral problems may not yet have become evident at this 
age26. Previous studies have shown effects of IUGR on behavioral outcome at lat-
er age, but all for children older than 2-years of age. A longer follow-up period is 
possibly needed to investigate behavioral problems in children born at term with 
growth restriction.
In this study we used postal questionnaires to assess neurodevelopmental and be-
havioral problems in these children. Unfortunately, a complete history and physical 
examination was non affordable within our study budget and with a postal enquiry 
we obtained information on the long-term outcome in growth-restricted infants 
and were able to compare the outcome at two years of age for the two manage-
ment strategies.
The response rate in the induction group was significantly higher when compared 
to the expectant management group. An explanation could be that the induced 
women had better memory of the trial due to the intervention and the fact that 
their child had to be admitted to hospital more frequently. Another possible re-
sponse bias could occur because parents of children who are performing poorly 
and have more problems would be less likely to participate in follow-up studies27. 
Mothers who responded to the questionnaires smoked less, were older and more 
frequently Caucasian than non-responders. These characteristics are found more 
often in groups who are more likely to participate in studies28. Furthermore there 
were no differences between the responders in the induction group compared to 
the expectant management group in any of the baseline variables, so we currently 
do not have any indications of bias. 
In conclusion, severe growth restriction (< p 2.3) and neonatal admission seem to 
be the most important predicting factors for neurodevelopmental problems at 
2-years of age in children born after suspected IUGR at term.  As induced babies are 
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admitted more frequently, but more babies become severely growth restricted af-
ter expectant management the challenge determining the optimal time to deliver 
remains. The negative effects of being born relatively premature must be weighed 
against the negative effects of becoming severely growth restricted. Further stud-
ies are needed to investigate patient and fetal factors to delineate those pregnan-
cies in which the fetus is actually growth restricted. If we can predict what fetus will 
reach its own growth potential and what fetus will cease to grow, we might foresee 
those who may actually benefit from induction. By that means we could attempt 
to limit unnecessary neonatal admissions due to iatrogenic late prematurity.  Also 
more detailed follow-up measures and studies in later life are needed in this group 
to study behavior, IQ, development and motor function of children born at term 
with growth restriction.
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Chapter 10 Comparison of induction of labor and expectant monitoring in intrauterine growth restriction at term 
through integration of trial outcomes and patient preferences
Abstract
Objective: Intrauterine growth restriction (IUGR) is associated with an increased 
risk for neonatal morbidity and mortality. When diagnosed at or near term, a pos-
sible treatment for IUGR is induction of labor. In DIGITAT, a large Dutch multicentre 
randomized controlled trial (RCT), we found no differences in neonatal outcome or 
mode of delivery between induction of labor and expectant management. The aim 
of this patient’s preference study alongside the RCT was to gain insight into how 
women value different obstetrical outcome scenarios. These values, in combina-
tion with the outcome distribution of the RCT, will indicate the preferred treatment 
in women with suspected IUGR after 36 weeks of pregnancy.
Methods: In the DIGITAT trial, 626 women with IUGR at term were randomized for 
induction of labor or expectant management. We used case scenarios (‘vignettes’), 
involving five important factors (‘attributes’) that were evaluated by 24 trial partici-
pants using a discrete choice experiment (DCE) and by visual analogue scale (VAS). 
We combined these outcome valuations with outcome distributions of the RCT, 
and calculated a mean outcome for the strategies induction of labor and expect-
ant management, respectively. These mean values were compared between the 
treatment groups using t-test for the total group and for subgroups, which were 
defined according to parity and gestational age. 
Results: Using the DCE there was no overall treatment preference for the total 
group or for any of the subgroups (p=.72). The VAS, however, did indicate prefer-
ence towards expectant management for the total group (p<.001) as well as for 
subgroups.
Conclusion: Based on the theoretical superiority of the DCE over the VAS method, 
the DCE results are leading. Patient’s preferences for expectant monitoring and 
induction of labor in case of IUGR at term are equal. These results reflect the out-
comes of the DIGITAT trial.
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Comparison of induction of labor and expectant monitoring in intrauterine growth restriction at term 
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Introduction
 Evaluation of medical interventions in clinical problems is often difficult because 
various outcomes are involved. In obstetrics, not only survival, but also the long-
term health of mother and child, as well as complications with short-term conse-
quences and the mode of delivery all should be considered in the decision which 
intervention is the best. An example of an obstetric problem where various out-
comes need to be considered is intrauterine growth restriction (IUGR) at term. In 
pregnancies complicated by IUGR at term there is an increased risk for neonatal 
morbidity and perinatal mortality, and there is concern about the long term health 
of the child 1-5. In case of IUGR at term, there are two treatment options: The preg-
nancy can be monitored expectantly, or labor can be induced. Induction of labor 
might prevent neonatal morbidity and perinatal mortality and it may improve 
long-term outcomes, but it also interferes with the process of natural birth at a 
possible increased risk of instrumental delivery. 
In the Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT; 
ISRCTN10363217), a large nationwide multicentre randomized controlled trial 
(RCT), induction of labor was compared to expectant monitoring in women with 
an IUGR-fetus beyond the 36th week of pregnancy. The study showed that in both 
strategies neonatal morbidity, the number of instrumental deliveries, and maternal 
outcomes were not different. There were also no differences in overall maternal 
health-related quality of life (HR-QoL) 6-8. It was concluded that both strategies ap-
pear equivalent in terms of neonatal and maternal health. However, in the accom-
panying editorial it was stated that, as the association between suboptimal growth 
and stillbirth is well accepted, it is appropriate to counsel the women because in a 
suspected growth-restricted pregnancy beyond 36 weeks, induction of labor may 
prevent the rare but devastating outcome of stillbirth. Whereas this strategy does 
not increase maternal risk, it might be the preferred option for many women 9.
Alongside DIGITAT we performed a patients’ preference study, in which patients 
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gave their valuations of different health outcome scenarios that were measured 
in DIGITAT. By combining true DIGITAT outcome data with the patients’ valuations 
of those outcomes, the result is an overall valuation of the outcomes in terms of 
preference from patients’ point of view.  Regarding the equivalency of the DIGITAT 
outcomes, patients’ preference can be put forward as the most important indicator 
for the evaluation of all outcomes taken together in the ultimate choice of treat-
ment 10. 
In this paper we present the expected patients’ preference of treatment in case of 
IUGR at term. The treatment options are induction of labor or expectant monitoring. 
We combined the DIGITAT outcomes with patients’ valuations of those outcomes. 
We evaluated preferences for the total group, as well as for subgroups based on 
gestational age and obstetric history.
Methods
General approach
The clinical data originated from DIGITAT (Disproportionate Intrauterine Growth 
Intervention Trial At Term ISRCTN10363217 6, a multicentre randomized controlled 
trial (RCT) performed in the Netherlands between November 2004 and November 
2008. The 650 included patients with a singleton pregnancy beyond 36+0 weeks 
gestation with suspected IUGR were randomly allocated to either induction of la-
bor within 48 hours or to expectant management. Main outcome measure was a 
composite of adverse neonatal outcome, defined as neonatal death before hospital 
discharge, a 5-minute Apgar score < 7, an umbilical artery pH <7·05 or admission to 
the neonatal intensive care unit. More details are provided in the original paper 8.
To arrive at the comparison of the patients’ preference between induction of labor 
and expectant management in case of IUGR at term, we made three steps. First, we 
developed and tested case scenarios among women who had participated in the 
DIGITAT study and women who were asked but had refused. Second, we combined 
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the obtained patients’ valuations’ with the observed clinical outcome data of the 
DIGITAT study, as well as rates obtained from the literature. From this combined 
dataset we calculated sum-scores for patients’ preferences per treatment alloca-
tion (induction or expectant management), and tested for differences between the 
treatments. Below we discuss these three steps.
Step 1: Development of case scenarios (‘vignettes’)
In the development of case scenarios, we first aimed to identify the most important 
factors that were involved in the choice between induction of labor and expect-
ant monitoring. To do so, we conducted interviews about the physical, psycho-
logical, and social burden and consequences of IUGR in a previous study 11. The 
interviewees were 10 women who participated in DIGITAT or HYPITAT (Hyperten-
sion and Preeclampsia Intervention Trial at Term 12 studies, and 10 medical experts 
(gynecologists, obstetricians, neonatologists, pediatricians). The interviews led to 
the definition of potential attributes: ‘Maternal health ante partum’, ‘time between 
diagnosis and delivery’, ‘process of delivery’, ‘maternal outcome’, and ‘neonatal out-
come’. Each attribute incorporated several levels. For example, in case of the attri-
bute process of delivery, we considered the attributes spontaneous onset of labor 
versus induction and primary caesarean section, as well as the mode delivery (vagi-
nal, vacuum or caesarean section), in all possible combinations (Table 1). For each 
attribute, we defined two to seven levels according to the interviewees’ responses, 
literature review, and expected primary and secondary outcomes from DIGITAT. 
More information about the vignettes is provided in a separate publication on this 
study (Bijlenga, Birnie, Bonsel, 2009 11.
Step 2: Obtaining patient valuations of case scenarios 
Patients’ valuations of the vignettes were established in group sessions 13. Partici-
pants were 24 patients (other than the pilot participants) who participated to ei-
ther DIGITAT or to a similar RCT about treatment preference in case of pregnancy-
induced hypertension (the HYPITAT trial 12. All participants valued the vignettes 
using the widely used weighting method discrete choice experiment (DCE) 13. The 
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DCE is believed to be a valid method to calculate utility and preference 14;15. We 
also show the results based on the visual analogue scale (VAS) values, which are 
not considered as a measure of preference, but may give support to the DCE out-
comes 16;17. The mean assigned weights using the methods in our previous study 
are shown in Table 1. Higher DCE and VAS valuation indicate higher preference. For 
example, the attribute ‘Neonatal outcome’ has lower preferences the worse the de-
scription of the levels. This indicates less preference of the higher levels of neonatal 
outcomes as compared to the baseline neonatal level ‘No complications’.
The health-related quality of life (HR-QoL) outcomes of the DIGITAT patients were 
also used in this study 6;7. As part of the HR-QoL, the participating women filled out 
the European Quality of life (EQ5D) at inclusion, 6 weeks postpartum, and 6 months 
postpartum. The EQ5D is a brief validated measure that provides a global health 
state rating of mobility, self-care, usual activities, pain/discomfort, and anxiety/de-
pression 18. Details of the DIGITAT HR-QoL study are described elsewhere 8. Using 
the HR-QoL outcomes we calculated the weights for the attributes Maternal health 
ante partum and for Maternal outcome (post partum), see also Table 1.
Step 3: Combining patient valuations and outcome data of the DIGITAT trial
In order to combine the patient valuations of the vignettes and the outcome data 
of the DIGITAT trial, we needed to define which DIGITAT outcomes can be assigned 
to which level of the attributes. Therefore, we defined ‘translation rules’ (see Table 
1). Most DIGITAT cases could be assigned using the translation rules, see Table 1. 
Some cases, however, were unclear to which of two adjacent levels they should be 
assigned. We presented these ambiguous cases to three neonatologists and asked 
them to which of the two adjacent levels they should be assigned.
Whereas we did not have any data on neonatal mortality from the DIGITAT trial, 
we used perinatal and neonatal mortality incidence data from the Dutch neonatal 
registry (PRN 2009) for the calculation of preference for the total group. These data 
are presented in Table 1 (attribute 5, level 5).
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Table 1
Translation rules to assign every clinical case to a level per attribute using observed clinical data from 
DIGITAT, and its DCE value (significant values are signed by *).
Attribute Used variable(s) Level Translation rules DCE valuespatients
DCE values
Lay people
A1: Maternal health 
ante partum
- RCT data: fetal movement, 
fetal cardiotocography (CTG). 
- HR-QoL data at inclusion: 
EQ Mobility, Pain/Discomfort, 
Anxiety/Depression
L1
All of the following: EQ Mobility<3; 
EQ Pain/Discomfort<3; EQ Anxiety/
Depression<3; normal fetal move-
ment; good fetal CTG.
Ref Ref
L2
At least one of the following: EQ 
Mobility=3; EQ Pain/Discomfort=3; 
EQ Anxiety/Depression=3; decre-
ased fetal movement; suboptimal 
fetal CTG.
0.3 -0.8
A2: Time between 
diagnosis and delivery
- RCT data: number of days 
between inclusion date and 
delivery date.
L1 ≤ 3 days Ref Ref
L2 > 3 days 5.3* -0.6
A3: Process of delivery - RCT data: induction of labor 
and mode of delivery.
L1 Vaginal delivery Ref Ref
L2 Induction of labour and vaginal delivery 2.3 -6.2*
L3 Vacuum or forceps 3.9 -1.4
L4 Induction of labour and vacuum or forceps 11.3 -1.1
L5 Primary caesarean 9.3 1.1
L6 Secondary caesarean 9.3 2.6
L7 Induction of labour and secondary caesarean 2.5 2.3
A4: Maternal outcome - RCT data: maternal length of 
hospital stay, type of hospital 
stay. 
- HR-QoL data at 6 months 
post partum: EQ Mobility, Pain/
Discomfort.
L1
All of the following: No stay; stay at 
the ward; ≤ 5 days stay at Medium 




At least one of the following: 6 
to 10 days stay at Medium care; 
< 5 days stay at High or Intensive 




At least one of the following: > 10 
days stay at Medium care; ≥ 5 days 
stay at High or Intensive care; EQ 
Mobility=3; EQ Pain/Discomfort=3.
-12.6* -16.3*
A5: Neonatal outcome - RCT data: neonatal length of 
hospital stay, type of hospital 
stay, type of complications; 
diagnosis at discharge.
L1 No hospital stay or stay at maternal ward. Ref Ref
L2 Stay at Medium care ≤ 10 days. 7.6* -2.3
L3
At least one of the following: > 10 
days stay Medium care; ≤ 5 days 
at high or intensive care; total 
hospital stay ≤ 14 days; diagnosis at 
discharge is not chronic disease.
1.0 -6.8*
L4
At least one of the following: > 
5 days at High or Intensive care; 
diagnosis at discharge is chronic 
disease.
-9.3* -20.8*
L5 Perinatal or neonatal death. -13.8* -33.1*
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We combined the clinical dataset and the patient’s valuations, using the translation 
rules. For example, if treatment X resulted in 11% and treatment Y in 9% second-
ary caesarean sections, and the preference value for caesarean section is -0.2, then 
the summed score for caesarean section in treatment X is -0.2*0.11= -0.022 and for 
treatment Y is -0.2*0.09= -0.018. In this example treatment Y is the preferred option 
since its sum-score is higher. Using paired t-test (in case of normal distributions) 
we made straightforward comparisons of the summed score for preference for in-
duction of labor versus expectant monitoring. We compared both the preference 
scores for the total group as well as for subgroups based on gestational age at in-
clusion (≤ 36+6, 37 to 38+6, and ≥ 39 weeks) and parity (nulliparous, multiparous). 
Analyses were conducted with SPSS 16.0 for Windows (SPSS Inc). A p-value ≤0.05 
(two sided) was considered to indicate statistical significance. 
Results
For this study we used data of all 650 randomized DIGITAT women, of which 321 
women had been randomized for induction of labor and 329 for expectant man-
agement. 
All maternal and procedural data could be directly translated to the attributes us-
ing the translation rules (Table 1). However, of the neonatal cases, 42 could not be 
straightforwardly translated to the either of the levels. A panel of three neonatolo-
gists assigned 11 of these neonatal cases to Attribute 5 (neonatal outcome), level 3 
(A5L3) and 31 cases to A5L4 (Table 1). After the translation of all clinical outcomes 
into the appropriate attributes and levels, the outcome distributions for the total 
group and for the subgroups emerged (Table 2). 
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Table 2
Observed outcome distribution in percentages according to treatment (20), for each attribute-level separa-
tely, for all patients and for the subgroups of patients based on parity and gestational age at inclusion. For 
an explanation of the Attributes and levels, see table 1.
Note: IL= Induction of labor; EM= Expectant monitoring; G1= Gestational age ≤ 36+6 weeks at inclusion; G2= 37 to 38+6 
weeks; G3= ≥ 39 weeks.
* Data from the Dutch neonatal registry (PRN 2009)
Subgroups: parity Subgroups: gestational age at inclusion
Attribute (A)













IL EM IL EM IL EM IL EM IL EM n=383 EM
A1L1 88.8 85.7 87.9 88.1 89.9 82.0 90.1 79.8 89.3 88.2 84.1 86.2
A1L2 11.2 14.3 12.1 11.9 10.1 18.0 9.9 20.2 10.7 11.8 15.9 13.8
A2L1 87.2 11.9 86.6 12.4 88.5 11.0 84.0 11.9 87.2 9.6 93.2 19.3
A2L2 12.8 88.1 13.4 87.6 11.5 89.0 16.0 88.1 12.8 90.4 6.8 80.7
A3L1 3.4 40.2 3.3 37.8 3.6 44.1 2.5 27.2 2.0 44.9 11.4 43.1
A3L2 74.1 37.8 61.3 31.3 90.6 48.0 75.0 42.2 76.0 38.0 63.6 31.0
A3L3 0.3 3.7 0.6 5.5 0 0.8 0 3.6 0.5 2.7 0 6.9
A3L4 8.1 4.6 14.4 7.0 0 0.8 6.3 4.8 7.1 4.3 15.9 5.2
A3L5 0.6 3.4 1.1 3.0 0 3.9 0 6.0 1.0 2.1 0 3.4
A3L6 0 2.1 0 3.0 0 0.8 0 1.2 0 1.6 0 5.2
A3L7 13.4 8.2 19.3 12.4 5.8 1.6 16.3 14.5 13.3 6.4 9.1 5.2
A4L1 97.4 99.1 95.4 99.0 100 99.2 98.7 97.6 97.3 9.4 95.3 100
A4L2 1.0 0.6 1.7 0.5 0 0.8 1.3 1.2 0.5 0.6 2.3 0
A4L3 1.6 0.3 2.9 0.5 0 0 0 1.2 2.1 0 2.3 0
A5L1 48.8 59.4 42.5 53.8 56.8 68.0 27.5 44.6 55.1 64.9 59.1 63.2
A5L2 32.2 21.5 35.9 24.9 27.3 16.4 40.0 21.7 29.6 22.2 29.5 19.3
A5L3 15.0 13.5 17.1 15.7 12.2 10.2 26.3 21.7 11.2 10.3 11.4 12.3
A5L4 4.1 5.5 4.4 5.6 3.6 5.5 6.3 12.0 4.1 2.7 0 5.3
A5L5 0.001* 0.005* 0 0 0 0 0 0 0 0 0 0
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From the calculation of the valuation per attribute, we calculated the valuation dis-
tributions for the total group and for the subgroups using the patients’ DCE and 
VAS valuations. All distributions were considered normal. The results of the t-test 
comparisons between the treatment options for the total group and for the sub-
groups are shown in Table 3. The table shows overall preference for expectant man-
agement in the total group as well as in the subgroups. The DCE preferences were 
equal between treatment options for both the total group and the subgroups. The 
VAS outcomes showed a treatment preference for expectant monitoring in the to-
tal group (p<.001) as well as for several subgroups (see Table 3).
Table 3
Comparison of the overall preference score according to treatment (20), for all patients and for the 
subgroup of patients, using the significant patient’s and lay people’s DCE values. Higher scores indicate 
stronger preference.
* The highly improbable significant weight for A5L2 has been ignored.
Note: G1= Gestational age ≤ 36+6 weeks at inclusion; G2= 37 to 38+6 weeks; G3= ≥ 39 weeks. 










Total group (N=650) -0.57 (2.39) -0.51 (2.11) .717
Total group with PRN data -0.59 (2.39) -0.58 (2.11) .945
Subgroup Nullipara (n=383) -0.79 (2.82) -0.54 (2.17) .326
Subgroup Multipara (n=266) -0.28 (1.60) -0.46 (2.03) .434
Subgroup G1 (n=165) -0.63 (2.35) -1.05 (2.96) .336
Subgroup G2 (n=383) -0.61 (2.50) -0.26 (1.53) .102
Subgroup G3 (n=101) -0.29 (1.92) -0.54 (2.19) .570
Subgroup Nullipapa*G1  (n=95) -0.89 (2.76) -1.05 (2.97) .780
Subgroup Nullipara*G2 (n=204) -0.86 (2.99) -0.27 (1.58) .082
Subgroup Nullipara*G3 (n=65) -0.34 (2.34) -0.52 (2.16) .884
Subgroup Multipara*G1 (n=59) -0.29 (1.64) -1.03 (2.98) .231
Subgroup Multipara *G2 (n=164) -0.32 (1.72) -0.24 (1.48) .733
Subgroup Multipara *G3 (n=30) 0.00 (0.00) -0.58 (2.32) .359
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Discussion 
We have taken all RCT data outcomes together and evaluated these in terms of pa-
tients’ preference for induction of labor or expectant management in case of IUGR 
at term. We compared the summed valuations of the DIGITAT outcomes 8. 
Our results show that, taken the outcomes of the total group, the DCE method did 
not indicate one preferred treatment over the other. The VAS indicated expectant 
management as an overall treatment preference. Also for most of the subgroups, 
which have been established according to the patient’s parity and gestational age, 
the VAS indicated preference towards expectant management. These findings are 
supplemental to, and a reflection of, the outcomes of the clinical trial 8. These re-
sults do not indicate either induction of labor or expectant management to be su-
perior in terms of patient’s preferences.
The DCE as a measure of preference is considered theoretically superior to the VAS. 
However, both the VAS and the DCE have their limitations. First of all, our main 
choice of method was the DCE method, which has proven to be a valid preference 
elicitation method in health care 19. However, as our previous research has indicat-
ed, the outcome may depend on the choice of method 11. We have backed up the 
DCE outcomes by VAS outcomes, which gave different results. According to the VAS 
outcomes, expectant management is superior in terms of patient’s preferences. 
However, the DCE outcomes are here the leading outcomes, which do not reflect 
superiority of any treatment. Second, in this paper we solely discuss patient’s pref-
erences, while previous study shows that doctor’s and the general public’s pref-
erences may differ13. We have limited our focus to patients, whereas in practice, 
patients are the key decision-makers in this particular setting. Finally, our study 
has focused on preference elicitation on the group level. Individual preferences 
may be different from the outcomes on the group level. We have observed in the 
DIGITAT trial that most patients did not want to participate as randomized patients 
indicated they wanted to wait instead of being randomized with a 50% chance of 
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induction of labor 8. This prior preference for expectant management is reflected 
in the VAS results, but not in the DCE results. While this does not mean that the DCE 
is a less valid valuation method, it does seem to reflect revealed preferences less 
accurate than the VAS.
In short, the equivalence of the patient’s preference scores for treatments in case 
of IUGR after 36 weeks of gestation reflects the equivalence of the clinical DIGITAT 
outcomes. Both treatments are safe and result in equal maternal and neonatal out-
comes and preferences. 
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Abstract
Objective: To compare perinatal outcomes of suspected versus non-suspected 
small-for-gestational age fetuses (SGA) at term.  
Methods: Retrospective cohort study among all term singleton neonates with a 
birth weight <10th percentile born in the Parkstad region between 01-01-2006 and 
03-31-2008. The subjects were assigned to a prenatally Suspected or Non-Suspect-
ed SGA group. Primary outcome was adverse neonatal outcome at birth, defined 
as a composite of intrauterine fetal death, Apgar <7 at 5 minutes, or pH umbilical 
artery <7.05. Secondary outcome included neonatal medium care unit (NMCU) ad-
mission ≥7 days.
Results: 430 subjects were included in the study; 36.7% was suspected of SGA. 
In the Suspected SGA group mean gestational age at birth and birth weight were 
significantly lower, whereas maternal morbidity was significantly higher. The in-
cidence of labor induction and elective cesarean section were also significantly 
higher in the Suspected SGA group. Total perinatal mortality was 2.1%. Identifica-
tion of SGA and subsequent management led to a significant decrease of adverse 
neonatal outcome at birth, but did not lead to a significant decrease in NMCU ad-
mission >7 days. 
Conclusions: Suspicion of SGA was associated with a more active management of 
labor and delivery, resulting in a better neonatal outcome at birth. 
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Introduction
Perinatal mortality in the Netherlands has gradually decreased from 10.9 per thou-
sand births in 1999, to 10.0 in 2004, and to 9.7 in 2007. This decreasing trend, how-
ever, is slower than in other European countries, resulting in a public and political 
debate on the organisation of obstetric care in the Netherlands1. A major contrib-
uting factor to perinatal mortality is the small-for-gestational age (SGA) fetus 2-4. 
Between 2000 and 2009, perinatal mortality rate in the Netherlands in SGA preg-
nancies was 1.79% 5. SGA is also associated with an increased neonatal morbidity 
6-7. Effects of SGA persist well beyond the neonatal period. Children with a history 
of SGA lag behind in somatic growth, neurodevelopmental performance, cogni-
tion and school achievements 8. SGA is associated with an increased late life preva-
lence of cardiovascular disease 9.  
Improving the prognosis of the SGA fetus by providing effective clinical manage-
ment is a great obstetrical challenge. In case SGA is suspected based on fundal 
height measurement, the diagnosis can be confirmed by ultrasound. Identifying 
SGA in low risk pregnancies is difficult 10-13. The detection rate after abdominal pal-
pation as a screening test by first line midwives subsequently confirmed by ultra-
sound, was 15% in a Dutch trial among 6318 singleton pregnancies 14. In a clinical 
setting in Sweden, 63% of all SGA fetuses were identified prenatally 15. 
There are no effective therapies to improve the growth pattern of the growth re-
stricted fetus 16. Monitoring the SGA fetus by ultrasound, Doppler and cardiotocog-
raphy may enable the treating physician to modulate the intensity of the controls 
and to precisely define the timing of delivery, when necessary 17-18. When optimal 
maternal and fetal monitoring can be provided, expectant management and labor 
induction have equivalent fetal and maternal outcomes 19.
The aim of this retrospective cohort study was to analyze the effect of suspicion 
and subsequent management of SGA at term in common daily practice on perina-
tal outcomes, in a well-defined region in the Netherlands.
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Methods
The study population consisted of all term (370 - 420 weeks’ gestation) singleton 
SGA neonates born between January 1, 2006 and March 31, 2008, in the Parkstad 
Heerlen region. Most babies were delivered in the Atrium Medical Centre Parkstad 
under supervision of an obstetrician, others were delivered at home or in the hos-
pital under supervision of a midwife of the Obstetrical Cooperate Association Heer-
len. 
Selection of the patients was based on the information available in their medical 
records. Eligible patients were assigned to a group with prenatally Suspected SGA 
or a group with prenatally Non-Suspected SGA. SGA was defined as a birth weight 
<10th percentile, based on weight curves provided by the Netherlands Perinatal 
Registration. SGA was considered suspected when this was described unambigu-
ously in the mothers’ pregnancy chart. The clinical surveillance protocol used in 
case of prenatally suspected SGA comprised of fetal ultrasounds with fetal-placen-
tal Doppler velocimetry weekly, and cardiotocography twice weekly or more fre-
quently depending on the severity of the growth restriction. 
Baseline characteristics of the mother and the neonate, characteristics of pregnan-
cy, labor and delivery, and perinatal outcomes were abstracted from the medical 
files. Maternal baseline characteristics included age at delivery, height, BMI, smok-
ing, use of drugs, alcohol or fetotoxic medication (e.g. SSRI’s, antiepileptic drugs), 
parity, and hypertensive disorders during pregnancy. Neonatal baseline character-
istics included gestational age at birth, birth weight and sex. Variables concerning 
pregnancy, labor and delivery included the moment of referral to the obstetrician, 
initiation of labor, analgesia, mode of delivery, and delivery complications. 
The primary outcome was the composite “adverse neonatal outcome at birth” de-
fined as intrauterine death, Apgar <7 at 5 minutes, or pH umbilical artery <7.05. 
Secondary outcomes included resuscitation, congenital anomalies, neonatal com-
plications (ranging from hypoglycemia to infections to encephalopathy) and neo-
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natal medium care unit (NMCU) admission ≥7 days. A NMCU is equipped for neo-
nates born after at least 32 weeks’ gestation who may need artificial ventilation for 
a maximum of 24 hours. 
Categorical variables are presented by number and percentage. Continuous vari-
ables are presented by mean and standard deviation. The Chi-square or Fisher’s 
exact test was performed for categorical variables, and the independent-samples 
t-test for continuous variables. Logistic regression was used to determine the ef-
fect of suspicion of IUGR on adverse neonatal outcome at birth as well as NMCU 
admission ≥7 days after correction for the clinically and statistically most impor-
tant maternal and neonatal variables, where the maximum number of variables 
is restricted by the total number of events. Variables with more than 5.0% missing 
data were not included in the logistic regression analysis, where the robustness of 
the results was tested by comparing them with those obtained after adding these 
variables to the model. The effect of suspicion of SGA and other variables on ad-
verse neonatal outcome at birth and NMCU admission ≥7 days were presented by 
the odds ratio with corresponding 95% confidence interval. Linearity assumption 
was checked by adding and testing a centered quadratic term, leaving this term in 
the model when significant. 
Results were considered statistically significant when the p-value was < 0.05. Statis-
tical analysis was performed using the SPSS program (version 17.0).
Results
Between January 1, 2006 and March 31, 2008, 4247 women were delivered of a 
term singleton neonate in the Parkstad region 5. From these neonates, 430 (10.1%) 
had a birth weight <10th percentile and were enrolled in the study. 158 (36.7%) of 
these SGA neonates were suspected prenatally and assigned to the Suspected SGA 
group. The remaining 272 (63.3%) neonates were assigned to the Non-Suspected 
SGA group. 
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In home deliveries (n=40), not all variables used in this study were consequently 
documented. For the total cohort, this resulted in missing data in the variables ma-
ternal length (6.5%), maternal BMI (19.8%), placenta weight (8.1%), umbilical artery 
pH (9.1%) and umbilical vein pH (10.9%). Of all other variables less than 0.1% of the 
data was missing. 
Maternal baseline characteristics are shown in Table 1. Compared to the Non-Sus-
pected SGA group, mothers in the Suspected SGA group were significantly taller 
and had a significantly lower BMI. Significantly more women in this group were 
smokers, used drugs, had an SGA in a previous pregnancy, and had hypertensive 
disorders during pregnancy.
Table 2 shows the neonatal baseline characteristics. Mean gestational age and 
birth weight were significantly lower for neonates in the Suspected SGA group 
Table 1
Maternal baseline characteristics







Age at delivery (years) (mean, SD) 28.4 (5.8) 29.4 (5.4) 0.069
Height (m) (mean, SD) 1.66 (0.07) 1.65 (0.07) 0.021
BMI (kg/m2) (mean, SD) 27.0 (5.2) 28.8 (4.6) 0.001
Smoking (n) 100 (63.3%) 107 (39.5%) <0.001
Drugs (n) 23 (14.6%) 11 (4.1%) <0.001
Alcohol (n) 9 (5.7%) 10 (3.7%) 0.330
Fetotoxic medication (n) 9 (5.7%) 13 (4.8%) 0.684
Multigravida (n) 85 (53.8%) 163 (59.9%) 0.215
IUFD* previous pregnancy (≥24 weeks) (n) 3 (3.5%) 4 (2.5%) 0.694
SGA previous pregnancy (n) 44 (51.8%) 56 (34.4%) 0.008
Hypertensive disorders (n)  23 (14.6%) 21 (7.7%) 0.024
Proteinuria (n) 17 (10.8%) 18 (6.6%) 0.130
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compared to the Non-Suspected SGA group. Significantly more neonates had a 
birth weight < p2.3 in the Suspected SGA group. 
As shown in Table III, 94.9% of women in the Suspected SGA group had prenatal 
care by an obstetrician, in contrast to 53.7% of women in the Non-Suspected SGA 
group. In the Suspected SGA group, induction of labor and elective cesarean sec-
tion were more frequently performed, whereas instrumental delivery and second-
ary cesareans were more common in the Non-Suspected SGA group. The incidence 
of meconium stained amniotic fluid was significantly lower in the  Suspected SGA 
group compared to the Non-Suspected SGA group, as were the incidence of epi-
siotomy or a 2nd, 3rd or 4th degree rupture, the mean amount of blood loss, the 









Gestational age at birth (days) (mean, SD) 275.1 (9.1) 280.2 (7.8) <0.001
Birth weight (g) (mean, SD) 2518.1 (331.7) 2770.7 (270.7) <0.001
Birth weight <0.001
<p2.3 (n) 68 (43.0%) 66 (24.3%)
>p2.3 - <p5 (n) 39 (24.7%) 73 (26.8%)
>p5 - <p10 (n) 51 (32.3%) 133 (48.9%)
Male sex (n) 74 (46.8%) 142 (52.2%) 0.283
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Table 3
Characteristics of pregnancy, labor and delivery
*** All except elective cesarean section
*** All except intrauterine deaths







Moment of referral to obstetrician <0.001
Primary pregnancy attendance by obstetrician (n) 64 (40.5%) 84 (30.9%)
Referred to obstetrician during pregnancy (n) 86 (54.4%) 62 (22.8%)
Referred to obstetrician during delivery (n) 8 (5.1%) 86 (31.6%)
Referred to obstetrician post partum (n) 0 (0.0%) 40 (14.7%)
Initiation of labor <0.001
Spontaneous (n) 101 (63.9%) 225 (82.7%)
Induction (n) 37 (23.4%) 33 (12.1%)
Elective cesarean section (n) 20 (12.7%) 14 (5.1%)
PROM* (n) 11 (8.3%) 30 (11.8%) 0.298
Augmentation* (n) 37 (27.0%) 76 (29.3%) 0.624
Analgesia 0.302
No analgesia (n) 73 (46.2%) 139 (51.1%)
Oral / systemic analgesia (n) 45 (28.5%) 72 (26.5%)
Epidural analgesia (n) 9 (5.7%) 23 (8.5%)
Spinal / General analgesia(n)  31 (19.6%) 38 (14.0%)
Mode of delivery 0.034
Spontaneous (n) 113 (71.5%) 201 (73.9%)
Instrumental (n) 13 (8.2%) 28 (10.3%)
Elective cesarean section (n) 20 (12.7%) 14 (5.1%)
Secondary cesarean section (n)  12 (7.6%) 29 (10.7%)
Meconium stained amniotic fluid (n)**  36 (22.8%) 92 (33.8%) 0.016
Mean length of 2nd stage of labor (min) (mean, sd)*** 17.9 (18.8) 22.4 (22.5) 0.056
Episiotomy or 2nd/3rd/4th degree rupture (n)*** 70 (55.6%) 154 (67.2%) 0.029
Mean blood loss (ml) (mean, sd) 362.5 (262.6) 440.9 (371.0) 0.011
Blood transfusion (n) 1 (0.6%) 14 (5.1%) 0.014
Mean weight placenta (g) (mean, sd) 475.4 (93.8) 522.5 (97.7) <0.001
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Table 4 presents the perinatal results. In the Suspected SGA group the incidence 
of adverse neonatal outcome at birth was lower compared to the Non-Suspected 
SGA group (3.8% vs. 9.0%, p= 0.056). Nine children died, resulting in a total peri-
natal mortality of 2.1%. In the Suspected SGA group, 2 children died during la-
bor. In one case a dying fetal heart rate tracing was recorded in the outpatient 
department, and the fetus died before an emergency cesarean section could be 
performed. In the other case, the pregnant woman was seen early in labor with few 
fetal movements, but was sent back home as the fetal heart rate tracing was mis-
takenly judged reassuring. Several hours later she presented with an intrauterine 
fetal death. 
In the Non-Suspected SGA group, six women had an intrauterine fetal death; three 
were caused by placental insufficiency, and one by a partial placental abruption, 
whereas in two women only positive neonatal and placental cultures were diag-
Table 4
Perinatal results







Composite adverse neonatal outcome at birth 6 (3.8%) 21 (9.0%) 0.056
Perinatal mortality total (n) 2 (1.3%) 7 (2.6%) 0.496
During pregnancy (n) 0 6 (2.2%)
During labor (n) 2 (1.3%) 0
After delivery (n) 0 1 (0.4%)
Live birth (n) 156 (98.7%) 266 (97.8%) 0.716
Apgar 1’ <7(n) 11 (7.1%) 32 (12.0%) 0.103
Apgar 5’ <7 (n) 3 (1.9%) 9 (3.4%) 0.548
pH umbilical artery <7.05 mol/L (n) 1 (0.6%) 9 (3.9%) 0.054
pH umbilical vein <7.05 mol/L (n) 0 (0.0%) 4 (1.8%) 0.151
Resuscitation (n) 16 (10.3%) 34 (12.8%) 0.438
Consultation pediatrician (n) 152 (96.2%) 237 (87.1%) 0.002
Admission NMCU (n) 90 (57.7%) 98 (36.8%) <0.001
Congenital anomalies (n) 11 (7.0%) 15 (5.5%) 0.550
Admission NMCU >7 days (n)* 55 (35.3%) 37 (13.9%) <0.001
Neonatal complications total (n) 87 (55.8%) 112 (42.3%) 0.007
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nosed without clinical signs of an intrauterine infection. Furthermore, in the Non-
Suspected SGA group one neonate died 3 days after emergency cesarean section 
for fetal distress. In this case it was decided to stop treatment because of irrevers-
ible cerebral damage. 
In the Suspected SGA group significantly more neonates needed consultation of a 
pediatrician, were admitted to the NMCU, stayed there >7 days, and had common 
complications like hypothermia, hypoglycemia, hyperbilirubinemia, respiratory 
distress, and infections. 
Table 5 shows that the crude odds ratio adverse neonatal outcome at birth when 
comparing Suspected with Non-Suspected SGA at term, was 0.40 ([95% CI 0.16-
1.02]; p=0.056). After correction for birth weight and hypertensive disorders, it was 
found that identification and subsequent labor and delivery management led to 
a significant decrease of adverse neonatal outcome at birth (OR  0.28 [95% 0.10-
0.79]; p= 0.016).
Table 6 shows that the crude odds ratio for NMCU admission ≥7 days when com-
paring suspected with non-suspected SGA at term, was 3.37 ([95% CI 2.09-5.44]; p= 
<0.001). After correction for gestational age at birth, birth weight, maternal smok-
ing, drug abuse and hypertensive disorders, it was found that suspicion and sub-
sequent labor and delivery management did not lead to a significant decrease in 
NMCU admission ≥7 days (OR 1.02 [95% CI 0.53-1.97]; p= 0.950). Similar results were 
obtained when the variables with >5.0% missing data were added to the model. 
Table 5
Multivariable logistic regression on adverse neonatal outcome at birth
* All except the neonate that died after delivery
Odds Ratio 
(95% CI) p-value Corrected Odds Ratio (95% CI)
Corrected 
p-value
Suspected SGA 0.40 (0.16-1.02) 0.056 0.28 (0.10-0.79) 0.016
Birth weight 1.00 (0.99-1.00) 0.538 0.99 (0.99-1.00) 0.171
Maternal hypertensive disorders 2.45 (0.93-6.45) 0.069 2.56 (0.94-6.98) 0.067
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Lower birth weight and maternal hypertensive disorders were independently as-
sociated with NMCU admission ≥7 days. For babies with a birth weight <p2.3, only 
birth weight and not maternal hypertensive disorders was independently associ-
ated with NMCU admission ≥7 days (data not shown). 
Between January 1, 2006 and March 31, 2008, 4247 women were delivered of a 
term singleton neonate in the Parkstad region 5 From these neonates, 430 (10.1%) 
had a birth weight <10th percentile and were enrolled in the study. 158 (36.7%) of 
these SGA neonates were suspected prenatally and assigned to the Suspected SGA 
group. The remaining 272 (63.3%) neonates were assigned to the Non-Suspected 
SGA group. 
In home deliveries (n=40), not all variables used in this study were consequently 
documented. For the total cohort, this resulted in missing data in the variables ma-
ternal length (6.5%), maternal BMI (19.8%), placenta weight (8.1%), umbilical artery 
pH (9.1%) and umbilical vein pH (10.9%). Of all other variables less than 0.1% of the 
data was missing. 
Maternal baseline characteristics are shown in Table 1. Compared to the Non-Sus-
pected SGA group, mothers in the Suspected SGA group were significantly taller 
and had a significantly lower BMI. Significantly more women in this group were 
smokers, used drugs, had an SGA in a previous pregnancy, and had hypertensive 
disorders during pregnancy.
Table 6
Multivariable logistic regression on NMCU admission >7 days
Odds Ratio 
(95% CI) p-value Corrected Odds Ratio (95% CI)
Corrected 
p-value
Suspected SGA 3.37 (2.09-5.44) <0.001 1.02 (0.53-1.97) 0.950
Gestational age at birth 0.91 (0.88-0.94) <0.001 1.03 (0.99-1.08) 0.138
Birth weight 0.99 (0.99-1.00) <0.001 0.99 (0.99-1.00) <0.001
Maternal smoking 1.33 (0.84-2.12) 0.226 0.82 (0.43-1.55) 0.533
Maternal drug abuse 3.70 (1.80-7.59) <0.001 2.39 (0.89-6.37) 0.083
Maternal hypertensive disorders 3.71 (1.93-7.12) <0.001 3.22 (1.30-8.01) 0.012
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Table 2 shows the neonatal baseline characteristics. Mean gestational age and 
birth weight were significantly lower for neonates in the Suspected SGA group 
compared to the Non-Suspected SGA group. Significantly more neonates had a 
birth weight < p2.3 in the Suspected SGA group. 
As shown in Table 3, 94.9% of women in the Suspected SGA group had prenatal 
care by an obstetrician, in contrast to 53.7% of women in the Non-Suspected SGA 
group. In the Suspected SGA group, induction of labor and elective cesarean sec-
tion were more frequently performed, whereas instrumental delivery and second-
ary cesareans were more common in the Non-Suspected SGA group. The incidence 
of meconium stained amniotic fluid was significantly lower in the  Suspected SGA 
group compared to the Non-Suspected SGA group, as were the incidence of epi-
siotomy or a 2nd, 3rd or 4th degree rupture, the mean amount of blood loss, the 
incidence of blood transfusions, and the mean placental weight.
Table 4 presents the perinatal results. In the Suspected SGA group the incidence 
of adverse neonatal outcome at birth was lower compared to the Non-Suspected 
SGA group (3.8% vs. 9.0%, p= 0.056). Nine children died, resulting in a total peri-
natal mortality of 2.1%. In the Suspected SGA group, 2 children died during la-
bor. In one case a dying fetal heart rate tracing was recorded in the outpatient 
department, and the fetus died before an emergency cesarean section could be 
performed. In the other case, the pregnant woman was seen early in labor with few 
fetal movements, but was sent back home as the fetal heart rate tracing was mis-
takenly judged reassuring. Several hours later she presented with an intrauterine 
fetal death. In the Non-Suspected SGA group, six women had an intrauterine fetal 
death; three were caused by placental insufficiency, and one by a partial placental 
abruption, whereas in two women only positive neonatal and placental cultures 
were diagnosed without clinical signs of an intrauterine infection. Furthermore, in 
the Non-Suspected SGA group one neonate died 3 days after emergency cesarean 
section for fetal distress. In this case it was decided to stop treatment because of 
irreversible cerebral damage. 
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In the Suspected SGA group significantly more neonates needed consultation of a 
pediatrician, were admitted to the NMCU, stayed there >7 days, and had common 
complications like hypothermia, hypoglycemia, hyperbilirubinemia, respiratory 
distress, and infections. 
Table 5 shows that the crude odds ratio adverse neonatal outcome at birth when 
comparing Suspected with Non-Suspected SGA at term, was 0.40 ([95% CI 0.16-
1.02]; p=0.056). After correction for birth weight and hypertensive disorders, it was 
found that identification and subsequent labor and delivery management led to 
a significant decrease of adverse neonatal outcome at birth (OR  0.28 [95% 0.10-
0.79]; p= 0.016).
Table 6 shows that the crude odds ratio for NMCU admission ≥7 days when com-
paring suspected with non-suspected SGA at term, was 3.37 ([95% CI 2.09-5.44]; p= 
<0.001). After correction for gestational age at birth, birth weight, maternal smok-
ing, drug abuse and hypertensive disorders, it was found that suspicion and sub-
sequent labor and delivery management did not lead to a significant decrease in 
NMCU admission ≥7 days (OR 1.02 [95% CI 0.53-1.97]; p= 0.950). Similar results were 
obtained when the variables with >5.0% missing data were added to the model. 
Lower birth weight and maternal hypertensive disorders were independently as-
sociated with NMCU admission ≥7 days. For babies with a birth weight <p2.3, only 
birth weight and not maternal hypertensive disorders was independently associ-
ated with NMCU admission ≥7 days (data not shown). 
Discussion
The incidence of SGA in the Parkstad region (10.1%) was similar to the incidence 
of SGA in the Netherlands (10.0%) based on the Netherlands Perinatal Registration 
curves 5.
SGA was suspected in only 36.7% of cases, which is remarkably lower than the 
63.0% found in a Swedish study 15. A possible explanation for this low detection 
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rate is, that the Swedish study was a clinical setting, whereas our study included 
pregnancy attendance by primary care midwifes at home as well. Estimating fetal 
weight is commonly performed only by abdominal fundal height measurement 
without a standardized protocol 16. Ultrasound was only used when SGA was sus-
pected and not as a routine procedure. The sensitivity of detecting SGA by mea-
suring the fundal height is higher when the pregnant mother has a lower BMI, as 
was demonstrated in this study. The relatively lower birth weight in the Suspected 
SGA group, which can be derived from the higher incidence of a birth weight ≤2.3 
percentile in this group, confirms that suspicion of SGA is also easier when the fe-
tus is smaller. SGA was suspected more frequently in mothers who smoked, used 
drugs, had an SGA in a previous pregnancy, or had hypertensive disorders. This 
was presumably because obstetric care workers are more alert for SGA in these 
pregnancies 19. 
The high percentage of non-suspected cases of SGA in this and other studies 10-
15 is of great concern. It remains a diagnostic challenge to identify those fetuses 
at risk of true SGA. Optimization of diagnostic tools is urgently needed, as both 
abdominal fundal height measurement and routine ultrasonography are insuffi-
cient to estimate fetal weight below the 10th percentile correctly 20-21. In a German 
study, serial ultrasound measurements of fetal weight resulted in detection of only 
30% of the SGA fetus 11. Customized growth centile charts are rarely applied in the 
Netherlands, but might identify the fetus at risk 13-22. 
Suspicion of SGA led to more active management. Gestational age at birth was sig-
nificantly lower in the Suspected SGA group, which can be partly explained by the 
higher incidence of labor inductions and elective cesarean sections in this group. 
This is in accordance with other studies 11-23-24. 
Logistic regression analysis showed, that suspicion of SGA followed by a more ac-
tive management of labor and delivery resulted in better neonatal outcomes at 
birth. This is in contrast with other studies, which reported that these interventions 
are associated with higher rates of obstetrical complications and neonatal morbid-
ity 18-25-28. As suggested by a previous study  active management is likely to be 
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advantageous for a genuine intrauterine growth restricted (IUGR) subpopulation 
that do not reach, because of inadequate placental function, their genetic growth 
potential. However, such a management might be detrimental for the constitution-
ally SGA fetuses who follow their own growth trajectory during pregnancy 29. Due 
to lack of data in this specific cohort, a reliable differentiation in to one of these 
groups (SGA or IUGR) is not feasible.
Perinatal mortality in this study was 2.1%, which is comparable with other studies 
2-5-30. During the same period the incidence of perinatal mortality in term single-
ton pregnancies not complicated by SGA in the Parkstad region was significantly 
lower; 5 in 3817 babies (0.13%) (RR 15.67; [95% CI 5.28-46.6]; p= <0.001) 5. This 
indisputably marks the importance of SGA as a risk factor for perinatal mortality. 
Whenever SGA at term is suspected, the pregnant women should be closely and 
continuously monitored as of the early stage of labor. In the recently published 
multicentre DIGITAT study in the Netherlands, in which 650 women with suspected 
IUGR at term were randomized to induction or expectant monitoring, no stillbirths 
or perinatal deaths occurred 19. A possible explanation for this favorable outcome 
is that in the randomized controlled DIGITAT trial the pregnant women with sus-
pected SGA may have been monitored more intensively than in regular daily prac-
tice. Suspicion of SGA and subsequent active management or intensive monitoring 
might have prevented the death of the fetus in at least the three cases of placental 
insufficiency in the Non-Suspected SGA group. However, even in the Suspected 
SGA group management of labor and delivery was not active enough to prevent 
the two cases of intrauterine fetal death. This pleads for more intensive monitoring 
and active management in pregnancies complicated by SGA at term.
In the Suspected SGA group, significantly more neonates were seen by a pedia-
trician, as this is routine policy in our O&G Department when SGA is suspected. 
Moreover, in this group significantly more neonates were admitted to the NMCU. 
The rate of NMCU admission ≥7 days was significantly higher in the Suspected SGA 
group. This can be explained by the significantly higher prevalence in the suspect-
ed SGA group of neonatal complications associated with low birth weight, ranging 
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from predominantly hypoglycemia to infections and incidentally encephalopathy. 
Identification and subsequent management of pregnancy, labor and delivery had 
no significant effect on the incidence of NMCU admission ≥7 days, whereas birth 
weight and maternal hypertensive disorders were independently associated with 
NMCU admission ≥7 days.
The main strength of this retrospective study is that it provides a better insight in 
common daily practice in a well-defined region in the south of the Netherlands 
without the bias of a study setting which is intrinsically to randomized controlled 
trials. 
This study has some limitations. A limited amount of data was missing, as is com-
mon in retrospective studies. Midwives performing home deliveries are instructed 
to admit neonates with a birth weight <10th percentile to the pediatrician at the 
Atrium Medical Centre. It is possible, that a few healthy neonates with a good start 
were not referred to the obstetrician, leading to underreporting. In the Suspected 
SGA group, 39 women participated in the DIGITAT or HYPITAT trial 19-31. From these 
patients, 15 underwent induction of labor as a result of randomization. So the 
number of inductions in this group might be overrepresented.
In conclusion, most cases of SGA were not suspected during pregnancy in this ret-
rospective study. SGA was predominantly suspected in women who were carrying 
a very small fetus, had a lower BMI, who smoked, used drugs, had a previous SGA, 
or had hypertensive disorders. Suspicion of SGA led to a more active management 
of labor and delivery. This resulted in better neonatal outcomes at birth, but was 
not active enough to prevent two cases of fetal death in the Suspected SGA group. 
Identification of SGA and a more active management also had no significant influ-
ence on the incidence of NMCU admission ≥7 days, which was associated with the 
lower birth weight of the neonates and the higher prevalence of maternal hyper-
tensive disorders in this group.
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General discussion and future perspectives. 
Intrauterine growth restriction is a major cause of perinatal morbidity and mor-
tality1-5; not only immediately after birth but also on the long term it can affect a 
child`s health.6-8 
Until recently, evidence from a RCT considering timing of delivery in at term IUGR 
was lacking.9 This thesis evaluates two different management strategies in at term 
growth restriction. We compared timing of delivery by planned, elective induction 
of labour with expectant management including fetal surveillance and monitoring 
of the mother in singleton pregnancies with cephalic presentation complicated by 
suspected intrauterine growth restriction beyond 36 weeks gestational age. The 
RCT aimed to show that both strategies were equivalent regarding adverse perina-
tal outcomes. Under the provision that both strategies are equally safe we would 
be able to perform secondary analysis such as comparing intervention rates, costs, 
maternal quality of life and long-term (neuro)development of the children.
Principle findings
•	 In a retrospective Dutch cohort of small for gestational age (SGA) babies born with 
a birth weight below the 10th percentile between 2000 and 2005, we found that 
induction of labour after 36 weeks gestation was associated with a higher risk of 
emergency caesarean section (CS), without improvement in neonatal outcome. 
Pregnant women with isolated SGA were more than 2 times likely and women 
with both SGA and hypertensive disorders were almost 3 times more likely to 
have emergency CS after induction compared to women with a spontaneous 
onset of labour. We concluded that prospective studies are needed to deter-
mine the best strategy in suspected IUGR at term.
•	 The DIGITAT trial, central in this thesis, concluded that both induction of labour as 
well as an expectant management policy with monitoring of mother and child are 
DEF-zw-Proefschrift-KIM-13april-2012.indd   192 13-4-2012   13:13:23
193
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safe strategies in at term IUGR. We found no perinatal deaths in either of the two 
groups, nor any difference in umbilical artery pH below 7.05, 5-minute Apgar 
below 7 or NICU admissions. 
•	 Maternal morbidity was comparable between the two strategies. Induction of 
labour did not lead to higher rates of vaginal operative deliveries or an increase of 
emergency caesarean sections. 
•	 The trial is underpowered for finding differences in stillbirth, therefore it is reason-
able to induce labour to pre-empt this most devastating outcome in IUGR preg-
nancies. 
•	 We found that significantly more babies were admitted to intermediate type of 
neonatal care (high care and medium care) after a policy of induction. The induced 
group babies were delivered on average 10 days earlier and subsequently 
weighing 130 grams less compared to expectant management babies. 
•	 More children get severely growth restricted after a policy of expectant manage-
ment (<P 2.3).
•	 To define if the excess of neonatal admissions were protocol driven due to the 
fact that these children were smaller and younger or if these children were in 
fact sicker, neonatal morbidity was examined in detail by assessing the MAIN-
score. The MAIN-score was comparable for both induction group babies as well as 
for expectant management group babies. In at term IUGR neonatal morbidity 
is relatively mild. However, for both strategies more children had a positive 
MAIN-score when born before 38 weeks gestational age, as compared to chil-
dren born beyond 38 weeks gestation. For as long as neonatal and maternal 
condition is reassuring, it is reasonable to prevent neonatal admissions by delay-
ing delivery beyond 38 weeks gestational age in at term IUGR. 
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•	 We explored generalisability of the results by assessing external validity of the 
trial. We compared outcomes of women who refused to participate to out-
comes of participants of the DIGITAT trial. Although these non-participants 
were in general healthier (i.e. they had lower BMI, smoked less and were higher 
educated), they tended to have less favourable outcomes. Only among non-
participants 3 babies died. We showed that participating in a RCT on IUGR did 
not increase the risk of bad outcome. We even proposed that participation in a RCT 
may be good for pregnant women. 
•	 We examined maternal health-related quality of life after induction of labour 
or expectant monitoring in pregnancy alongside the trial at several points in 
time. No clinically relevant differences between the two strategies at 6 weeks 
or 6 months post partum on any summary measures were found. Women in 
both groups showed lower scores on the mental component (MCS) of short 
form (SF-36) at all time measurements, showing lower mental health com-
pared to an average Dutch population. In short, induction of labour in at term 
IUGR does not affect the long-term maternal quality of life.
•	 As both strategies were comparable in terms of physical and mental health 
outcomes, we performed a cost-minimisation analysis in which only the direct 
medical costs of both strategies were compared. Induction generated more 
direct medical costs, because of longer stay in the labour room and more neo-
natal high care and medium care admissions. Expectant management had an 
excess of ante partum costs due to maternal admissions for maternal and fetal 
monitoring. Altogether, we showed comparable costs for induction and expect-
ant management. 
•	 Patient’s preferences for expectant management and induction of labour in case 
of IUGR at term are equal. 
•	 We assessed (neuro)developmental outcome and behavioural problems of the 
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children at two years of age by postal questionnaires:1) the Ages and Stages 
Questionnaire (ASQ), and 2) the Child Behavior Checklist (CBCL). We found no 
significant differences in developmental or behavioural outcomes at 2-years of 
age. Severe growth restriction (P<2.3) and neonatal admission were found to be 
the most important predictive factors for (neuro)developmental problems at 2 
years of age in children born after suspected IUGR at term.
•	 In a retrospective study of neonates born between January 1, 2006 and March 
31, 2008, we found that most cases of SGA were not identified as such. SGA 
was predominantly detected in women who were carrying a very small fetus, 
had a lower BMI, who smoked, used drugs, had a previous IUGR, or had hyper-
tensive disorders. Suspicion of SGA led to a more active management of labour 
and delivery. This resulted in better neonatal outcomes at birth compared to IUGR 
not suspected during pregnancy. Not all cases of fetal death in the Suspected 
IUGR group can be prevented. 
Strengths, limitations and implication
The main strength of the DIGITAT study is the randomised comparison of two de-
livery and management strategies in suspected IUGR at term. We advise  induction 
of labour in at term IUGR beyond 38 weeks gestational age to pre-empt perinatal 
mortality, providing maternal and fetal monitoring. 
No other appropriate randomised control trials in this particular area have been 
performed. This prospective approach was feasible through collaboration of more 
than 50 hospitals embedded within the structure of the Dutch obstetric consor-
tium.10 Academic hospitals, general teaching as well as non-teaching hospitals par-
ticipated to the DIGITAT trial, throughout the country. This has resulted in a  study 
population , which reflects a general population of pregnant women suspected 
of at term IUGR, and makes the results generally applicable. Like the smaller ran-
domised pilot trial we found comparable neonatal and maternal outcomes.11 This 
equipoise of induction and expectant management is in contrast to findings of the 
General discussion and future perspectives. 
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HYPITAT trial where maternal outcomes as well as the operative delivery rates were 
in favour of induction of labour.12 For at term IUGR both strategies are safe.
The strength of this prospective study lies in the fact that it demonstrates safe man-
agement in suspected IUGR at term, rather than discussing treatment strategies 
with the knowledge of SGA in hindsight. In March 2008, before the results of the 
DIGITAT trial were known, Dutch gynaecologists and residents were asked for their 
opinion about at term IUGR through questionnaires. They assumed that induction 
of labour would increase the rate of caesarean sections and only a minority as-
sumed that it would lower the rate of CS (Chapter 1). This was in agreement with 
our findings from a retrospective study (Chapter 2), where we found higher rates 
of operative deliveries after induction of labour. In contrast, we did not observe 
higher operative delivery rates after induction of labour in the trial, which is in ac-
cordance with recent prospective intervention trials.12-14 There are several alterna-
tives to explain this contradiction between our retrospective and prospective find-
ings. In our observational study only children born SGA are included and therefore 
selection took place by looking back at children with the highest risk. Additionally, 
we do not know if SGA was identified or not in these children. In our prospective 
study children were suspected of IUGR. Some of these children were born with a 
birth weight above P10, may be also due to the fact that they were induced, avert-
ing further growth restriction. This also might be the reason for a lower risk for 
operative delivery. Since the operative deliveries were comparable between the 
two strategies it seems reasonable to induce labour to pre-empt stillbirth. For as 
long as neonatal and maternal condition is reassuring, delaying delivery beyond 38 
weeks gestational age may prevent neonatal admissions, because the MAIN-scores 
as well as neonatal admissions were higher at week 36 and 37 (Chapter 4).
Additional strength of the study is that we tested external validity and generalis-
ability of data by examining non-participants in the same prospective way.15-17 
While none of the children of participating women died, perinatal deaths did occur 
among non-participants. Since all deaths were after a relative long period of ex-
pectant monitoring, these findings might imply that waiting too long for spontane-
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ous delivery in IUGR imposes risk of perinatal morbidity and mortality, imaginably 
also due to the lack of protocol driven management. Our data are in accordance 
with many other studies suggesting that participation in a randomised trial or pro-
tocol driven management improves outcomes regardless of the actual treatment 
given.18-20 Probably both obstetricians and patients are more alert to their medical 
status when they participate in a study. 
Even when study results seem applicable to other populations it does not automat-
ically mean that the policies are also applicable in these populations.21 The results 
of the DIGITAT study should be extrapolated with caution to settings where close 
monitoring cannot be offered, e.g. in less-developed countries or in women who 
are unlikely to follow instructions or redraw from fetal monitoring. 
A limitation of the study is that women whose fetus was already presumed to be 
at high risk (e.g. because of fetal brain-sparing) were excluded from randomisation 
and were induced.22 Likewise other women, whose pregnancy was not presumed 
to be at risk (e.g. still growing along its own growth curve), were not included be-
cause of fear for unnecessary and possible harmful inductions. This inclusion bias 
might have affected external validity of the trial.16 By prospectively following non-
participants we addressed inclusion bias to a certain extent. However, to examine 
outcomes of eligible pregnant women who beforehand were excluded by their 
doctors is impossible. 
The fact that induction of labour in IUGR does not affect the long-term maternal 
quality of life is a very relevant finding. Also in women with gestational hyper-
tension or pre-eclampsia QoL was unaffected by induction.23 May be induction 
of labour relieves a feeling of insecurity for these women with complicated preg-
nancies. In both groups of randomised women with at term IUGR after 6 months 
of age mental health stayed below the mean Dutch and U.S. mental component 
score outcomes. Probably worries or anxiety about the child’s health persist in both 
groups even after 6 months of age. This is in contrast to women with hypertension 
complicating pregnancy who showed equal to population average MCS scores 6 
weeks and 6 months after childbirth.23 
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The DIGITAT trial is the first RCT that includes an economic analysis of labour man-
agement and outcomes in at term IUGR. Unfortunately we have no data on health 
care utilisation after hospital discharge for the randomised women. Therefore we 
do not know if medical costs, sick leave from work (indirect non-medical costs), 
mode of travelling to hospital and the use of informal care given by partner and/ or 
family (direct non-medical costs) were different between the two strategies. 
Since for both strategies the rate of neonatal admissions is lower beyond 38 weeks 
gestation, we speculate that delaying delivery up to 38 weeks would be more cost-
effective, as compared to induction before 38 weeks gestational age. 
The DIGITAT RCT is the only study that looked at long-term outcomes of children 
suspected of IUGR after labour induction or expectant management prospectively. 
We have shown that severe growth restriction (<P 2.3) and neonatal admissions 
are the most important predicting factors for (neuro)developmental problems at 
2-years of age in children born after suspected IUGR at term. 
Unfortunately, a complete history and physical examination at 2 years of age was 
not feasible with our budget. Therefore we sent out questionnaires to most of the 
women in the study. Response rates were 54% in the induction group and 46% in 
the expectant group. This might have lead to non-response bias: we cannot ex-
clude that children with worse outcomes were not in this analysis, possibly leading 
to different outcomes showing superiority of one of the two strategies. 
The DIGITAT trial was not powered to detect perinatal mortality as this would re-
quire thousands of women, which was not feasible. 
Lack of power is probably the main reason why we did not detect perinatal deaths 
in the trial. There are two other possible explanations for the discrepancy between 
prospective (no perinatal deaths in the randomised DIGITAT study) and retrospec-
tive findings (associations between IUGR and perinatal mortality). Firstly, the DIGI-
TAT women were identified as having IUGR. As we found in our study described in 
chapter 13 suspicion of IUGR is associated with active management of labour and 
delivery, resulting in a better neonatal outcome at birth compared to cases where 
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diagnosis was missed. The fact that we found that identification of IUGR favours 
neonatal outcomes is in contrast to other studies that showed higher intervention 
rates without improving neonatal outcomes after identification of IUGR.24;25 Sec-
ondly, women as well as doctors are probably more alert because they participate 
in a trial, presumably inflicting active management as soon as conditions deterio-
rate. Positive effects of this vigilance may well be shown in the non-participants 
study (Chapter 6), where 3 perinatal deaths did occur among non-participants, 
most likely due to the lack of protocol-driven management, even though they 
were suspected to be too small.
The challenge of screening and treating IUGR is to distinguish before childbirth 
fetuses with (genuine) growth restriction and those that are constitutionally small. 
We included women who were suspected of IUGR and defined IUGR by fetal ab-
dominal circumference (FAC) < P10, estimated fetal weight (EFW) < P10, flattening 
of the growth curve, or combinations of these inclusion criteria, as measured with 
ultrasound. We included them irrespective of Doppler recordings and irrespective 
of individualised customised growth. Recent observational studies show that in 
term growth restriction decreased Medial Cerebral artery Pulsatility Index (MCA-
PI), indicative of fetal brain-sparing, could be a proxy for adverse neonatal outcome 
at term, independently of UA-PI.22 This screening tool for determining the optimal 
timing of delivery in at term IUGR has not been investigated in randomised trials 
yet. 
Since MCA-PI was not routinely used by the start of the DIGITAT trial in 2004, we 
do not know which fetuses might have suffered from brain-sparing at term. Also 
customised growth curves are not routinely applied in the Netherlands as a screen-
ing tool. 
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Future Perspectives
Whereas important questions about at term IUGR have been answered, several 
questions exist, and are substrate for further analysis and set-up of future studies.
The crux in IUGR is to detect children with genuine growth restriction. Individu-
alising fetal growth might help to identify fetuses suffering from genuine growth 
restriction.26-28 Although not defined as a primary outcome in our study, we have 
collected the determinants of customised birth weight curves prospectively, i.e. 
maternal height and weight, smoking, racial background, EFW, sex and gestational 
age. We plan to calculate customised growth curves to examine if these curves will 
better predict which children have genuine growth restriction and who might ben-
efit from induction. 
Since MCA-Doppler recordings have been done prospectively in 57 patients we 
plan to analyse them and associate the outcomes with neonatal outcomes and 
operative deliveries. 
Catch up growth, crossing of neonatal birth weight percentiles, is one of the pos-
sible important characteristic of genuine IUGR which however can only be deter-
mined after birth. Catch-up growth is also associated with early origins of insulin 
resistance and obesity.29 We asked trial participants to fill out length and weight of 
the children at several moments in time during the two year follow-up and we will 
look at catch-up growth of these children and compare the two strategies.
In addition evaluation of Ponderal index and subcutaneous fat distributions as mea-
sured by subscapular and triceps skinfold thickness are within the scope of future 
secondary analyses of the DIGITAT trial. With the knowledge of true growth restric-
tion after birth, we might be able to determine before birth the risk factors and 
characteristics of these children. By this means it could provide new insights in the 
selection of children that might benefit of induction.
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Plans to study influences of IUGR on blood pressure, obesity and insulin resistance, as 
well as school performance and (neuro)development on the even longer term (e.g. 10 
years of age) have been made. 
A different approach to identify the fetus at highest risk for adverse outcome is 
to search for additional diagnostic markers to improve the detection of children 
with an EFW below the 3rd percentile. By developing a diagnostic risk score, among 
women suspected of having intrauterine growth restriction (IUGR) at 36 to 41 
weeks, that can differentiate between an estimated fetal weight < vs. > 3% for ges-
tational age, we would be able to detect a vulnerable group of children. Validation 
of the score could be performed in the non-participant group of women and in 
different retrospective cohorts. These studies are underway.
The DIGITAT study population was diverse and it is conceivable that not all women 
have the same a-priori risks of adverse outcome. Treatment selection markers are 
biomarkers that can prospectively identify individuals who are likely to benefit 
from a specific treatment, separating them from individuals for whom the more 
limited health gains do not outweigh the safety and side effects of treatment.30 
We will examine possible biomarkers from the DIGITAT data to evaluate their prog-
nostic value as treatment selection markers in at term IUGR. By this means we try 
to advance to determine the best strategy by tailoring the treatments for at term 
IUGR.
Conclusion
IIn conclusion, induction of labour and expectant management, while strictly 
monitoring mother and child both are safe strategies in at term growth restriction. 
Concerning obstetrical and neonatal outcomes - not only immediately after birth, 
but also on the long-term, health costs, maternal quality of life and maternal pref-
erences, both strategies are comparable. To pre-empt the devastating outcome of 
stillbirth it is reasonable to induce labour after 38 weeks of gestation. 
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Hypothetically we could prevent 1 neonatal admission due to complications of rel-
ative prematurity, by delaying induction in 10 pregnancies suspected of IUGR be-
yond 38 weeks. Further delaying delivery to later gestational ages will increase the 
proportion of severely growth restricted children (<P 2.3) which is not desirable. 
To determine genuine growth restriction and to detect the fetuses at highest risk 
for adverse outcome remains a great challenge. Customised growth, development 
of diagnostic risk scores and integration of UA-, and MCA-Doppler recordings are 
entries for future studies in at term IUGR. By development of treatment selection 
markers we can evaluate if tailor-made treatment for the individual women whose 
pregnancy is complicated by growth restriction at term is possible; to induce la-
bour or to await spontaneous delivery with expectant management. 
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Chapter 13 Summary
This thesis describes the results of the DIGITAT trial (Disproportionate Intrauterine 
Growth Intervention Trial At Term) and concentrates on strategies in intrauterine 
growth restriction (IUGR) at term. 
Chapter 1
Chapter 1 forms the introduction of this thesis and gives a set-up to the DIGITAT trial. 
Around 9% to 11% of children is born with a birth weight below the 10th percentile 
and defined as small-for-gestational age (SGA). A significant part of these children 
are born in the term period. Pregnancies complicated by intrauterine growth restric-
tion (IUGR) and children born small-for-gestational-age are known to have higher 
risk of perinatal mortality and neonatal morbidity, not only immediately after birth 
but also on the longer term. The terms intrauterine growth restriction (IUGR) and 
small-for-gestational-age (SGA) have been used interchangeably, creating confu-
sion on the topic. In this way studies looking at associations between smallness 
and adverse neonatal outcomes have been blurred. In the introduction of this the-
sis definitions of SGA and IUGR are discussed. The methods to improve screening 
and identification of IUGR are discussed, as well as an insight in the latest opinions 
about the importance of Doppler-recordings of middle cerebral artery (MCA). To 
deal with at term pregnancies complicated by suspicion of IUGR there are two man-
agement strategies to approach the fetus at risk for morbidity and mortality. Would 
the fetus fare better by further growing and maturing in a possible undernourished 
environment, and thus postponing delivery with an expectant management? On 
the other hand induction of labour might pre-empt possible morbidity and still-
birth, may be at the cost of an increase in operative deliveries, and complications of 
relative (iatrogenic) prematurity. Results from prospective randomised trials as well 
as consensus among Dutch gynaecologists and residents about management and 
timing of delivery in at term IUGR were lacking. To deal with these questions about 
the controversial management of IUGR at term the DIGITAT trial (Disproportion-
ate Intrauterine Growth Intervention Trial At Term) was designed. Embedded in the 
structure of the Dutch Obstetrical Consortium more than 50 hospitals, academic 
and non-academic, participated to this randomised controlled trial to enrol 650 
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women whose pregnancy was complicated by suspected IUGR at term. The aim 
of the study was to compare the effect of induction of labour with an expectant 
monitoring policy for suspected intrauterine growth restriction at term in single-
ton pregnancies in cephalic presentation beyond 36 weeks gestation on neonatal 
and obstetrical outcomes.
Chapter 2 
This chapter presents the results of a retrospective cohort of SGA children in the 
Netherlands. Data of the National Dutch Perinatal Registry (PRN) were used of all 
nulliparae between 2000 and 2005 with a singleton in cephalic presentation be-
yond 36+0 weeks, with a birth weight below the 10th percentile. We analysed two 
groups of pregnancies: (I) with isolated SGA and (II) with both SGA and hyperten-
sive disorders. Onset of labour was related to route of delivery and neonatal out-
come. Induction was associated with a higher risk of emergency caesarean section 
(CS), without improvement in neonatal outcome. For women with isolated SGA the 
relative risk of emergency CS after induction was 2.3 (95% Confidence Interval [CI] 
2.1 to 2.5) and for women with both SGA and hypertensive disorders the relative 
risk was 2.7 (95% CI 2.3 to 3.1). In concord with other retrospective studies it was 
concluded from this retrospective cohort that induction in pregnancies compli-
cated by SGA at term was associated with a higher risk of instrumental deliveries 
without improvement of neonatal outcome. 
Chapter 3
The full study protocol of the DIGITAT trial is described in this chapter. All women 
with a singleton pregnancy, with a child in cephalic presentation, with suspicion 
of IUGR (Fetal Abdominal Circumference < 10th centile, Estimated Fetal Weight < 
10th percentile as defined by local protocols, or decreased relative growth though 
still > 10th centile) and a gestational age between 36+0 weeks and 41+0 weeks 
were eligible. Women with a history of caesarean section, serious congenital de-
fects, ruptured membranes, renal diseases, diabetes mellitus, or positive HIV se-
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rology were excluded. After written consent, pregnant women suspected of IUGR 
were randomised by means of a web-based application. Stratification was applied 
for previous vaginal birth (nullipara versus multipara) and for centre. Patients that 
withheld consent for randomisation were asked permission for data collection on 
pregnancy outcome and date were collected in the same prospective way. Before 
randomisation baseline demographics, past obstetric and medical history were 
collected for all women and cervical length was measured.
The study was staffed by obstetricians, research nurses, and midwives associated 
with the Dutch Obstetric Consortium. They counselled and recruited participants, 
monitored compliance with allocated treatment protocols, and collected outcome 
data. 
Participants were either allocated to an induction of labour group, where induction 
had to take place within 48 hours of randomisation or to an expectant monitor-
ing group. In the expectant group women had to be monitored until the onset 
of spontaneous labour with daily fetal movement counts and twice weekly fetal 
heart rate tracings, ultrasound examination, maternal blood pressure measure-
ment, assessment of proteinuria, laboratory tests of liver and kidney function, and 
full blood count. Women were monitored as either an outpatient or an inpatient, 
according to local protocol. In the expectant monitoring group, induction of labour 
or planned caesarean section was performed for obstetrical indications—such as 
suboptimal fetal heart rate tracings, prolonged rupture of membranes, or postma-
turity between T+7 and T+14 days—at the obstetrician’s discretion. Women that 
were registered as non-participants were treated according to the opinion of their 
attending doctor with either an induction of labour or an expectant management 
policy.
The primary outcome was a composite measure of adverse neonatal outcome. This 
was defined as death before hospital discharge, five minute Apgar score of less 
than 7, umbilical artery pH of less than 7·05, or admission to neonatal intensive 
care. Secondary outcomes were delivery by caesarean section, instrumental vagi-
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nal delivery, length of stay in the neonatal intensive care or neonatal ward, mater-
nal length of stay in the hospital, and maternal morbidity. The latter was defined 
as post-partum haemorrhage of more than 1000 mL, development of gestational 
hypertension or pre-eclampsia (according to International Society for the Study of 
Hypertension in Pregnancy criteria), eclampsia, pulmonary oedema, thromboem-
bolism, or any other serious adverse event.
Other secondary outcomes were a maternal health-related quality of life study and 
follow up of children’s behavioural-, and (neuro)development by administering 
postal enquiries: the Child Behaviour Checklist-CBCL and Ages and Stages Ques-
tionnaire- ASQ after 2 years. Under assumption of comparable adverse outcomes 
a cost-minimisation analysis, in which only the costs of both strategies would be 
compared, was performed. 
The trial was designed as an equivalence trial in which the null hypothesis was that 
the difference in the risk of the composite outcome between the two treatment 
groups was greater than 5.5% (absolute percentage). Assuming that the rate in the 
control group was 6% (on the basis of data from the National Dutch Perinatal Reg-
istry), this meant that we would exclude the null hypothesis and conclude that the 
two treatments were equivalent if the boundaries of the confidence interval of the 
observed risk difference were between -5.5% and 5.5%. With a 0.05 risk of type I er-
ror (α) and 80% (1-β) power, we calculated that we would require 650 participants 
(325 per group). 
Data were analysed according to the intention to treat principle. Equivalence of 
the primary outcome measure was tested by checking if the 95% CI of the risk dif-
ference lay within the equivalence margins. Treatment effects were presented as 
differences in means or percentages with 95% confidence intervals (CI). 
Chapter 4
The results of the DIGITAT trial are described in chapter 3. In this multicentre ran-
Summary
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domised equivalence trial (the Disproportionate Intrauterine Growth Intervention 
Trial At Term (DIGITAT)) eight academic and 44 non-academic hospitals in the Neth-
erlands participated to included eligible women between November 2004 and 
November 2008. A total of 1116 women with a singleton pregnancy in cephalic 
presentation, with a pregnancy suspected of IUGR beyond 36 weeks gestation 
were identified. Of these women, 466 declined randomisation, of whom 452 gave 
authorisation for use of their medical data. 
321 women were randomly assigned to induction and 329 to expectant monitor-
ing. Compared with the induction group, women in the expectant monitoring 
group were more likely to have a Bishop score of less than or equal to 6 and ges-
tational hypertension, but otherwise the two randomised arms were comparable. 
Women who declined randomisation were older, had a higher education level, 
were less likely to smoke, had a lower body mass index (BMI), and were less likely 
to have a fetal abdominal circumference below the 10th centile. Most women who 
were randomised met either the fetal abdominal circumference below 10th centile 
inclusion criterion or the estimated fetal weight below the 10th centile criterion. 
Only 13 women in the induction group and 10 women in the expectant monitoring 
group were included because of flattening of the growth curve in isolation.
Induction was performed in 306 (95.6%) of the women in the induction group, re-
sulting in a median time from randomisation to onset of labour of 0.9 days (IQR 
0.7 to 1.7) in the induction group and 10.4 days (IQR 5.6 to 16.0) in the expectant 
monitoring group. In the expectant monitoring group labour was induced in 166 
(50.6%) women.
Caesarean sections were performed on 45 (14.0%) mothers in the induction group 
and 45 (13.7%) in the expectant monitoring group (difference 0.3%, 95% CI -5.0% 
to 5.6%).
One (0.3%) woman allocated to induction of labour died at home 10 days after de-
livery. She had delivered a healthy child vaginally at 38+4 weeks of gestation after 
spontaneous onset of labour. No cause for her death was found at postmortem and 
it was classified as a serious unrelated adverse event. No women in the expectant 
monitoring group died during the study. All other maternal outcomes were com-
parable between the two groups.
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There were no stillbirths or perinatal deaths. A total of 17 (5.3%) neonates in the 
induction arm and 20 (6.1%) neonates in the expectant monitoring arm had the 
primary composite adverse neonatal outcome (difference 0.8%, 95% CI - 4.3% to 
2.8%). No differences between groups in any of the components of the composite 
adverse neonatal outcome were found. Median birth weight was lower in the in-
duction group than in the expectant monitoring group (2420 g v 2550 g; difference 
130 g, 95% CI 188 g to 71 g; P<0.001). Despite this difference, more fetuses in the 
expectant monitoring arm had a birth weight below the third percentile (100 (31%) 
v 40 (13%); difference 18.1%, 95% CI 24.3% to 12.0%; P<0.001).
More neonates in the induction group were admitted to a ward providing an inter-
mediate level of neonatal care (155 (48.4%) v 118 (36.3%); difference 12.1%, 95% CI 
4.6% to 19.7%; P<0.05).
In conclusion, we found equivalent fetal and maternal outcomes for induction 
and expectant monitoring in women with suspected intrauterine growth restric-
tion at term, indicating that both approaches are acceptable. However, it is rational 
to choose induction to prevent possible neonatal morbidity and stillbirth on the 
grounds that we showed no increase in operative and instrumental delivery rates. 
By inducing labour in cases of intrauterine growth restriction, infants that will not 
grow any further can be released from their undernourished environment. 
Chapter 5
In this chapter we describe details of a sub-analysis, by reporting neonatal morbid-
ity between the two strategies based on a validated morbidity assessment index 
for newborns (MAIN). This score was developed to provide a numeric index of early 
neonatal outcomes of prenatal care and adverse prenatal exposures in babies de-
livered beyond 28 weeks of gestation. This sub-analysis was done mainly because 
we had found a significant difference in neonatal admissions to an intermediate 
type of care (48% v. 36%; difference 12%, 95% CI: 5% to 20%, P<0.05) in the DIGITAT 
trial. Complications of late prematurity might have explained this difference, since 
children in the induction group were born on average ten days earlier than in the 
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expectant group (266 days v 277 days; difference -9.9 days, 95% CI: -11 to -9). How-
ever, the difference may simply reflect policies for admission to intermediate levels 
of care related to prematurity rather than clinically relevant morbidity. In addition, 
more children were severely growth restricted in the expectant group, defined as a 
birth weight below the third percentile (13% v 31%; difference -18%, 95% CI -24% 
to -12%) and therefore had a possible higher risk of neonatal morbidity. 
The MAIN score was assessed in 308 induction group babies and in 315 expect-
ant management group babies. The categories of the MAIN scores (no/minimal, 
mild, moderate and severe morbidity) did not differ between the induction and 
expectant group. Morbidity in at term IUGR was relatively mild, and comparable 
for both induction and expectant management. When we looked at components 
of the MAIN score, more children suffered from hyperbilirubinemia >220 mmol/L 
or the need for phototherapy after induction of labour (n=32 (10.4%) for induction 
v n=18 (5.7%) for expectant management; difference 4.7%, 95% CI 0.4% to 8.9%, 
p<0.05). 
For the outcomes neonatal admissions, a positive MAIN score and composite ad-
verse outcome, we compared induction to an expectant management in women 
randomised before 38 weeks, from 38 till 40 weeks and after 40 weeks. The only 
difference was a higher percentage of neonatal admissions after induction before 
38 weeks gestational age; 125 (61%) admissions v 92 (44%) after expectant man-
agement; difference 16%, 95% CI 6.7% to 26%, p=0.001). 
We concluded that the apparent excess of neonatal care admission in the induc-
tion arm of the DIGITAT trial was probably a benign side effect of late prematurity 
and neonatal admission policies, rather than a marker of serious neonatal morbid-
ity.  If a policy of induction for near term growth restriction is to be followed, defer-
ring induction until 38 weeks if feasible, while strictly monitoring mother and child, 
may prevent complications of late prematurity. Late effects of these policies need 
further study. 
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Chapter 6
Chapter 6 describes the results of the non-randomised women. All pregnant wom-
en who had a singleton pregnancy beyond 36+0 weeks’ gestation with suspected 
intrauterine growth restriction who declined randomisation in the DIGITAT trial, 
but who gave authorisation for the use of their medical data were registered as 
non-participants. Identical data were collected prospectively. 
The same primary outcome, a composite measure of adverse neonatal outcome 
(neonatal death before hospital discharge, a 5-minute Apgar score < 7, an umbilical 
artery pH <7·05 or admission to the neonatal intensive care unit) was used as well as 
operative delivery. Comparisons were between participants and non-participants, 
regardless of the group they were randomised to or treatment received. 
In addition to 650 randomised women, 452 women consented for use of their med-
ical data. Non-participants were older, had a lower body mass index (BMI), smoked 
less frequently and had a higher level of education.
A total of 37 (6%) infants of participants experienced the composite adverse neo-
natal outcome, compared with 32 (8%) in the non-participants (adjusted differ-
ence -2.0%, 95% CI -5.2% to 1.1%). In the non-participants group 3 (0.7%) deaths 
(2 stillbirths, 1 neonatal death) occurred, whereas no perinatal deaths occurred in 
the randomised group of women (difference -0.7%, 95% CI -1.4% to 0.1%, p=0.06). 
Caesarean sections were performed on 90 (14%) participants and on 71 (16%) 
non-participants (adjusted difference -2.8%, 95% CI -7.5% to 1.8%). In almost all 
comparisons, we found a tendency towards a more favourable neonatal outcome 
in women who were randomised. After adjustment for baseline imbalances in ma-
ternal age, smoking, BMI, education level and hypertensive disorders the adjusted 
difference and (95% CI) for perinatal death after participation in the trial was -0.5% 
(-1.4% to 0.4%, p=0.27).
We found a tendency towards more favourable outcomes in women randomised 
to the DIGITAT trial than in women who refused to participate, even after adjust-
ing for baseline characteristics. We concluded that participation in a randomised 
clinical trial on growth restriction did not increase the risk of bad outcome. This 
information can be used when counselling women for trials.
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Chapter 7
In this chapter Maternal health-related quality of life after induction of labour or 
expectant monitoring in pregnancy complicated by intrauterine growth retarda-
tion at term is described. 
Both randomised and non-randomised women were asked to participate in the 
health-related quality of life (HR-QoL) study. Women were asked to fill out written 
validated questionnaires, covering background characteristics, condition-specific 
issues and the Short Form (SF-36), European Quality of Life (EuroQoL 6D3L), Hos-
pital Anxiety and Depression scale (HADS), and Symptom Check List (SCL-90) at 
baseline (before and after randomisation), 6 weeks postpartum and 6 months post-
partum. We compared the difference scores of all summary measures between the 
two management strategies by ANOVA. A repeated measures multivariate mixed 
model was defined to assess the effect of the management strategies on the physi-
cal (PCS) and mental (MCS) components of the SF-36. The analysis was by inten-
tion to treat. 361 randomised and 198 non-randomised patients were analysed. 
There were no clinically relevant differences between the treatments (induction 
or expectant management) at 6 weeks or 6 months postpartum on any summary 
measures; e.g., on the SF-36 (PhysicalComponentScore (PCS): P = 0.09; MentalCom-
ponentScore (MCS): P = 0.48). The PCS and the MCS were below norm values at 
inclusion. The PCS improved over time but stayed below norm values at 6 months, 
while the MCS did not improve. Main conclusion was that in pregnancies compli-
cated by IUGR beyond 36 weeks, induction of labour does not affect the long-term 
maternal quality of life compared to expectant management
Chapter 8
After showing comparable medical outcomes and QoL, the economic impact of 
the two strategies is analysed. We used a health care perspective, in which only 
medical costs are included, with a time horizon from randomisation until hospital 
discharge. Thereby, by documenting details on utilisation of health care resources, 
we provided insight in the clinical origins of costs associated with management of 
these high-risk pregnancies. As both strategies were comparable in terms of health 
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outcomes, we performed a cost-minimisation analysis in which only the costs of 
both strategies were compared. We differentiated three phases of the clinical pro-
cess in which costs arise:  ante partum costs (from the moment of randomisation 
until childbirth), costs related to the delivery, and postpartum costs (from the mo-
ment of childbirth until hospital discharge). Resource use during the admission 
period was documented in the Case Report Form (CRF). The following resource 
items were collected: maternal and neonatal admissions, method of delivery, out-
patient visits, medication, maternal laboratory tests, cardiotocograms (CTGs) and 
fetal ultrasounds. Maternal admissions were differentiated into three levels of care 
(intensive, medium, or ward). Neonatal admissions were divided into four levels of 
care (intensive, high, medium, or ward). Ante partum expectant monitoring gener-
ated more costs, mainly due to longer  ante partum maternal stays in hospital. For 
the durante partu and postpartum stage, induction generated more direct medical 
costs, due to longer stay in the labour room and longer duration of neonatal high 
care/medium care admissions. From a health care perspective, both strategies gen-
erated comparable costs: on average € 7,106 per patient for the induction group 
(N=321) and € 6,995 for the expectant management group (N=329) with a cost dif-
ference of € 111 (95%CI: - € 1,296 to € 1,641). We can conclude that in women with 
pregnancies complicated by IUGR at term, induction of labour generates identical 
health care costs as compared to expectant management.
Chapter 9
In a secondary analysis we studied long term outcomes looking at the effects on 
(neuro)developmental and behavioural outcome at 2 years of age of induced la-
bour compared with expectant management in intrauterine growth restricted 
infants. Parents of 2-year old children included in the DIGITAT-trial were asked to 
answer the Ages and Stages Questionnaire (ASQ) and Child Behaviour Check List 
(CBCL). The Ages and Stages Questionnaire is a screening questionnaire designed 
to detect developmental delay in children. The Child Behavior Checklist consists of 
100 items concerning behavioural problems, on the basis of which a Total Problem 
score can be computed.  It also informs on 7 narrow band syndrome scales (emo-
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tionally reactive, anxious/depressed, somatic complaints, withdrawn, sleep prob-
lems, attention problems and aggressive behaviour), and two broad-band scales 
(internalizing and externalizing behaviour).  We approached 582 (89.5%) of 650 
parents. The response rate was 50%. Of these children, 27% had an abnormal score 
on the ASQ and 13 % on the CBCL. Results of the ASQ and the CBCL for the two 
policies were comparable. Low birth weight, positive morbidity assessment index 
(MAIN score) and admission to intermediate care, increased the risk of an abnormal 
outcome of the ASQ. This effect was not seen for the CBCL. With this secondary 
analysis we showed that in women with IUGR at term, both a policy of induction of 
labour and expectant management do not affect developmental and behavioural 
outcome when compared to expectant management. 
Chapter 10
Whereas medical outcomes, maternal health-related QoL, costs and also long-term 
(neuro)development at 2 years of age of children born after IUGR are comparable 
between induction and expectant management women’s preferences for one of 
the two strategies become even more interesting. To gain insight into how women 
value different obstetrical outcome scenarios, we compared induction of labour 
and expectant monitoring in intrauterine growth restriction at term through in-
tegration of trial outcomes and patient preferences. We used case scenarios (‘vi-
gnettes’), involving five important factors (‘attributes’) that were evaluated by 24 
trial participants using a discrete choice experiment (DCE) and by visual analogue 
scale (VAS). We combined these outcome valuations with outcome distributions 
of the RCT, and calculated a mean outcome for the strategies induction of labour 
and expectant management, respectively. These mean values were compared be-
tween the treatment groups using t-test for the total group and for subgroups, 
which were defined according to parity and gestational age. Using the DCE there 
was no overall treatment preference for the total group or for any of the subgroups. 
The VAS, however, did indicate preference towards expectant management for the 
total group as well as for subgroups. Based on the theoretical superiority of the 
DCE over the VAS method, the DCE results were leading. Therefore patient’s prefer-
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ences for expectant monitoring and induction of labour in case of IUGR at term 
were equal. These results reflected the outcomes of the DIGITAT trial.
Chapter 11
Chapter 11 presents the results from a retrospective cohort study among all term 
singleton neonates with a birth weight <10th percentile born in the Parkstad region 
(Heerlen) between 01-01-2006 and 03-31-2008. The aim of the study was to com-
pare perinatal outcomes of suspected versus non-suspected small-for-gestational 
age fetuses (SGA) at term. The subjects were assigned to a prenatally Suspected 
or Non-Suspected SGA group. SGA was considered suspected when this was de-
scribed unambiguously in the mothers’ pregnancy chart. The clinical surveillance 
protocol used in case of prenatally suspected SGA comprised of fetal ultrasounds 
with fetal-placental Doppler velocimetry weekly, and cardiotocography twice 
weekly or more frequently depending on the severity of the growth restriction. 
Primary outcome was adverse neonatal outcome at birth, defined as a composite 
of intrauterine fetal death, Apgar <7 at 5 minutes, or pH umbilical artery <7.05. Sec-
ondary outcome included neonatal medium care unit (NMCU) admission ≥7 days. 
A total of 430 subjects were included in the study; 36.7% was suspected of SGA. 
In the Suspected SGA group mean gestational age at birth and birth weight were 
significantly lower, whereas maternal morbidity was significantly higher. The inci-
dence of labour induction and elective caesarean section were also significantly 
higher in the Suspected SGA group. Total perinatal mortality was 2.1%. The crude 
odds ratio of adverse neonatal outcome at birth when comparing Suspected with 
Non-Suspected SGA at term, was 0.40 (95% CI 0.16-1.02, p=0.056). After correction 
for birth weight and hypertensive disorders, it was found that identification and 
subsequent labour and delivery management led to a significant decrease of ad-
verse neonatal outcome at birth (OR  0.28, 95%CI 0.10-0.79, p= 0.016).
Identification of SGA and subsequent management led to a significant decrease 
of adverse neonatal outcome at birth, but did not lead to a significant decrease in 
NMCU admissions longer than 7 days. In conclusion suspicion of SGA was associ-
ated with a more active management of labour and delivery, resulting in a better 
neonatal outcome at birth.
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Chapter 12 
General discussion - principle findings:
•	 In a retrospective Dutch cohort of children born small for gestational age (SGA) 
induction of labour after 36 weeks gestation was associated with a higher risk 
of emergency caesarean section (CS), without improvement in neonatal out-
come. 
•	 The DIGITAT trial, basis of the thesis, concluded based on equivalence of the 
primary outcome of the trial, a composite adverse outcome of neonatal mor-
bidity, that both induction of labour as well as an expectant management 
policy are safe strategies in at term IUGR. 
•	 Induction of labour did not lead to higher rates of vaginal operative deliveries 
or an increase of emergency caesarean sections in the DIGITAT study. 
•	 Even though both policies are safe, it is not unreasonable to induce labour to 
pre-empt the most devastating outcome in IUGR, stillbirth. 
•	 Significantly more babies were admitted to intermediate type of neonatal care 
(high care and medium care) after a policy of induction of labour. 
•	 More children get severely growth restricted after a policy of expectant man-
agement (<P 2.3).
•	 The MAIN-score was comparable for both induction group babies as well as 
for expectant management group babies. More children had a positive MAIN-
score when born before 38 weeks gestational age, as compared to children 
born beyond 38 weeks gestation. Therefore, for as long as neonatal and ma-
ternal condition is reassuring, it is feasible to defer delivery beyond 38 weeks 
gestational age in at term IUGR. 
•	 We showed that participating in a RCT on IUGR did not increase the risk of 
bad outcome, and this information can be used when counselling women for 
participation in a RCT. 
•	 Induction of labour in at term IUGR does not affect the long-term maternal 
quality of life.
•	 From a health-care perspective, induction and expectant management gener-
ate comparable costs. 
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•	 Patient’s preferences for expectant monitoring and induction of labour in case 
of IUGR at term are equal, and reflects the equivalence of the primary out-
comes on top of medical outcomes, costs and QoL. 
•	 We found no significant differences in developmental or behavioural out-
comes at 2-years of age in children born at term with a clinical suspicion of 
growth restriction under a policy of induction of labour v expectant manage-
ment. Severe growth restriction (P<2.3) and neonatal admission were found to 
be the most important predictive factors for (neuro)developmental problems 
at 2 years of age in children born after suspected IUGR at term.
•	 Suspicion of IUGR compared to cases where IUGR is not identified as such led 
to a more active management of labour and delivery, resulting in better neo-
natal outcomes at birth. 
In conclusion, induction of labour and expectant management, while strictly moni-
toring mother and child both are safe strategies in at term growth restriction. Con-
cerning obstetrical and neonatal outcomes - not only immediately after birth, but 
also on the long-term, health costs, maternal quality of life and maternal prefer-
ences, both strategies are comparable. To pre-empt the devastating outcome of 
stillbirth it is reasonable to induce labour after 38 weeks of gestation. 
Hypothetically we could prevent 1 neonatal admission due to complications of 
relative prematurity, by delaying induction in 10 pregnancies suspected of IUGR 
beyond 38 weeks. Further delaying delivery to later gestational ages will increase 
the proportion of severely growth restricted children (<P2.3) which is not desirable. 
To determine genuine growth restriction and to detect the fetuses at highest risk 
for adverse outcome remains a great challenge. Customised growth, development 
of diagnostic risk scores and integration of UA-, and MCA-Doppler recordings are 
entries for future studies in at term IUGR. By development of treatment selection 
markers we can evaluate if tailor-made treatment for the individual women whose 
pregnancy is complicated by growth restriction at term is possible; to induce la-
bour or to await spontaneous delivery with expectant management.
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In dit proefschrift  worden verschillende behandel strategieën van a terme groe-
ivertraging beschreven. De DIGITAT trial (Disproportionate Intrauterine Growth 
Intervention Trial At Term), een multicentrum gerandomiseerde studie is de basis 
voor dit proefschrift. In deze gerandomiseerde studie werd inleiding van de baring 
vergeleken met een expectatief beleid bij vrouwen wiens zwangerschap gecompli-
ceerd werd door een a terme intra-uteriene groeivertraging.
Hoofdstuk 1
Hoofdstuk 1 is de introductie van het proefschrift. Het beschrijft de verschillende 
facetten van a terme groeivertraging en vormt de onderbouwing van de DIGITAT 
studie. Ongeveer 9% tot 11 % van de neonaten heeft een te laag geboorte gewicht 
voor de zwangerschapsduur (<P10). Een aanzienlijk deel van deze pasgeborenen 
wordt  geboren op de a terme leeftijd. Zwangerschappen die gecompliceerd wor-
den door groeivertraging hebben een hoger risico op perinatale sterfte en neo-
natale morbiditeit. Deze kinderen hebben niet alleen direct na de geboorte een 
hogere kans op morbiditeit, maar ook op latere leeftijd lopen deze kinderen een ho-
ger risico op neurologische ontwikkelingsachterstand en chronische ziekten, zoals 
diabetes mellitus. Onderzoek naar groeivertraging wordt bemoeilijkt door het feit 
dat verschillende definities van groeivertraging frequent door elkaar heen worden 
gebruikt. In de introductie worden de verschillende definities van groeivertraging 
en te klein voor de leeftijd, zogenaamd small-for-gestational age (SGA), bespro-
ken. Vanwege de mogelijk ernstige gevolgen van IUGR is identificatie van groeiver-
traagde kinderen dus van groot belang. Verschillende screenings methoden om 
het onderscheid te maken tussen constitutioneel te klein en pathologisch te klein 
worden besproken. Tevens worden de laatste opvattingen over het belang van ce-
rebrale bloedstroom distributie bij a terme groeivertraging weergegeven. Wanneer 
eenmaal de verdenking op IUGR is gerezen zijn er in feite twee strategieën om de 
intra-uterien groeivertraagde zwangerschappen te benaderen. Moet een expecta-
tief beleid gevolgd worden met maternale en foetale bewaking, zodat de kinderen 
nog kunnen groeien en rijpen, totdat de baring zich spontaan inzet? Of moet de 
baring ingeleid worden om morbiditeit en eventuele sterfte te voorkomen, mo-
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Nederlandse samenvatting
gelijk ten koste van een hoger aantal kunstverlossingen en sectio caesarea, en 
gevolgen van (iatrogeen geïnduceerde) relatieve prematuriteit van de kinderen? In 
Nederland bestonden geen richtlijnen die antwoord gaven op vraagstukken ron-
dom groeivertraging op de a terme leeftijd. In 2008 werd een enquête verstuurd 
naar gynaecologen en arts-assistenten nog voordat de resultaten van de DIGITAT 
trial bekend werden. De resultaten hiervan geven de verdeeldheid over het onder-
werp weer. Om duidelijkheid te krijgen over wat nu de beste benadering is van a 
terme groeivertraging, inleiden of afwachten, werd de DIGITAT studie opgezet. Met 
behulp van de infrastructuur van het Nederlands verloskundige consortium werd 
deze gerandomiseerde studie uitgevoerd in 8 universitaire en 44 niet-universitaire 
ziekenhuizen. Zo konden 650 vrouwen met een door groeivertraging gecomplic-
eerde a terme zwangerschap gerandomiseerd worden voor inleiden van de baring, 
danwel voor een afwachtend beleid. De uitvoering van de studie werd mogelijk 
gemaakt door subsidie van ZonMw, Nederlands doelmatigheidsonderzoek (num-
mer 945-04-558).
Hoofdstuk  2
Hier worden de resultaten van een retrospectieve studie van een cohort Neder-
landse kinderen met een geboortegewicht onder de 10de percentiel beschreven. 
We gebruikten data van de stichting Perinatale Registratie Nederland (PRN). Alle 
nulliparae die bevielen tussen 2000 en 2005 van een eenling in hoofdligging na 
36+0 weken, met een geboortegewicht onder de 10de percentiel werden geïn-
cludeerd. Twee groepen vrouwen werden bekeken: (I) vrouwen van wie alleen het 
kind te klein was, en  (II) vrouwen die zowel een te klein kind, als ook een zwanger-
schapshypertensie of pre-eclampsie hadden. Van deze vrouwen werd de invloed 
van de start van de baring op de wijze van bevallen en de neonatale uitkomsten 
bekeken. In groep I (alleen klein kind) bleek inleiding geassocieerd met een meer 
dan 2 keer hogere kans op een sectio caesarea, zonder verbetering van de neona-
tale uitkomsten, OR 2.3 (95% betrouwbaarheidsinterval  (BI) 2.1 tot 2.5). In groep II 
(klein kind en hypertensieve aandoening) was het risico op een sectio bijna 3 keer 
zo groot, OR 2.7 (95% BI2.3 to 3.1).  Conform andere retrospectieve studies vonden 
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wij dat inleiding van de baring bij een laag geboortegewicht op de a terme leeftijd 
was geassocieerd met een hoger risico op een sectio caesarea en vaginale kunst-
verlossing  zonder dat dit resulteert in een betere neonatale uitkomst.
Hoofdstuk 3 
In hoofdstuk 3 wordt het volledige studie protocol van de DIGITAT studie bes-
chreven. Vrouwen met een eenlingzwangerschap, met een kind in hoofdligging, 
bij wie er verdenking was op groeivertraging (gedefinieerd als een echografisch 
gemeten buikomtrek < P10, een geschat foetaal gewicht onder de P10, of een 
relatieve groeivertraging door afbuiging van de groeicurve) konden tussen de 
36+0 en 41+0 weken geïncludeerd worden. Vrouwen met een sectio caesarea in de 
anamnese, langdurig gebroken vliezen, nier ziekten, diabetes mellitus, of met posi-
tieve HIV serologie en zwangerschappen met een congenitaal afwijkende foetus 
kwamen niet in aanmerking. Nadat de vrouwen een toestemmingsverklaring had-
den getekend werden zij via een web-based computer programma gerandomi-
seerd. Er werd gestratificeerd voor een eerdere vaginale bevalling (nullipara versus 
multipara) en voor het deelnemende centrum. Vrouwen die deelname weigerden 
werden om toestemming gevraagd voor het vervolgen van hun medische uit-
komsten en hun gegevens werden op dezelfde prospectieve manier verzameld. 
Baseline karakteristieken zoals medische en obstetrische voorgeschiedenis werden 
voor randomisatie verzameld en de cervixlengte werd gemeten.
De studie werd gecoördineerd door gynaecologen en research medewerkers, 
die aangesloten waren bij het Nederlands verloskundig consortium. Vrouwen die 
gerandomiseerd werden voor inleiding moesten binnen 48 uur ingeleid worden. 
Vrouwen die voor de afwacht groep lootten werden vervolgd door middel van ten 
minste tweewekelijkse CTG controles, anamnese van foetale beweging, tenminste 
wekelijks echo-onderzoek,  bloedonderzoek, en urinecontrole op eiwit. Deze con-
troles werden poliklinisch of tijdens een ziekenhuisopname verricht, afhankelijk 
van de ernst van de groeivertraging. In de afwachtgroep werd gewacht totdat de 
baring spontaan op gang kwam, of totdat een primaire sectio nodig vanwege 
obstetrische indicatie of totdat een inleiding van de baring geïndiceerd was, zoals 
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bijvoorbeeld bij langdurig gebroken vliezen, een suboptimaal CTG, of bijvoorbeeld 
vanwege serotiniteit. Vrouwen die geregistreerd werden als weigeraar werden vol-
gens locaal protocol door hun behandelend arts gevolgd.
De primaire uitkomst was een slechte neonatale uitkomst, samengesteld uit ster-
fte voor ontslag uit het ziekenhuis, een Apgar score lager dan 7 na 5 minuten, een 
arteriële navelstreng pH van 7·05 of minder of opname op de neonatale intensive 
care unit (NICU). Secundaire uitkomsten waren het percentage vaginale kunstver-
lossingen en sectio caesarea, opnameduur op de NICU, maternale opnameduur 
en maternale morbiditeit, gedefinieerd als maternale sterfte, fluxus post-partum 
(meer dan 1000 cc bloedverlies), ontwikkeling van zwangerschapshypertensie, 
pre-eclampsie of eclampsie, longoedeem, diepe veneuze trombose of andere 
ernstige complicaties. 
Als belangrijke overige secundaire uitkomsten werden de maternale kwaliteit van 
leven en de (gedrags)neurologische ontwikkeling van kinderen op 2 jarige leeftijd 
onderzocht.  Dit laatste gebeurde met de Child Behaviour Checklist (CBCL) en Ages 
and Stages Questionnaire (ASQ). Er vanuit gaande dat de medische uitkomsten 
gelijk zouden zijn, werd tevens een kosten-effectiviteits studie uitgevoerd.
De studie werd opgezet als een equivalentie studie met als nul hypothese dat het 
verschil in risico op de primaire uitkomst  tussen de twee groepen groter zou zijn 
dan 5.5% (absolute percentage). Dat betekende dat we de nul hypothese zouden 
verwerpen en de twee strategieën gelijk waren als de grenzen van het betrouw-
baarheidsinterval van het gevonden risicoverschil zouden vallen tussen -5.5% and 
5.5%. Met een type I error (α) van 0.05 en power van 80% (1-β) power, zouden er 
650 vrouwen (2x325) geïncludeerd moeten worden. De resultaten werden geana-
lyseerd volgens het “intention to treat” principe. 
Hoofdstuk 4
Hierin worden de primaire en enkele secundaire uitkomsten van de DIGITAT be-
sproken. Tussen november 2004 en november 2008 werden in totaal 1116 vrou-
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wen met een eenling zwangerschap in hoofdligging, met en verdenking op groe-
ivertraging vanaf 36 weken gevraagd om deelname. Van hen wilden 466 vrouwen 
niet gerandomiseerd worden, en van deze 466 vrouwen gaven er 452 toestem-
ming voor het vervolgen van hun medische uitkomsten.
321 vrouwen werden gerandomiseerd voor inleiding van de baring en 329 voor 
een afwachtend beleid. Vrouwen die in de afwachtgroep zaten hadden vaker een 
Bishop score van 6 of minder en hadden vaker zwangerschapshypertensie, maar 
verder waren ze vergelijkbaar bij randomisatie. Vrouwen die als weigeraar werden 
geregistreerd waren ouder, hoger opgeleid, hadden een lager BMI, rookten mind-
er, en hadden minder vaak een buikomtrek onder de P10 als inclusiecriterium. Van 
de gerandomiseerde vrouwen hadden de meesten een foetus met een buikomtrek 
onder de P10, een geschat foetaal gewicht onder de P10, een afbuigende groei, of 
een combinatie van deze criteria. Slechts 13 vrouwen in de inleidgroep en 10 vrou-
wen in de afwachtgroep hadden als enige inclusiecriterium een afbuigende groei.
306 (95.6%) vrouwen uit de inleidgroep werden daadwerkelijk ingeleid, result-
erend in een gemiddeld interval tussen randomisatie en start van de baring van 
0.9 dagen (interquartile range(IQR) 0.7 tot 1.7). In de afwachtgroep bedroeg dit 
interval gemiddeld 10.4 dagen (IQR 5.6 tot 16.0). In de afwachtgroep werden 166 
(50.6%) vrouwen uiteindelijk ingeleid. 45 (14.0%) moeders in de inleidgroep en  45 
(13.7%) in de afwachtgroep (verschil 0.3%, 95% BI -5.0% tot 5.6%) kregen een sec-
tio caesarea. Een vrouw (0.3%) uit de inleidgroep stierf 10 dagen na de bevalling. 
Zij beviel vaginaal na een spontane start van een gezond kind bij 38+4 dagen. Ob-
ductie leverde geen duidelijke verklaring voor deze sterfte en werd uitgeboekt als 
serieuze complicatie, niet gerelateerd aan de studie. In de afwachtgroep was geen 
maternale sterfte. Alle andere maternale uitkomsten waren vergelijkbaar.
 
In geen van beide groepen was er sprake van perinatale sterfte.17 (5.3%) neo-
naten in de inleidgroep en 20 (6.1%) in de afwachtgroep hadden een slechte uit-
komst (verschil 0.8%, 95% BI - 4.3% tot 2.8%). Op geen van de onderdelen van de 
samengestelde primaire uitkomst (5 min Apgar, navelstreng pH of NICU opname) 
vonden we verschillen tussen de twee groepen.  Kinderen in de inleidgroep waren 
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gemiddeld 130 gram lichter en 10 dagen jonger (2420 gram versus 2550 gram; ver-
schil 130 g, 95% BI 188 g tot 71 g; P<0.001). Desondanks was het percentage ernstig 
groeivertraagde kinderen (<P 2.3) groter na een afwachtend beleid (100 (31%) v 40 
(13%); verschil 18.1%, 95% BI 24.3% tot 12.0%; P<0.001). Significant meer kinderen 
uit de inleidgroep werden op de kinderafdeling opgenomen (155 (48.4%) 
v 118 (36.3%); verschil 12.1%, 95% BI 4.6% tot 19.7%; P<0.05).
We concludeerden dat inleiden van de baring en een afwachtend beleid bij vrou-
wen met een verdenking op a terme IUGR vergelijkbare foetale en maternale uit-
komsten geeft.  Dit betekent dat beide strategieën veilig zijn. Echter, aangezien er 
geen verhoogd risico op een kunstverlossing of sectio caesarea is na inleiding, is het 
aannemelijk om een beleid van inleiden te kiezen om een eventuele vruchtdood te 
voorkomen. Door de baring in te leiden kan de foetus die niet meer groeit uit zijn 
ondervoede omgeving bevrijd worden. 
Hoofdstuk 5
In dit hoofdstuk wordt de neonatale morbiditeit in detail vergeleken tussen de 
beide strategieën. Aanleiding tot deze studie was het significante verschil dat we 
vonden in het aantal opnames op de kinderafdeling tussen de beide groepen, ten 
nadele van inleiden. We vroegen ons af of dit alleen te wijten was aan het feit dat 
de kinderen gemiddeld 10 dagen jonger en 130 gram lichter waren en misschien 
vanwege ziekenhuis protocol werden opgenomen. Waren deze kinderen nu echt 
zieker, of waren de kinderen die opgenomen werden na een expectatief beleid 
misschien wel zieker, mede omdat ze ernstiger groeivertraagd raakten? Om dit 
objectief te vergelijken werd van alle opgenomen kinderen de gevalideerde mor-
bidity assessment index for newborns (MAIN) score bepaald. Deze score geeft een 
cijfermatige indexering van vroege perinatale uitkomsten van obstetrisch beleid 
van kinderen die geboren zijn na 28 weken. The MAIN score kon van 308 ingeleide 
vrouwen en van 315 expectatieve groep vrouwen berekend worden. Er werd geen 
verschil in de MAIN score categorieën  (geen/minimale, milde, middelmatige en 
ernstige morbiditeit) gevonden tussen de groepen. Morbiditeit bij a terme groei-
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vertraging is relatief mild en vergelijkbaar voor zowel inleiding als een afwachtend 
beleid. Het item hyperbilirubinemia >220 mmol/L of de noodzaak tot fototherapie 
werd significant vaker gescoord na inleiding van de baring (n=32 (10.4%) voor in-
leiding versus n=18 (5.7%) voor een afwachtend beleid; verschil 4.7%, 95% CI 0.4% 
tot 8.9%, p<0.05). Vervolgens werden de twee groepen op de uitkomsten neona-
tale opnames, een positieve MAIN score en een samengestelde slechte uitkomst 
vergeleken in vrouwen gerandomiseerd voor 38 weken, vanaf 38 tot 40 weken en 
na 40 weken. We vonden dat in dat geval alleen het percentage opnames op de 
kinderafdeling significant hoger was na een inleiding voor 38 weken; 125 (61%) 
opnames na een inleiding versus 92 (44%) na een afwachtend beleid; verschil 16%, 
95% CI 6.7% tot 26%, p=0.001). 
We concludeerden dat het overschot aan opnames op de kinderafdeling na een 
inleiding in de DIGITAT studie een bijverschijnsel is van relatieve late prematuriteit 
en geen kenmerk van ernstige neonatale morbiditeit. Wanneer men kiest voor een 
inleiding van de baring bij IUGR rond de a terme leeftijd, dan heeft het de voorkeur 
om dit uit te stellen tot na 38 weken zwangerschap. Op die manier kunnen de com-
plicaties ten gevolge van relatieve prematuriteit beperkt worden, mits moeder en 
kind strikt bewaakt worden. 
Hoofdstuk 6
In hoofdstuk 6 worden de resultaten van niet-gerandomiseerde vrouwen be-
schreven. Alle vrouwen die voor de DIGITAT studie in aanmerking kwamen, maar 
die niet gerandomiseerd wilden worden, werden gevraagd om toestemming voor 
het prospectief volgen van hun medische gegevens.  Precies dezelfde data werden 
verzameld en in de data-base ingevoerd. Dezelfde primaire uitkomsten als van de 
gerandomiseerde vrouwen werden geanalyseerd. 452 vrouwen gaven toestem-
ming om als weigeraar vervolgd te worden. Deze weigeraars waren ouder, hadden 
een lagere body mass index (BMI), rookten minder en waren hoger opgeleid. Bij 37 
(6%) van de kinderen van gerandomiseerde deelnemers versus 32 (8%) kinderen 
van weigeraars (gecorrigeerde verschil -2.0%, 95% BI -5.2% tot 1.1%) was er sprake 
van een slechte uitkomst. 3 (0.7%) kinderen van weigeraars stierven (2 intra-ute-
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riene vruchtdoden en 1 neonatale sterfte), terwijl er in de gerandomiseerde groep 
geen een kind stierf ( aangepaste verschil -0.7%, 95% BI -1.4% tot 0.1%, p=0.06). 
90 (14%) gerandomiseerde vrouwen versus 71 (16%) weigeraars (aangepast ver-
schil  -2.8%, 95% BI -7.5% tot 1.8%) ondergingen een sectio caesarea. In bijna alle 
vergelijkingen was er een trend naar betere uitkomsten onder de gerandomis-
eerde deelneemsters aan de DIGITAT studie. Na correctie voor verschillende basis 
karakteristieken zoals maternale leeftijd, roken, BMI, opleiding en hypertensieve 
aandoeningen was het aangepaste risicoverschil en het 95% betrouwbaarheidsin-
terval voor perinatale sterfte -0.5% (95% BI -1.4% tot 0.4%, p=0.27). Concluderend 
vonden we dat, zelfs na correctie voor basis karakteristieken, vrouwen die deel-
name weigerden neigden naar slechtere uitkomsten. Meedoen aan een studie 
naar a terme groeivertraging had de deelneemsters geen nadeel opgeleverd. Deze 
bevinding kan helpen bij het rekruteren van vrouwen voor gerandomiseerde studies.
Hoofdstuk 7
Hoofdstuk 7 geeft de resultaten weer van de maternale gezondheidsgerelateerde 
kwaliteit van leven (HR-QoL) na inleiding van de baring danwel na een expecta-
tief beleid van vrouwen met een groeivertraagde foetus. Zowel gerandomiseerde 
vrouwen, als weigeraars werden gevraagd aan de HR-QoL studie mee te doen. De 
vrouwen werden gevraagd om gevalideerde HR-QoL vragenlijsten in te vullen; de 
Short Form (SF-36), European Quality of Life (EuroQoL 6D3L), Hospital Anxiety and 
Depression scale (HADS), en Symptom Check List (SCL-90). De vragenlijsten werden 
bij inclusie, 6 weken post partum en 6 maanden post partum ingevuld. 361 geran-
domiseerde en 198 weigeraars werden geanalyseerd. Er werden geen klinische rel-
evante verschillen gevonden tussen inleiden of afwachten in de groepen 6 weken 
na de bevalling, noch na 6 maanden. Dit gold voor alle verschillende vragenlijsten. 
De (PhysicalComponentScore (PCS) en de MentalComponentScore (MCS) van de 
SF-36 waren bij inclusie lager ten opzichte van de algemene nedelandse populatie. 
De PCS verbeterde na verloop van tijd, maar de MCS bleef verlaagd na 6 maanden. 
De belangrijkste conclusie was dat inleiden van de baring geen effect heeft op de 
lange termijn HR-QoL.  
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Hoofdstuk 8
Nadat we equivalentie op neonatale en maternale uitkomsten, operatieve ingrepen 
en kwaliteit van leven hadden aangetoond werden de kosten van de twee strate-
gieën vergeleken. Vanuit een gezondheidsperspectief werden de medische kosten 
berekend die gemaakt werden vanaf het moment van inclusie tot aan het ontslag 
uit het ziekenhuis na de bevalling. Er werd een onderscheid gemaakt tussen 3 fas-
es: ante partum kosten (vanaf randomisatie tot de bevalling), kosten gerelateerd 
aan de bevalling, en post partum kosten (vanaf geboorte tot ontslag uit het zieken-
huis). Gegevens over de volgende medische kosten werden verzameld: maternale 
en neonatale opnames, manier van bevallen, polikliniekbezoeken, medicatie, ma-
ternaal bloedonderzoek, cardiotocografieën (CTGs) en foetale echografieën. Een 
afwachtend beleid genereerde ante partum meer kosten, voornamelijk door een 
langere ziekenhuisopname voor de bevalling voor foetale en maternale bewaking. 
In de fase van de bevalling en in de post partum fase genereerde de inleidgroep 
meer medische kosten door langere opname op de verloskamers en vanwege 
meer neonatale opnames post partum. In totaal genereerde de beide strategieën 
vergelijkbare kosten: in de inleidgroep  gemiddeld € 7,106 per patiënt en € 6,995 
per patiënt in de afwachtgroep, met een gemiddeld verschil van € 111 (95% BI:
 - € 1,296 tot € 1,641). We concludeerden dat een strategie van inleiden van de bar-
ing en een afwachtend beleid bij verdenking op a terme groeivertraging vergelijk-
bare kosten genereert.
Hoofdstuk 9
Op 2 jarige leeftijd werd de lange termijn gedragsneurologische ontwikkeling van 
de kinderen geanalyseerd. Deze resultaten worden in hoofdstuk 9 gepresenteerd. 
Op 2 jarige leeftijd werden de Ages and Stages Questionnaire (ASQ) en de Child 
Behaviour Check List (CBCL) aan ouders die deelnamen aan de DIGITAT studie ver-
stuurd. De Ages and Stages Questionnaire is een vragenlijst die screent op neu-
rologische ontwikkelingsstoornissen. De CBCL vragenlijst bestaat uit 100 items die 
betrekking hebben op gedragsproblemen van kinderen. Uit deze 100 items kan 
een totale score berekend worden. 582 (89.5%) van de  650 ouders werden bena-
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derd voor het invullen van de lijsten, met een respons van 50%. Van deze kinderen 
had  27% een abnormale score volgens de ASQ and 13 % volgens de CBCL. Resul-
taten van de ASQ en de CBCL waren voor inleiding van de baring en een expec-
tatief beleid vergelijkbaar. Een zeer laag geboortegewicht (<P2.3), een positieve 
morbidity assessment index (MAIN score) en een opname op de kinderafdeling 
verhoogden de kans op een abnormale score op de ASQ, maar niet op de CBCL. 
Met deze secundaire lange termijn analyse toonden we aan dat er geen verschil 
was in (gedrags)neurologische ontwikkeling op 2 jarige leeftijd tussen de beide 
strategieën. 
Hoofdstuk 10
We toonden aan dat de medische uitkomsten, de maternale QoL, de kosten en 
de gedragsneurologische ontwikkeling van de kinderen op 2 jarige leeftijd gelijk 
waren. Dat maakt de voorkeur die vrouwen hebben voor een van beide strate-
gieën nog interessanter. Om inzicht te krijgen in hoe vrouwen met een intra-ute-
riene groeivertraging a terme verschillende obstetrische uitkomsten beoordelen, 
vergeleken we inleiding van de baring met een expectatief beleid door de DIGITAT 
studie resultaten en de preferenties van deze vrouwen te integreren. We gebruik-
ten verschillende scenario`s (zogenaamde ‘vignettes’), die vijf factoren omvatten 
(zogenaamde ‘attributen’) die door 24 deelnemende vrouwen beoordeeld werden. 
Er werden twee waarderingsmethoden gebruikt; de discrete choice experiment 
(DCE) en een visual analogue scale (VAS). Deze uitkomsten werden gecombineerd 
met de uitkomsten van de trial en zo werd er een gemiddelde uitkomst voor beide 
strategieën berekend. Bij het gebruik van de DCE zagen we geen voorkeur voor 
een van beide strategieën. Bij het gebruik van de VAS zagen we wel een voorkeur 
voor een expectatief beleid. Echter aangezien de DCE in het algemeen wordt be-
schouwd als een superieure methode werden de resultaten van de DCE aange-
houden. De conclusie was dat er geen voorkeur is voor een inleiding, danwel voor 
een afwachtend beleid bij a terme groeivertraging, hetgeen een weerspiegeling is 
van de primaire en secundaire uitkomsten van de DIGITAT studie. 
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Hoofdstuk 11
We beschrijven hier de resultaten van een cohort kinderen met een geboorte-
gewicht onder de 10de percentiel (=geïdentificeerd), bij wie er voor de geboorte 
een vermoeden was op groeivertraging a terme vergeleken met kinderen die pas 
na de geboorte als te klein geïdentificeerd werden (=niet geïdentificeerd). Alle a 
terme eenlingen geboren tussen 01-01-2006 and 03-31-2008 met een geboorte 
gewicht <P10 geboren in de Parkstad regio (Heerlen) werden bekeken. 
Wanneer er duidelijk in de status van de zwangeren werd geschreven dat er een 
vermoeden was op groeivertraging werden de kinderen als geïdentificeerd te klein 
(groeivertraagd) beschouwd, bij de overige kinderen werd de groeivertraging als 
niet-geïdentificeerd beschouwd.  Foetale bewaking in de geïdentificeerde groep 
bestond uit foetale echografie met wekelijks meten van de foeto-placentaire 
Dopplersnelheid, tweewekelijkse CTG`s of frequentere CTG`s afhankelijk van de 
ernst van de groeivertraging. De primaire uitkomst was een slechte neonatale uit-
komst gedefinieerd als een samengestelde maat voor intra-uteriene vruchtdood, 
een Apgar <7 na 5 minuten, of een arteriële navelstreng pH onder de 7.05. Neona-
tale medium care unit (NMCU) opname langer dan 7 dagen was een secundaire 
uitkomst. 430 vrouwen werden in de studie geïncludeerd; in totaal werd 36.7% als 
te klein geïdentificeerd. In deze geïdentificeerde groep was zowel de amenorrhoe-
aduur als het gemiddelde geboorte gewicht lager, terwijl de maternale morbiditeit 
hoger was. Het aantal inleidingen van de baring en electieve sectio caesarea was 
significant hoger ten opzichte van de niet- geïdentificeerde groep. De totale peri-
natale sterfte was 2.1%. Het ongecorrigeerde odds ratio (OR) voor slechte uitkomst 
voor geïdentificeerde versus niet-geïdentificeerde kleine kinderen a terme bed-
roeg 0.40 (95% BI 0.16-1.02, p=0.056). Na correctie voor geboorte gewicht en hy-
pertensieve aandoeningen bleek ante partum identificatie van te kleine kinderen 
het risico op een slechte uitkomst significant te verlagen (OR  0.28, 95%BI 0.10-0.79, 
p= 0.016). Concluderen leidt identificatie van te kleine kinderen tot een actiever 
beleid met als gevolg betere neonatale uitkomsten. 
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Hoofdstuk 12 
bevat de discussie van dit proefschrift. Hierin worden de belangrijkste bevindingen 
van de DIGITAT trial en andere (secundaire) studies benoemd:
•	 In een retrospectief Nederlands cohort van te kleine kinderen (geboorte ge-
wicht onder de P10) is inleiding van de baring na 36 weken geassocieerd met 
een hogere kans op vaginale kunstverlossingen en sectio caesarea, zonder 
verbetering van de neonatale uitkomsten.
•	 De DIGITAT studie, bron van dit proefschrift, liet vergelijkbare neonatale en 
maternale uitkomsten zien wanneer inleiding van de baring vergeleken werd 
met een expectatief beleid. Beide strategieën zijn veilig in geval van verdenk-
ing op IUGR a terme. 
•	 In deze prospectieve studie leidde inleiding van de baring niet tot een hoger 
sectio percentage, noch tot een hoger aantal vaginale kunstverlossingen. 
•	 Ook al zijn beide strategieën veilig, toch is het redelijk de baring in te leiden 
om een eventuele vruchtdood in geval van a terme groeivertraging te voorko-
men. 
•	 Meer kinderen worden opgenomen op de kinderafdeling na een strategie van 
inleiden van de baring. 
•	 Na een afwachtend beleid wordt het percentage kinderen met een ernstige 
groeivertraging (<P2.3) groter.
•	 De MAIN score was vergelijkbaar voor kinderen geboren na inleiding en ge-
boren na een afwachtend beleid.  Kinderen geboren voor 38 weken hadden 
vaker een positieve MAIN score vergeleken met kinderen geboren na 38 wek-
en. Zolang de maternale en foetale conditie het toelaten is het wenselijk om 
een inleiding van de baring bij a terme groeivertraging uit te stellen tot na 
38 weken. Hiermee kunnen de gevolgen van relatieve prematuriteit door een 
relatief vroege inleiding beperkt worden.
•	 We lieten zien dat het mee doen aan een gerandomiseerde studie naar a terme 
groeivertraging geen nadelige gevolgen heeft voor de maternale en neona-
tale uitkomsten. 
•	 Inleiden van de baring bij a terme groeivertraging heeft geen effect op de ma-
ternale gezondheidsgerelateerde kwaliteit van leven. 
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•	 Vanuit een gezondheidsoogpunt genereren inleiden van de baring en een ex-
pectatief beleid bij a terme IUGR vergelijkbare kosten.
•	 Vrouwen met een a terme groeivertraging hebben een gelijke voorkeur voor 
inleiding of afwachten.
•	 Op 2 jarige leeftijd is er geen verschil in (gedrags)neurologische ontwikkel-
ing tussen inleiden of afwachten. Ernstige groeivertraging (<P2.3) en opname 
op de kinderafdeling zijn de belangrijkste voorspellers voor problemen in de 
neurologische ontwikkeling (gemeten met de Ages and Stages Questionnair) 
op 2 jarige leeftijd. 
•	 Ante partum verdenking op groeivertraging leidt tot een actiever beleid re-
sulterend in betere neonatale uitkomsten bij a terme groeivertraging ten op-
zichte van kinderen die pas na de geboorte te klein blijken te zijn. 
Conclusie
Zowel inleiden van de baring als een expectatief beleid, met foetale en maternale 
bewaking, zijn veilige strategieën in a terme groeivertraging. 
Directe neonatale en maternale uitkomsten, het percentage kunstverlossingen 
en sectio caesarea, de maternale kwaliteit van leven, de kosten, als ook de (ge-
drags)neurologische ontwikkeling van de kinderen op 2 jarige leeftijd zijn gelijk. 
Het is echter redelijk om de baring in te leiden na 38 weken zwangerschapsduur 
om een eventuele vruchtdood te voorkomen, mits de maternale en foetale condi-
tie dit toestaan. In theorie zou door bij 10 vrouwen de inleiding tot na 38 weken 
uit te stellen 1 neonatale opname door gevolgen van relatieve late prematuriteit 
vermeden kunnen worden. Verder uitstel van de baring maakt de kans op ernsti-
gere groeivertraging (<P2.3) alleen maar groter. Het blijft een uitdaging om echte 
groeivertraging a terme op te sporen om zo de kinderen die het hoogste risico 
op morbiditeit en mortaliteit hebben te identificeren. Het individualiseren van de 
groeicurves (eigen groeipotentie bepalen) en ontwikkelen van diagnostische ri-
sicoscores, integratie van Doppler metingen in de navelstreng en arteria cerebri 
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media vormen een opzet naar toekomstige studies. Door het ontwikkelen van 
behandel-selectie-markers, zogenaamde treatment selection markers, zouden we 
kunnen evalueren of het mogelijk is de juiste zorg voor de individuele patiënt in 
geval van a terme groeivertraging te leveren: inleiden van de baring of een expec-
tatief beleid met bewaking van moeder en kind.
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Dit  proefschrift is de uitkomst van een geplande en gewenste zwangerschap. 
Zoals voor de meeste bevallingen geldt, moet je deze goed voorbereiden, hard 
werken en volhouden. Bij de conceptie van de DIGITAT studie, het voldragen ervan 
en de totstandkoming van dit proefschrift zijn veel mensen betrokken geweest. 
De studie was de eerste studie die binnen het Verloskundig Consortium Nederland 
subsidie kreeg van ZonMw, en heeft daarmee als kartrekker van het Consortium 
een hele belangrijke rol vervuld. Ik wil veel mensen bedanken voor hun rol en bijdrage 
aan de studie, aan dit proefschrift en nog wat meer.
In het bijzonder gaat mijn dank uit naar mijn promotores en co-promotores,  pro-
fessor Jan van Lith, professor Ben Willem Mol, doctor Sicco Scherjon, doctor Saskia 
le Cessie.
Beste Jan, in de korte tijd dat ik jou heb leren kennen hebben we prettig samengewerkt 
en mooie resultaten behaald. Als fellow-achtige  onder jouw leiding heb ik het enorm 
op prijs gesteld dat je me zo bij alle staf aangeleden betrokken hebt. Dat ik me op 
die manier als jonge klare gynaecoloog in de verloskunde heb kunnen verdiepen is 
heel erg waardevol. 
Beste Ben Willem, aanvoerder en drijfveer van het Consortium. Ik ben er trots op 
dat ik, toen het Consortium nog in de kinderschoenen stond, al betrokken was en 
heb bij kunnen dragen aan wat nu zo professioneel is geworden. Er moest zo veel 
gebouwd, geregeld en bedacht worden om het zo geolied als het nu loopt te krij-
gen. Het was nooit gelukt zonder jouw overheersende doorzettingsvermogen en 
vastberadenheid. Veel dank voor de stenen die je hebt bijgedragen. 
Beste Sicco, wat een mazzel dat Claudia mij bij jou introduceerde. Het was voor 
mij een unieke kans om me in te zetten voor het vak en te laten zien dat ik ent-
housiast was en misschien wel wat kon. Het heeft een fantastisch geslaagd project 
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opgeleverd, waardoor veel zwangere vrouwen nog steeds naar alle tevredenheid 
thuis zorg kunnen ontvangen. Zo kwam ook DIGITAT op pijn pad en ik kwam in 
opleiding. Met jouw vrolijke en positieve karakter hebben we er steeds de schoud-
ers onder gezet, wat resulteerde in een hele mooie publicatie. Jouw “PRIMA!`s” blijken 
dus echt waar. Ik hoop dat we nog veel plezier beleven in het samenwerken.
Beste Saskia, jij wist als geen ander mijn gedachten over bepaalde problemen om 
te zetten in wetenschappelijke vragen en oplossingen. Dankzij jouw enthousiasme 
ben ik de statistiek als een goede vriend gaan zien, waar je eigenlijk heel veel lol 
mee kan beleven. Het samenwerken om ruim 1800 variabelen weer aan twee strat-
egieën  te koppelen, de database op te schonen en SPSS echt heel goed onder de 
knie te krijgen was een uitdaging. Het feit dat we nu weer jonge nieuwe onder-
zoekers samen enthousiast kunnen maken vind ik heel erg leuk, en ik hoop dan 
ook nog vaak op C7 onder het genot van een goede espresso op bezoek te mogen 
komen.
Dear Jim, it was a good idea of you and Sicco to design a trial that tried to answer 
questions about growth restriction where the GRIT had stopped. You have been of 
unutterable help for the manuscripts of the trial by answering our questions, and 
“un-Dutching”  my writing style, and coming to the point.
Beste Eduard, geweldig dat onze muzikale band tot jouw aanwezigheid op mijn 
promotie heeft geleid. Fantastisch dat wij nog net voor jouw afscheid op je kunnen 
rekenen, heel bijzonder. 
Beste Frans, met jouw doortastende aanpak werden er 2 groepen vrouwen geran-
domiseerd en was de pilot van DIGITAT een feit. Het was de bougie voor alles wat 
volgde. Op het ochtendrapport had je het knap lastig bij opleider Roumen als je 
iemand vergat te includeren voor DIGITAT, begreep ik van een van jouw toenma-
lige assistenten.  Voor al die inclusies, de retrospectieve studies en je bijdrage aan 
alle artikelen dank ik je.
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Beste Denise, Corine en Sylvia. De CRF`s, de database, de verwerking van gegevens 
en informatieverwerking voor de website, de eerste praatjes met de research 
medewerkers, dat hebben we allemaal samen voor elkaar gekregen, het was een 
mooi avontuur. 
Alle research medewerksters van het Verloskundig Consortium, Maya, de andere 
onderzoekers en betrokken gynaecologen, heel veel dank voor de prettige samen-
werking en jullie inzet om de studie tot een succes te maken. In het bijzonder wil 
ik Clara en Marjolein bedanken. We lieten ons niet uit het veld slaan door de mat-
tenklopper, en Clara, al die vragenlijsten en telefoontjes en mailtjes om iedereen 
achter zijn broek aan te zitten zijn niet voor niets geweest. Veel dank.
Beste Linda, onze wekelijkse afspraakjes zijn heel vruchtbaar geweest. Zo ambi-
tieus en vlijtig als jij bent, dat gaat zeker beloond worden.
Lieve maatjes, dank voor jullie vertrouwen in mij, al tijdens mijn opleiding. Het is 
heel bijzonder dat jullie mij de mogelijkheid gaven om me in te kunnen zetten 
op wetenschappelijk gebied. Ik steek iedere ochtend met plezier de straat over 
naar het Bronovo. Robert, ik vind het nog steeds een eer dat ik mijn oude opleider 
mocht opvolgen en jij mij zulke bijzondere patiënten toevertrouwt. 
Lieve Hélène en Cas; eerst bazen, toen maten en nu paranimfen, dat is toch mooi!  
Lieve pa, grote beer, wij en jouw kleine beren hadden je er zo graag bij gehad, 
vandaag en nog heel veel jaren. Lieve (o)ma, dapper en zorgzaam. We zullen ook 
goed voor jou zorgen. 
Lieve Hans en Annelies, die koude kant is altijd heel erg warm, ben ik toch niet zo`n 
enig kind.
Lieve mam, dankzij jou ben ik er, en mede dankzij jou ben ik zoals ik nu ben, dank 
je en wees maar trots op jou en mij. 
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Liefste Jan Willem, tegen jou ja zeggen, is het beste wat ik ooit heb kunnen doen. 
Tim, Anne Jet en Hidde, van ons samen. En ik ga niet zeggen, zonder jou was dit 
proefschrift nooit gelukt, want dat was het wel, maar zonder jou wil ik het niet en 
daarom, alles is twee! 
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